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2Abstract
Articular cartilage repair of post-traumatic articular cartilage defects and well-defined 
articular cartilage pathology is challenging in clinical practice and has been the focus of 
investigations for many years. In the present thesis a newly developed polymer system, 
based  on  poly-ethyl-methacrylate  [PEMA]  polymer  and  tetra-hydro-furfuryl 
methacrylate  [THFMA]  monomer  has  been  exploited  for  the  repair  of  large,  full­
thickness  articular cartilage  defects,  created  in a weight-bearing  surface  in the  rabbit 
knee joint.  The method of implantation is  simple and easily reproducible  and can be 
performed in one stage with open arthrotomy or arthroscopy in clinical applications.
Intravenous  administration of the monomer did not elicit significant cardiorespiratory 
side effects. The repair tissue in defects treated with PEMA/THFMA was compared to 
control  defects  that  healed  ‘naturally’.  Macroscopic  and  histological/histochemical 
evaluation  using  the  newly  developed  Articular  Cartilage  Repair  Scoring  System, 
immunohistochemistry,  electron  microscopy,  image  analysis  as  well  as  biochemical 
analysis were used for the characterisation of the repair tissue. The results demonstrated 
that the PEMA/THFMA polymer enhanced significantly the quality of repair up to 1  year 
post-operatively.  The  repair tissue  contained numerous  chondrocytes  producing  large 
amounts  of proteoglycans  and collagen type  II,  and  it was  completely bonded to  the 
adjacent normal articular cartilage in the vast majority of the specimens.
The  enhancing  effect  of  PEMA/THFMA  in  articular  cartilage  defects  was  also 
demonstrated in three age  groups of rabbits  at 6  weeks,  thus  increasing the potential 
clinical applications of the polymer. Furthermore, PEMA/THFMA was compared to the 
conventional bone cement PMMA/MMA. At 6 weeks post-implantation PEMA/THFMA 
produced significantly superior repair tissue, compared to PMMA/MMA, confirming the 
importance of the properties of the new polymer. Finally, PEMA/THFMA was exploited 
as a potential drug delivery system in vivo by loading human growth hormone in the 
polymer. It was shown that the loaded polymer repaired the defects with a proliferative 
type of tissue, resembling immature articular cartilage.
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COMPOSITION OF ARTICULAR CARTILAGE
Articular cartilage varies in thickness, cell density, matrix composition, and mechanical 
properties within the same joint, amongst joints, and amongst species; however, in all 
synovial joints it consists of the same general structure and performs the same functions 
(Athanasiou et al 1991). On wet weight basis the water content may lie in the range of 65 
to 80%, collagen in the range of 15 to 25%, and proteoglycans in the range of 3 to 10% 
(Maroudas,  1979).  The cells contribute little to the volume of the tissue, about  1% in 
human articular cartilage (Buckwalter et al 1988).
Although  cells  and  matrix  are  structurally  separate,  they  are  functionally  very 
interdependent.  Chondrocyte  activity is  necessary  for the  synthesis  and  physiological 
degradation  of  matrix  components,  while  the  matrix  plays  an  important  part  in 
maintaining the homeostasis of the chondrocyte's environment (Mitchell and Shepard, 
1989). Despite its unimpressive appearance and low level of metabolic activity, detailed 
study of the morphology and biology of adult articular cartilage  shows that it has an 
elaborate, highly-ordered structure and that a variety of complex interactions between the 
chondrocytes  and  the  matrix  actively  maintain  the  tissue  (Buckwalter  and  Mankin, 
1997).
CHONDROCYTES
Cartilage first forms from undifferentiated mesenchymal cells that cluster together and 
synthesize cartilage collagens, proteoglycans, and non-collagenous proteins.  The tissue 
becomes  recognizable  as  cartilage  under  light  microscopy  when  an  accumulation  of 
matrix separates the cells and they assume a spherical shape (Buckwalter and Mankin, 
1997).  It was previously believed that chondrocytes in adult cartilage cannot undergo 
division;  however,  cell  division has been demonstrated  (Rothwell  and  Bentley,  1973, 
Bentley  1985).  The  internal  structure  of a  chondrocyte  is  typical  of cells  active  in 
producing and secreting proteins. Under the electron microscope they reveal prominent 
nucleoli,  and a basophilic cytoplasm with abundant rough endoplasmic reticulum and 
prominent Golgi apparatus.
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All of the major components of the matrix are synthesized and secreted by chondrocytes. 
The  same  cell  can  sythesize  the  precursors  of collagen  and  the  proteoglycans.  The 
chondrocytes also secrete metabolic enzymes which play a role in the slow turn-over of 
the matrix components.  Individual  chondrocytes  are  surprisingly active metabolically. 
They have a glycolytic rate per cell similar to that of cells in vascularized tissues but the 
total metabolic activity of the tissue is low because of the low cell density. To produce a 
tissue that can provide normal function of the synovial joint, the chondocytes must first 
synthesize  appropriate  types  and  amounts  of macromolecules  and then  assemble  and 
organize them into  a highly ordered framework.  Maintenance  of the  articular  surface 
requires  turnover  of  the  matrix  macromolecules  and  probably  alterations  in  the 
macromolecular  framework  of the  matrix  in  response  to  the  use  of  the  joint.  To 
accomplish these activities, chondrocytes must sense changes in the composition of the 
matrix as well as changes in the demands placed on the articular surface; the cells must 
then  respond  by  synthesizing  appropriate  types  and  amounts  of  macromolecules 
(Buckwalter and Mankin, 1997).
During skeletal growth the chondocytes produce new tissue to expand and remodel the 
articular surface.  The cells proliferate rapidly and synthesize large volumes of matrix. 
The  cell  density is  high  and  the  cells  reach their highest  level  of metabolic  activity 
(Buckwalter and Mankin, 1997). After completion of skeletal growth, most chondrocytes 
probably  never  divide  and  the  volume  of  the  cartilage  tissue  does  not  change 
substantially. The synthetic activity of the cells, however, continues suggesting ongoing 
internal remodeling of the macromolecular framework of the matrix. Enzymes produced 
by  chondrocytes  presumably  are  responsible  for  degradation  of  the  matrix 
macromolecules,  and  chondrocytes  probably  respond  to  the  presence  of fragmented 
matrix  molecules  by  increasing  their  synthetic  activity  to  replace  the  degraded 
components (Buckwalter, 1995). With aging, the capacity of the cells to synthesize some 
types of proteoglycans and their response to stimuli, including growth factors, decrease 
(Gueme et al  1995). Age-related changes may limit the ability of the chondrocytes to 
maintain the tissue and therefore contribute to the degeneration of the articular cartilage 
(Martin and Buckwalter, 1996).
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MATRIX 
Tissue fluid
Fluid contributes 60% to 80% of the wet weight of cartilage and consists of water with 
disolved  gases,  small  proteins  and  metabolites  (Maroudas  and  Schneiderman,  1987). 
Tissue  fluid  also  contains  a  high  concentration  of cations  to  balance  the  negatively 
charged proteoglycans.  This high water concentration is characteristic and determines 
the properties of the articular cartilage.  The water interacts with the  structural matrix 
molecules [particularly the large aggregating proteoglycans]  and it is loosely bound to 
them so to be able to maintain hydration of the cartilage and at the same time to allow 
exchange with fluids outside the tissue. The articular cartilage has no vascular supply 
and, therefore, the function of the chondrocytes depends entirely on the interaction of the 
tissue  fluid  and  the  matrix  macromolecules.  The  diffusion  properties  of the  articular 
cartilage do not change during skeletal maturation (Torzilli et al 1998).
Structural macromolecules
Structural  macromolecules  constitute  about  20-40%  of the  wet  weight  of the  tissue. 
Collagens contribute about 60% of the dry weight, of cartilage; proteoglycans 25-35%, 
and non-collagenous proteins and glycoproteins 15-20% (Buckwalter et al 1990).
Collagens
Articular cartilage contains mutliple genetically distinct collagen types, specifically types 
II, VI, IX, X, and XI (Eyre et al 1992). Types II, IX, and XI form the cross-banded fibrils 
seen with electron microscopy. The organisation of these fibrils into a tight meshwork 
that extends throughout the tissue provides the tensile stiffness and strength of articular 
cartilage and contributes to the cohesiveness of the tissue by mechanically entrapping the 
large proteoglycans (Sandell, 1995).
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The principle collagen is collagen type II4  which accounts for 90% to 95% of the total 
cartilage  collagen  (Buckwalter  et  al  1990)  and  forms  the  primary  component  of the 
cross-banded  fibrils.  Collagen  type  II  is  found  in  tissues  with  high  water  and 
proteoglycans content,  suggesting that this type of collagen has specific properties, to 
create and maintain a highly-hydrated matrix.
Type II collagen consists of 3 a (II)-chains. Each alpha chain forms a tight left-handed 
helix and  three helico-alpha chains wrapped around each other in a right-handed helix to 
form  a  tropocollagen  molecule  with  the  configuration  being  made  more  stable  by 
covalent  and  hydrogen  bonds  between the  polypeptide  molecules.  The  tropocollagen 
molecule  [molecular  weight  280,000-540,000]  is  300nm  long  and  1.4nm  thick.  The 
tropocollagen molecules then aggregate into microfibrils  [3.5nm thick]  which,  in turn, 
aggregate into collagen fibres. The collagen fibres are again stabilized by covalent and 
hydrogen  bonds.  The  precursor  molecule  [procollagen]  of  the  collagen  fibres  is 
synthesised  and  secreted  by the  chondrocytes,  but  fibrogenesis  occurs  extracellularly 
(Grant and Prockop, 1972, Eyre, 1980). The procollagen consists of 100 repeating amino 
acid triplets each with Glycine at the third position, the other two varying in type but 
often being the amino acids hydroxyproline and hydroxylysine -  substances rarely found 
outside collagen.
The functions and interrelationships of the quantitatively minor collagens remain unclear 
but the speculation is that they contribute to the formation and stability of the type II 
collagen fibril meshwork (Mayne and Irwin, 1986, Apone et al 1987). Type VI collagen 
appears  to  form  an  important  part  of  the  matrix  immediately  surrounding  the 
chondrocytes  and  to  help  chondrocytes  attach  to  the  matrix  (Hagiwara  et  al  1993, 
Marcellino  and  McDevitt,  1995).  Type  IX  collagen molecules  bind  covalently to  the 
superficial layers of the cross-banded fibrils and project into the matrix, where they also 
can bind covalently to other type IX collagen molecules. Type X collagen is present only 
near  the  cells  of  the  calcified  cartilage  zone  suggesting  that  it  has  a  role  in  the 
mineralization  of  the  cartilage  (Buckwalter  and  Mankin,  1997).  Type  XI  collagen 
molecules bind covalently to type II collagen molecules and probably form part of the 
interior  structure  of the  cross-banded  fibrils.  The  functions  of type  IX  and  type  XI 
collagens remain uncertain, but presumably they help to form and stabilize the collagen 
fibrils  assembled primarily  from type  II  collagen  The  projecting  portions  of type  IX
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collagen molecules may also help to bind together the collagen fibril meshwork and to 
connect the meshwork with proteoglycans (Bruckner et al 1988, Diab et al 1996).
Proteoglycans
Proteoglycans  form the major macromolecule of the cartilage matrix and exist mostly  in 
the  form  of proteoglycan  aggregates  (Carney  and  Muir,  1988).  They  have  multiple 
forms, including large aggregating proteoglycans, large non-aggregating proteoglycans 
and  small  non-aggregating  proteoglycans.  Large  aggregating  proteoglycan  monomers 
[aggrecans] fill most of the interfibrillar space of the cartilage matrix, contributing about 
90%  of  the  total  cartilage  matrix  proteoglycan  mass;  large  non-aggregating 
proteoglycans  contribute  10%  or  less;  and  small  non-aggregating  proteoglycans 
contribute about 3%, although because of their small size they may present in equal or 
higher  molar  amounts  (Hardingham  et al  1992,  Rosenberg,  1992,  Poole  et  al  1996). 
Proteoglycan  monomers are large hydrophilic molecules and consist of a protein core 
and  one  or  more  glycosaminoglycan  chains  [long  unbranched  polysaccharide  chains 
consisting  of  repeating  disaccharides  that  contain  an  amino  sugar].  Each  unit  of 
disaccharide  has  at least one negatively  charged  carboxylate  or  sulfate  group,  so  the 
glycosaminoglycans  form long  strings  of negative charges that repel  other negatively 
charged  molecules  and  attract  cations  (Roughley  and  Lee,  1994).  The  resultant high 
osmolality accounts for the retention of water in cartilage. Glycosaminoglycans found in 
cartilage  include  hyaluronic  acid,  chondroitin  sulfate,  keratan  sulfate,  and  dermatan 
sulfate.  The  concentrations  of  these  molecules  varies  among  sites  within  articular 
cartilage and also with age, injury to the cartilage, and disease (Hardingham et al 1992, 
Rosenberg,  1992).  Most  aggrecans  non-covalently  associate  with  hyaluronic  acid 
[hyaluronan]  and  link proteins  [small  non-collagenous proteins]  to  form proteoglycan 
aggregates. The proteoglycan-hyaluronide aggregates are very large  [molecular weight 
about  50  x  106].  Large  aggregates  may  have  more  than  300  associated  aggrecan 
molecules (Buckwalter et al  1994). Proteoglycan aggregates have a central backbone of 
hyaluronan.  Link proteins  stabilize the association between monomers  and hyaluronic 
acid and appear to have a role in directing the assembly of aggregates. The formation of 
aggregates  helps  to  anchor  proteoglycans  within  the  matrix,  preventing  their 
displacement during deformation of the tissue, and helps to  organize and stabilize the 
relationship between proteoglycans and the collagen meshwork (Tang et al 1996).
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Non-aggregating proteoglycans include decorin, biglycan, and fibromodulin. Decorin has 
one dermatan-sulfate chain, biglycan has two dermatan-sulfate chains, and fibromodulin 
has several keratan-sulfate chains (Roughley and Lee, 1994). The small non-aggregating 
proteoglycans have shorter protein cores than the aggrecan molecules and they do not fill 
large volume of the tissue and do not directly contribute to the mechanical behaviour of 
cartilage.  Instead,  they  bind  to  other  macromolecules  and  probably  influence  cell 
function. Fibronectin and albumin have also been detected in the surface of bovine and 
human articular cartilage (Noyori et al 1998). Decorin and fibromodulin bind with type 
II  collagen  and  may  have  a  role  in  organizing  and  stabilizing  the  type  II  collagen 
meshwork (Hedbom and Heinegard, 1993, Hedlund et al 1994). Biglycan is concentrated 
in the pericellular matrix and may interact with type VI collagen (Roughley and Lee,
1994).  The  small  proteoglycans  also can bind transforming  growth factor-p  and  may 
influence the activity of this cytokine in cartilage (Hildebrand et al 1994).
Non-collagenous proteins and glycoproteins
There  is  a  wide  variety  of these  molecules  within  normal  articular  cartilage.  They 
primarily  consist  of  protein  and  have  a  few  attached  monosaccharides  and 
oligosaccharides (Heinegard et al  1995). Anchorin CII, a collagen-binding chondrocyte 
surface protein, may help to anchor chondrocytes to the collagen fibrils of the matrix 
(Pfaffle  et  al  1990).  Cartilage  oligomeric  protein,  an  acidic  protein,  is  concentrated 
primarily within the territorial matrix of the chondrocyte and appears to be present only 
within  cartilage  and  to  have  the  capacity to  bind  chondrocytes  (Hedbom  at  al  1992, 
DiCesare et al  1994). This molecule may have value as a marker of cartilage turnover 
and  of the  progression  of cartilage  degeneration  in  patients  who  have  osteoarthrosis 
(Lohmander et al  1994,  Sharif et al  1995).  Fibronectin and tenascin,  non-collagenous 
matrix proteins found in a variety of tissues, also have been identified within cartilage. 
They may have roles in matrix organization, cell-matrix interactions, and the responses 
of the tissue in inflammatory arthritis and osteoarthrosis (Salter,  1993, Chevalier et al 
1994, Hayashi et al 1996, Savarese et al 1996).
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Chapter I
ZONES
Human articular cartilage varies  from  1mm to  7mm in thickness.  Morphological  and 
biochemical  examinations  demonstrated  four  layers  or  zones  proceeding  from  the 
articular surface to the subchondral bone. The differences among zones reflect transition 
from resistance to prominent shear force at the joint surface to more.compressive force 
deeper in the cartilage (Singh, 1994). Although the boundaries between the zones cannot 
be sharply defined, zonal organization has functional importance (Aydelotte et al 1992).
Zone I (superficial, tangential, gliding):  This thinnest zone consists of two layers, a 
sheet of fine fibrils with no  cells that covers the joint surface,  and a deeper layer of 
flattened ellipsoid chondrocytes arranged with their axes parallel to the articular surface. 
Chondrocytes in the superficial zone synthesize matrix with high collagen and low (the 
lowest of all zones) proteoglycan concentration (Aydelotte et al  1992).  The superficial 
zone has its abundant collagen fibrils arranged parallel to the articular surface to resist 
tensile and shear forces (Mow and Rosenwasser, 1988). Changes in this zone change the 
mechanical  behaviour  of  the  tissue  and  may  contribute  to  the  development  of 
osteoarthrosis. The densely packed collagen fibrils also act as a barrier to the passage of 
large molecules such as antibodies and other proteins, thus isolating, the cartilage from 
the  immune  system.  Disruption  of  this  zone  may  release  cartilage  molecules  that 
stimulate an immune or inflammatory response (Guilak et al 1994).
Zone II (intermediate, transitional, middle): This zone has several times the volume 
of the superficial zone. The chondrocytes are spheroidal with more synthetic organelles. 
They  synthesize  a  matrix  with  higher  concentration  of  proteoglycans  and  lower 
concentration  of  water  and  collagen  although  the  fibrils  are  of  larger  diameter 
(Buckwalter and Mankin,  1997). The collagen fibrils lie at oblique angles relative to the 
articular surface.
Zone III (deep, mediate, middle, radial):  In this zone spheroidal cells are aligned in 
columns perpendicular to the joint surface.  This  zone contains the largest in diameter 
collagen fibrils, the highest concentration of proteoglycans, and the lowest concentration 
of water. The collagen fibrils lie also perpendicular (radial) to the articular surface. The
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collagen fibres pass into the tidemark, a thin basophilic line seen on light microscopy 
sections. This is decalcified articular cartilage that roughly corresponds to the boundary 
between calcified and uncalcified cartilage.  One  study revealed a band  of fine  fibrils 
corresponding  to  the  tidemark  suggesting  that  it  represents  a  well  defined  matrix 
structure (Redler et al  1975). Oegema and Thompson (1995) believe that the tidemark 
represents  a high  watermark  for calcification.  Zones  II  and  III  form the  bulk  of the 
cartilage  thickness  and  provide  most  of the  resistance  to  static  compression  loading 
(Singh, 1994). Zones I, II and III merge imperceptibly while zones III and IV meet at the 
weakly basophilic tidemark (Oegema and Thompson, 1995).
Zone  IV  (calcified):  This  zone  lies  adjacent  to  the  subchondral  bone.  Most  of the 
collagen  fibres  are  arranged  perpendicular  to  the  subchondral  bone.  The  matrix  is 
impregnated with hydroxyapatite, bonding the cartilage to the irregular surface  of the 
subchondral  bone  (Buckwalter,  1983).  It has  few  chondrocytes  which  are  smaller  in 
volume  and  they  have  low  level  metabolic  activity  which  may  have  a  role  in  the 
development of osteoarthrosis (Oegema and Thompson, 1995).
REGIONS OF THE MATRIX
Variations in the matrix within zones allow the distinction of three regions (Buckwalter 
et all 990):
-the pericellular region surrounds the cell surface and is rich in proteoglycans. It has 
little type II non-fibrillar collagen fibres (Hagiwara et al 1993, Marcellino and McDevitt, 
1995) and it also contains the non-collagenous protein anchorin CII (Pfaffle et al 1990). 
-the territorial region surrounds cells or clusters of cells and their pericellular matrix. 
Nearer to the cell, thin collagen fibrils adhere to the pericellular matrix. At a distance 
from the cell, the collagen fibrils intersect and form a fibrillar basket around the cells 
which may provide protection for the chondrocytes during loading and deformation of 
the cartilage.
-the  interterritorial  region  makes  up  most  of the  volume  of the  mature  articular 
cartilage  and  contains  the  largest  diameter  collagen  fibrils  (Buckwalter  and  Mankin, 
1997).
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THE BENNINGHOFF MODEL
Damage to the collagen fibril network is likely to be one of the earliest signs of osteoarthrosis. 
The  local  stresses  and  strains  in  the  collagen  fibrils,  which  cause  the  damage,  cannot  be 
determined without taking the local arcade-like collagen-fibril structure into account (Wilson et 
al 2004). In the classic Benninghoff model of cartilage organisation, the tangential surface fibres 
are presented as an extension of radial fibres, which have arched in the transitional zone thus 
forming arcades of collagen extending from the bone to the cartilage  surface (Benninghoff, 
1925). While modem microscopy indicates that these do not exist as discrete collagen bundles, 
the collagen orientation carries out a similar function.  The more or less vertically oriented 
collagen fibres of the transitional zone and the radial zone below it are designed to resist the 
stress of load bearing (Lehman, 1973). Clark in 1985 found by scanning electron microscopy on 
adult  rabbit  articular  cartilage  that  the  fibrous  framework  was  found  to  be  similar to  that 
proposed by Benninghoff (Clark, 1985). The same author in 1990 traced fibres in both animal 
and human articular cartilage, which originated in the radial zone into the surface where they 
flattened and overlapped in a common direction (Clark, 1990). This study shows that the fibrous 
tangential zone is continuous to the fibres of the radial zone, similar to that described in the 
classic  Benninghoff model.  The  findings,  however,  differ  to  those  originally  reported  by 
Benninghoff in two ways:  the fibres do not interdigitate in the transitional zone but instead 
overlap as thin lamellae and also the fibrous lamellae on the surface are not anchored in the 
periosteum. De Bont et al in 1986 could not confirm by scanning electron microscopy the arcade 
model of Benninghoff concluding that the organization of collagen fibrils in hyaline cartilage 
shows a three-dimensional network of randomly oriented fibrils (De Bont et al, 1986). Hwang et 
al in 1992 using optical silver staining technique on 60 human cases concluded that in the normal 
articular cartilage,  the collagen fibrils  in the  superficial zones were compactly arranged  into 
layers of decussating flat ribbons mostly parallel to the artificial split lines. The fibrils showed a 
tendency to condense into vertical arcade columns under girded by tangential bundles  in the 
intermediate zone. In the deep zone, the fibrils formed a random meshwork (Hwang et al, 1992). 
A cryotechnical processing technique applied on adult human articular cartilage showed that the 
tendency of fibrils to form bundles is greater in deeper zones than in more superficial ones. A 
duality in the orientation of fibrils and fibril bundles is observed within interterritorial matrix 
compartment:  superimposed upon the well-characterised  arcade-like  structure  formed  by one 
subpopulation is another more randomly arranged one (Hunziker et al,  1997).  A more recent 
clinical study (Seidel and Grunder, 2005) using non-invasive magnetic resonance images detects 
early osteoarthritic changes in joints based on the changes of the arcade model of collagen fibres 
in the articular cartilage.
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Fig.I.3.a
Histochemical appearance of normal articular cartilage:
The chondrocytes in the superficial [s] zone are flattened, lying parallel to the articular 
surface,  while  the  chondrocytes  in  the  deep  [d]  zones  are  round,  lying  in  vertical 
columns. Proteoglycans are detected in all zones with higher concentration in the deeper 
zones [zonal differentiation]. (Safranin-0 staining, x 66)
Fig.I.3.b
Immunohistochemical appearance of normal articular cartilage:
Collagen type II is detected in the deep zone [cart]  and to a lesser extent the calcified 
zone below the tidemark [►]. The subchondral bone does not contain collagen type II 
and is stained negative. (Silver-enhanced colloidal gold immuno-staining, x 66)
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Fig.1.4
Ultrastructural appearance of normal articular cartilage:
Chondrocytes contain pronounced rough endoplasmic reticulum [er] and large nucleus 
[n]. Numerous cytoplasm processes [►] are extending into the extracellular matrix [mj. 
(Urany  I acetate and Reynold’ s lead citrate staining, x 6477, the bar equals 2pm)
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CHONDROCYTE -  MATRIX INTERACTIONS
Chondrocytes and matrix interact throughout life. Chondrocytes synthesize and degrade 
matrix macromolecules. The balance between these activities appears to be controlled by 
cytokines (which are synthesized and released by the cells) with catabolic and anabolic 
effects.  Interleukin-1   [IL-1]  induces  the  expression  of  matrix  metalloproteases  that 
degrade  matrix  macromolecules  and  interferes  with  the  synthesis  of  matrix 
proteoglycans. Insulin-like Growth Factor-I [IGF-1] and Transforming Growth Factor-p 
[TGF-p]  oppose  these  catabolic  activities  by  stimulating  matrix  synthesis  and  cell 
proliferation (Lotz et al 1995, Trippel, 1995).
The  matrix  also  transmits  signals  resulting  from  mechanical  loading  of the  articular 
surface to the chondrocytes. The chondrocytes respond to these signals by altering the 
matrix.  It  has  been  shown  that  persistent  abnormal  decrease  in  joint  loading  or 
immobilization of a joint decreases the concentration of proteoglycans and proteoglycan 
aggregates in articular cartilage and alters the mechanical properties. Resumption of the 
use  of the joints restores the composition and the mechanical properties  (Buckwalter,
1995). Maintenance of the normal composition of articular cartilage requires a minimum 
level of loading and motion of the joint. Repetitive loading and motion of the joint at 
greater than normal levels may increase the synthetic activity of chondrocytes, but the 
chondrocytes  have  limited,  if  any,  ability  to  expand  the  tissue  volume  in  adults 
(Buckwalter  and  Mow,  1992).  How  mechanical  loading  influences  the  function  of 
chondrocytes  is  not well  known but deformation of the  matrix  produces  mechanical, 
electrical  and  physicochemical  signals  that  may  stimulate  chondrocytes  (Gray,  1988, 
Grodzinsky, 1993, Lee and Bader, 1995)
BIOMECHANICAL PROPERTIES
Articular cartilage has two main functions: to distribute joint loads and reduce stresses, 
and to  allow movement between opposing surfaces with the minimum of friction and
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wear.  Articular  cartilage  does  not  exist  in  complete  anatomical  isolation  and  the 
properties of the synovial fluid and the functions of the synovial membrane are clearly 
important in cartilage homeostasis, as well as the mechanical effects of the subchondral 
bone (Mow et al 1989).
Articular  cartilage  is  a  viscoelastic  substance  that  is  biphasic.  The  fluid  phase  is 
composed  of water  with  disolved  inorganic  salts.  The  solid  phase  is  made  up  of an 
organic solid matrix, ie collagen and proteoglycans. The water concentration differs in 
the various layers of cartilage, being 80% at the surface and falling to 65% in the deep 
zone.  Seventy per cent of the water is intermolecular and is available to move when a 
load or pressure gradient is applied. Mature articular cartilage is also anisotropic. It has 
different mechanical properties depending on the direction it is loaded. This is due to the 
relationships of the collagen fibre arrangements, their cross-linking, and variations in the 
collagen-proteoglycan interactions (Mow et al 1989). The mixture of collagen fibrils and 
proteoglycan aggregates gives hyaline cartilage its unique physiological properties. The 
collagen  fibrils  provide  elements  of  high  tensile  strength,  while  the  proteoglycan 
aggregates exert an internal swelling pressure due to their hydrophilic character.
In situ,  in normal cartilage, the proteoglycan aggregates are compressed to  about one 
fifth of their potential volume and have a constant tendency to swell. They are protected 
from swelling to their maximum volume by their topographical entanglement within the 
fibrous  collagen meshwork and,  in turn,  the collagen fibres  and  fibrils  are  put under 
stretch, thereby increasing their tensile properties. Thus the biomechanical properties of 
cartilage  are  dependent  on  this  interaction  between  the  collagen  fibres  and  the 
proteoglycan  aggregates  (Broom,  1984).  If  a  constant  load  is  applied  to  articular 
cartilage, it will initially deform rapidly and then as the stress decreases, cartilage will 
show slow progressive increasing deformation, known as creep, until a steady state of 
deformation  is  reached,  known  as  stress  relaxation.  Both  creep  and  stress  relaxation 
occur through interstitial fluid movement and macromolecular movement. Compression 
tends  to  cause  movement  of  fluid,  whereas  shear  tends  to  cause  movement  of 
macromolecules.  Kerin  et  al  (1998)  have  shown  that  cartilage  strength  increased 
following  creep-induced  water  loss,  and  initial  mechanical  damage  could  propagate 
under  moderate  cyclic  loading.  The  structure  of the  collagen  of  articular  cartilage
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exhibits a zone-specific deformation that is dependent on the magnitude and type of load 
(K’a’ab et al 1998).
Articular  cartilage  is  porous  and  freely  permeable.  However,  under  high  loads  the 
movement  of  water  in  hindered  by  the  effect  of  the  frictional  drag  of  the 
macromolecules.  This  causes  a decrease  in the  flow and therefore  stiffens  the tissue, 
allowing greater resistance to the higher load. Tension alters the molecular structure of 
articular cartilage, the organization of collagen fibres, and the collagen fibre cross-links. 
They are, in effect, pulled apart. The tissue will become more swollen as permeability is 
increased and therefore fluid moves in leading to a decrease in the compressive stiffness 
(Mow et al 1989). The role of the stiffness of the collagen network in limiting hydration 
in  normal  cartilage  and  ensuring  a high proteoglycan  concentration  in the  matrix,  is 
essential for effective load-bearing and is lost in osteoarthritis (Basser et al 1998).
The  surface  of cartilage  is  believed not to be perfectly  smooth  but to  have  structure 
resembling that of a golf ball and it is thought that these pits play an importnant role in 
lubrication  (Bentley,  1987).  The  lubrication  system  of  the  articular  cartilage  is  a 
sophisticated  system  and  is  a  combination  of an  absorbed  lubricant  on  the  articular 
surface (boundary lubrication), and lubricant in a film between the articulating surfaces 
[fluid film lubrication].  The lubricant in boundary lubrication is  a glycoprotein called 
lubricin. Fluid film lubrication is thought to be elastohydrodynamic. The sliding action 
of the articular surfaces forms a film and the pressure generated deforms the cartilage to 
increase the bearing contact area which, in turn, decreases the ability of the film to be 
dissipated. It therefore allows high load-bearing. Under load, fluid is also forced out of 
the cartilage adding lubricant to the system during movement.  Under extreme loading 
conditions,  such  as  prolonged  standing  after  impact,  surface-to-surface  contact  may 
occur, but the surfaces are still protected by the layer of lubricin (Mow et al 1989).
NUTRITION
Articular  cartilage  is  a highly specialized tissue  and relatively isolated.  It has  neither 
blood,  lymphatic nor nerve  supply. Nutrients and waste products  are diffused through 
cartilage by movement of synovial fluid. The movement comes about by the changing 
loads and pressure gradients that occur during physiological activity.  In vivo  work on
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human femoral heads has suggested that the pumping effect is only important for large 
molecules, whereas small molecules such as oxygen and glucose can disolve freely even 
when cyclical loading occurs (O’Hara et al 1990).
Chondrocytes derive their nutrition from nutrients in the synovial fluid. To reach the cell, 
these nutrients must pass through a double diffusion barrier: the synovial tissue and fluid, 
and the cartilage matrix. The matrix is not only restrictive with respect to the size of the 
materials but also with respect to their charges and to other features such as molecular 
configuration. The nature of this system leaves chondrocytes with a low concentration of 
oxygen  relative  to  most  other tissues,  therefore,  they  depend  primarily  on  anaerobic 
metabolism (Fischer et al 1995).
DEGENERATION OF ARTICULAR CARTILAGE
AETIOLOGY
Isolated defects of articular cartilage and osteochondral defects that result from trauma 
often leave most of the articular surface intact (Levy et al 1996). Clinical experience has 
shown, however, that, when left untreated, chondral injuries fail to heal and that defects 
that involve a major portion of the articular surface may progress to symptomatic 
degeneration of the joint (Maletius and Messner, 1996, Messner and Gillquist, 1996).
Infectious as well as inflammatory diseases of the joints, some anti-inflammatory drugs, 
joint  immobilization,  surgical  intervention  to  the joints,  ligamentous  instability,  and, 
even, possibly, joint irrigation can stimulate degradation of proteoglycans  or suppress 
proteoglycan synthesis  (Reimann et al  1982, Donohue et al  1983, Reagan et al  1983, 
Brandt and Adams,  1989, Branstein et al  1990, Gradinger et al  1995).  Papain in large 
doses  causes diffuse superficial breakdown of the surface of the cartilage  via disruption 
of the organic matrix (Bentley,  1971).  Ovalbumin immunization and subsequent intra- 
articular  injection  simulate  the  effects  of rheumatoid  arthritis  (Pettipher  et  al  1989). 
Inborn errors of collagen metabolism have a direct effect on the organic matrix (Hull and 
Pope,  1982).  Hemarthrosis  and  septic  arthritis  produce  free  radicals  that  also  have 
destructive effects (Blake et al 1989).
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AGE-RELATED CHANGES
Superficial  fibrillation of articular cartilage  occurs  in many joints  in association with 
increasing age and does not appear to cause symptoms or to affect the function of the 
joint  adversely.  Age-related,  non-progressive,  superficial  fibrillation  of cartilage  and 
focal lesions of the articular surface must be distinguished from degeneration of articular 
cartilage occuring as part of the syndrome of osteoarthrosis (Mankin and Buckwalter, 
1996).
Chondrocyte  apoptosis  plays  a  role  in  some  aspect  of maintenance,  remodeling,  or 
turnover of mature articular cartilage. The increase in apoptosis associated with aging 
could contribute to the greater risk of cartilage degeneration (Adams and Horton,  1998). 
Chondrocyte apoptosis and proteoglycan depletion are anatomically linked and may be 
mechanistically related (Hashimoto et al 1998).
CARTILAGE BREAKDOWN
The  key  to  cartilage  destruction  is  degradation  of the  collagen-proteoglycan  matrix 
(Mow  et  al  1989).  Collagen-proteoglycan  matrix  disruption  can  occur  either  at  a 
mechanical level, eg by high stress from joint incongruity or ligament rupture, or at a 
biochemical  level,  eg  by  disordered  collagen  metabolism,  or  proteolytic  enzyme 
degradation.  Traumatic  effects  will  initially  cause  localized  injury,  whereas  at  a 
biochemical level articular cartilage damage is likely to be diffuse.
Mechanical aspects
Wear is the removal of material from solid surfaces by mechanical action (Mow et al
1989). It can be interfacial, due to the action of the bearing surfaces, or fatigue, due to 
bearing  deformation under load.  The macroscopic  effects  of cartilage  breakdown can 
cause vertical splits which may penetrate through the whole depth of the cartilage. The 
critical  point  is  that  once  the  collagen-proteoglycan  matrix  is  disrupted,  the  rate  of 
interfacial  and  fatigue  wear  will  accelerate.  Fissure  formation  and  propagation  is  a 
significant element of cartilage degeneration (Chin-Purcell and Lewis,  1996). Splits and
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cracks observed in diseased cartilage may be initiated, or propagated, by tensile stress 
(Kelly and O’Connor, 1996). A resultant swelling of the cartilage is due to distension of 
the proteoglycan  aggregates;  further damage  causes  stress  fractures  of more  collagen 
fibrils and proteoglycan and collagen escape (Roberts et al 1986).
Biochemical aspects
There are two cells directly involved in cartilage breakdown, the synoviocyte and the 
chondrocyte. Early synoviocyte-initiated damage will cause diffuse superficial cartilage 
destruction, whereas  early chondrocyte-initiated damage  can be  local  and involve the 
deeper  layers,  as  would  be  expected  after trauma,  or  more  diffuse,  if production  of 
abnormal collagen is involved. Once the stage of collagen-proteoglycan disruption has 
occured to any significant extent, then the destructive processes on the cartilage will be 
both  mechanical  and  biochemical.  Disintegrating  cartilage  fragments  have  a  strong 
inflammatory effect on  synovium,  and areas  of abnormal  cartilage  will  be  subject to 
adverse mechanical  loading. A cycle of progressive destruction is then in place, as is 
typically observed in osteoarthritis (Donnell, 1994).
Both  the  chondrocytes  and the  synoviocytes  produce  the  pro-inflammatory  cytokines 
Tumour Necrosis Factor-a [TNF-a] and Interleukin-1   [IL-1] which in turn cause these 
cells to  synthesize  enzymes  [proteinases]  which degrade proteoglycans  and collagens. 
The source of these proteinases is dependent upon the type of disease. In osteoarthritis, 
the  chondrocytes  are the most probable  source,  whilst in highly inflamed rheumatoid 
joints, synovial fibroblasts and macrophages as well as the chondrocytes play a role in 
tissue destruction (Cawston and Rowan, 1998).
There are four main classes of proteinases and they are named according to the chemical 
group  involved  in  catalysis.  The  aspartate  proteinase  [cathepsins  D]  and the  cysteine 
proteinases  [cathepsins  B,H,K,L,S]  act  at  low  pH  and  are  thought  to  act  within  the 
lysosomal  system  where  they  degrade  proteins  intracellularly.  Secreted  serine 
proteinases  [elastase,  cathepsin  G,  plasmin,  plasminogen  activator]  and 
metalloproteinases  [collagenases,  stromelysins,  gelatinases,  membrane-bound  MMPs] 
act extracellularly at neutral pH (Barrett, 1997).
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Cathepsins  have  a  direct  action  on  proteoglycan  breakdown  (Bentley  et  al  1981). 
Cathepsins B,H and L are present in elevated levels in antigen-induced arthritis whilst 
cathepsin B and cathepsin D are raised in osteoarthritic tissues (Everts et al 1996).
The metalloproteases have direct effects on the collagen-proteoglycan matrix causing it 
to breakdown (Pelletier and Martel-Pelletier,  1989). Matrix metalloproteinases [MMPs] 
can collectively degrade all the components of the extracellular matrix. They all contain 
a zinc atom [Zn2+] at their catalytic centre and are all synthesised as inactive proenzymes 
which require activation before thay can degrade matrix.  Activation of pro-MMPs  by 
removal of the propeptide that maintains MMPs in inactive form is an important control 
point in tissue turnover (Vincenti et al  1994).  Plasmin activity as well as other serine 
proteinases may activate pro-MMPs (Nagase and Woessner, 1993).
All  connective  tissues  contain  endogenous  Tissue  Inhibitors  of  Metalloproteinases 
[TIMPs  1-4]  which  bind  tightly  to  active  MMPs.  This  family  of small  polypeptide 
inhibitors  plays  an  important role  in controlling tissue  breakdown by blocking  MMP 
activity (Cawston, 1996).
TNF-a and IL-1  also stimulate the chondrocytes to produce interleukin 6  [IL-6] which 
may have an inhibitory effect on metalloprotease synthesis (Shinmei et al 1990).  TNF-a 
also stimulates synoviocytes to synthesize prostaglandins, in particular prostaglandin E2 
[PGE2]. This causes plasma to be extravasated into the synovium leading to synovitis, 
but inhibits lymphocyte proliferation.  PGE2 also has an inhibitory effect on IL-1  thus 
reducing  its  effect  on  metalloprotease  production  and  cartilage  matrix  breakdown 
(Bunning  and  Russell,  1989).  TNF-a  is  inhibited  by  y-interferon  [y-IFN]  which  is 
produced by T lymphocytes in response to IL-2. The latter is found in large quantities in 
rheumatoid arthritis (Pettipher et al 1989, Vignon et al 1990).
JOINT USE
Chondrocytes  adapt  to  the  unloaded  condition  by  decreasing  proteoglycan  synthesis 
(Jurvelin et al  1989). Cyclical loading of cartilage stimulates matrix .synthesis, whereas
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prolonged static loading or the absence of loading and motion causes degradation of the 
matrix  and,  eventually,  degeneration  of the joint  (Buckwalter,  1995).  Moderate  and 
possibly even strenuous regular activity does not cause degeneration in normal joints. 
Repetitive intense joint loading may lead to an early onset of degeneration. Participation 
in sports or other activities that repetitively expose joints to high levels  of impact or 
torsional  loading  may increase  the  probability of joint degeneration  (Buckwalter  and 
Lane,  1996).  Newton  et  al  (1997)  showed  that  a  lifetime  of regular  weight-bearing 
exercise  in  dogs  with  normal  joints  did  not  cause  alterations  in  the  structure  and 
mechanical properties of articular cartilage that might lead to degeneration. Ottemess et 
al  (1998)  concluded  that  a  sedentary  lifestyle  in  the  hamster  leads  to  a  lower 
proteoglycan content in the cartilage and a lower synovial fluid volume, associated with 
cartilage fibrillation, pitting and Assuring.
OSTEOARTHRITIS 
CLINICAL SYNDROME
The degeneration, or the progressive loss of normal structure and function of articular 
cartilage is an integral part of the clinical syndrome of osteoarthrosis, also referred to as 
degenerative joint  disease,  degenerative  osteoarthritis,  osteoarthritis,  and  hypertrophic 
osteoarthritis.  The  diagnosis  of osteoarthrosis  requires  the presence  of symptoms  and 
signs  that  may  include joint  pain,  restriction  of motion,  crepitus  with  motion, joint 
effusions,  and  deformity.  The  progressive  breakdown  of cartilage  and  the  manifest 
clinical  features  distinguish  osteoarthritis  from  age-related  changes.  Evidence  of 
synovitis is frequently present, but inflammation is not a major component (Buckwalter 
andMankin, 1997).
EPIDEMIOLOGY
Osteoarthrosis  occurs  most  commonly  in  the  foot,  knee,  hip,  spine,  and  hand joints. 
Thirty-nine million men and 115 million women is one estimate of the number of people 
world-wide  with  knee  osteoarthritis  alone.  No  country  studied  so  far  is  free  of the
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problem, and the prevalence in China is as high as it is in Iceland, America or the Middle 
East (Murray and Lopez,  1996). Radiographically based studies suggest that, at the age 
of 70 years, the prevalence of moderate and severe osteoarthritis of the finger joints rises 
to 70% among women and 50% among men, that of the knees affects 30% of women and 
50%  of men,  and  that  of the  hips  13%  of women  and  10%  of men.  Reported  pain 
correlates best with radiographic grade and severity at the hip, and then at the knee, with 
less  than  40%  of people  with  severe  radiographic  hand  osteoarthritis  reporting  pain 
(Erhardt,  1995).  Osteoarthritis  is  the  indication  for  21,000  hip  and  7,000  knee 
arthroplasties  annually  in  the  United  Kingdom  (Wynne,  1998).  The  proportion  of 
subjects over 50 years in the general population who report knee pain and disability of 
sufficient severity to justify early knee joint replacement is about 2%, twice as common 
in women compared with men (Tennant et al 1995).
GENETICS
Recent studies have shown significant familial clustering for hand and knee osteoarthritis 
(Hirsch et al  1998, Felson et al  1998). A greater association in radiological features of 
hand  and knee  osteoarthritis  has  also  been  shown  amongst monozygotic  twins  when 
compared with dizygotic twins, confirming a genetic influence at these sites (Spector et 
al 1996).
Osteoarthritis has been linked to the COL2A1 gene on chromosome 12 encoding type II 
procollagen (Vikkula et al  1993). Some reports have suggested linkage to chromosome 
2q.  Potential  candidate  genes  mapping to  this  region include  fibronectin,  the  alpha-2 
chain  of collagen  type  V,  and  the  interleukin-8  receptor  (Wright  et  al  1996).  Some 
research  has  also  shown  that  candidate  genes  associated  with  osteoarthritis  are  the 
vitamin D receptor gene (Keen et al 1997), the oestrogen receptor gene (Ushiyama et al 
1998) and the Insulin-like growth factor 1 gene (Meulenbelt et al 1998).
The immediate clinical relevance of these findings is that they identify family history as 
a major risk factor for osteoarthritis. Studies of family aggregation, however, show that 
there is considerable variation in the distribution of joint involvement in those at equal 
risk. This suggests that the action of biomechanical or other local environmental factors
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on predisposed joints determine the rate of development of disease (Felson and Zhang, 
1998).
AETIOLOGY
Osteoarthrosis develops most commonly in the absence of a known cause (primary or 
idiopathic osteoarthrosis). It can also develop as a result of joint injury, infection, or one 
of  a  variety  of  hereditary,  developmental,  metabolic,  and  neurological  disorders 
(secondary osteoarthrosis).  The  age  of onset associated with secondary osteoarthrosis 
depends on the underlying cause; thus, it may develop in young adults and even children 
as well as the elderly. In contrast, there is a strong association between the prevalence of 
primary osteoarthrosis and increasing age (Peyron, 1988).
PATHOGENESIS
Osteoarthritis  is  initiated  by  multiple  factors.  Protein-kinase  C,  gas  mediators 
[superoxide anion and nitric oxide] and proteinases are all involved (Tanaka et al 1998). 
Nitric oxide is a highly reactive, cytotoxic free radical that has been implicated in tissue 
injury  in  a  variety  of diseases.  Cartilage  obtained  from  patients  with  osteoarthritis 
produces  significant  amounts  of  nitric  oxide  ex  vivo.  In  vitro,  nitric  oxide  exerts 
detrimental  effects on chondrocyte functions,  including the  inhibition of collagen and 
proteoglycan synthesis, and enhances apoptosis (Amin and Abramson, 1998).
The primary changes consist of loss of articular cartilage, remodelling of subchondral 
bone,  and  formation  of  osteophytes  (Schiller,  1995).  It  has  been  suggested  that 
osteoarthritis may be secondary to stress fracture of the collagen fibrils (Kempson et al 
1968). Loss of the larger aggregates appears to be one of the earliest changes associated 
with osteoarthrosis and immobilization of the joint. Increasing age is also associated with 
loss  of  large  aggregates  from  articular  cartilage  (Buckwalter  et  al  1994).  Early 
osteoarthritis  is  characterized  by  fibrillation  of  the  superficial  surface,  loss  of 
proteoglycans  and  collagen,  and  increase  in  water  content.  The  basal  calcified  layer 
expands, and thickening of the subchondral bone occurs. It has been suggested that the
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zone of calcified cartilage may be reactivated in osteoarthritis  and may progressively 
calcify the unmineralized cartilage (Oegema et al 1997).
The  arthritic  joints  become  hypervascularized  but  the  venous  outflow  is  delayed, 
resulting in a rise in the intraosseous pressure. Cartilaginous debris in the synovial fluid 
may lead to inflammation and subsequent fibrosis of the synovial membrane and joint 
capsule. Osteophyte formation involves de novo regeneration of fibrocartilage from the 
tissues  at  the  transitional  zone  at  the  margin  of the  joint  surface.  As  the  disease 
progresses, the surface irregularities become clefts, more of the articular surface becomes 
roughened  and  irregular,  and  the  fibrillation  extends  deeper  into  the  cartilage  until 
fissures reach subchondral bone. As the cartilage fissures grow deeper, the superfical tips 
of  the  fibrillated  cartilage  tear,  releasing  free  fragments  into  the  joint  space  and 
decreasing the thickness of the cartilage. At the same time, enzymatic degradation of the 
matrix further decreases the volume of the cartilage. Eventually the progressive loss of 
articular cartilage leaves only dense and often necrotic ebumated bone (Buckwalter and 
Mankin, 1997).
IMAGING
Plain radiographs are the simplest and most widely use method of joint evaluation and 
monitoring of the disease. The Altman and the members of the American Rheumatism 
Association Subcommittee on Classification of Osteoarthritis system based on clinical 
and radiographic criteria (Altman et al  1986, Altman et al  1991)  are most commonly 
adapted. The presence of osteophytes seems to best differentiate osteoarthritis (Menkes,
1991)  although part of the osteophyte is ossific and radiopaque, but part is cartilaginous 
and not visible on x-ray films (Bentley, 1985, Bentley, 1987). Other methods of imaging 
such as nuclear scans, arthrography and computed tomography are of limited use because 
they are unable to detect early cartilage abnormalities (Blackburn et al  1996). Magnetic 
resonance imaging [MRI] has the advantages of multiplanar imaging, soft tissue contrast, 
and  non-invasiveness.  Like  radiography,  it  can  underestimate  the  extent  of cartilage 
abnormality.  The  most  sensitive  technique  for  measuring  superficial  articular 
abnormalities  is  arthroscopy  of the joint  (Blackburn  et  al  1996).  Wada  et  al  (1998) 
reported  a  high  correlation  of  medial  compartment  knee  osteoarthrits  between
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radiography and arthoscopic findings and a poor correlation of lateral compartment knee 
osteoarthritis.
TREATMENT 
Analgesics and NSAIDs
Simple  analgesics  and  non-steroidal  anti-inflammatory  drugs  [NSAIDs]  are  the  most 
commonly  used  agents  for  the  relief of the  symjptoms.  Paracetamol  is  the  preferred 
analgesic for long-term use because of its minimal side effects. Aspirin inhibits cathepsin 
production  from  chondrocyte  lysosomes.  A  beneficial  effect  of  aspirin  on  induced 
superficial lacerations has been shown (Ginsberg et al  1968). No effect, however, was 
noted with the  use  of aspirin in patients  with  chondromalacia patellae  (Bentley  et al 
1981).  NSAIDS  inhibit  cyclo-oxygenase  production  which  converts  arachidonic  acid 
into  prostaglandins.  This  therefore  reduces  both  the  pain  and  swelling  of  synovial 
inflammation. Unfortunately, it also suppresses the inhibitory effect of prostaglandin on 
IL1  and so it accelerates cartilage breakdown  (Pettipher et al  1989, Vignon et al 1990). 
Corticosteroids and some NSAIDs have also been found to decrease glycosaminoglycan 
synthesis  (Dingle, 1996).
Chondroprotective agents
Glucosamine-sulphate given exogenously has been shown to have stimulatory effects on 
chondrocytes and synoviocytes in vivo  (Jimenez and Dodge,  1996, Helio et al  1996). 
High  grade  chondroitin-sulphate  has  been  shown  to  have  clinical  and  anti-catabolic 
effects, including the competitive inhibition of metalloproteinases and down-regulation 
of interleukin-1   (Verbruggen et al  1998, Busci and Poor,  1998).  Because glucosamine 
and chondroitin-sulphate have different but complementary mechanisms of action, using 
these  two  compounds  together  produces  a  synergistic  response  in  articular  cartilage 
(Hungerford, 1998).
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Bracing
The use of braces  specifically designed for osteoarthritis  sufferers  can be effective in 
taking the load off the affected compartment of the joint. During gait, the knee joint is 
subjected to  a varus moment,  which shifts the joint load to the  medial  compartment. 
Higher loads intensify pain and may contribute to degenerative changes. Valgus bracing 
applies valgus correction to the knee and reduces medial compartment load (Horlick and 
Loomer, 1993).
Pulsed electromagnetic fields
Pulsed  Electromagnetic  Fields  (PEMF)  have  been  used  widely  to  treat  non-healing 
fractures. In cartilage, PEMF produce an electromagnetic phenomenon which stimulates 
the synthesis of the matrix components fromi the chondrocyte (Trock,  1994). No useful 
clinical affect has been demonstrated as yet.
Intra-articular steroids
The  use  of  intra-articular  steroids  is  strongly  contested  in  the  literature. 
Chondroprotection by corticosteroids has been  indicated  (Williams  and Brandt,  1985, 
Pelletier et al  1987).  Others have argued against their use in humans because of direct 
and side effects (Salter et al  1964, Behrens et al  1975). Low-dose long-acting steroids 
intra-articularly seem to overcome the adverse reactions. They are thought to act directly 
on  the  chondrocyte  and  inhibit  metalloprotease  production  (Pelletier  and  Martel- 
Pelletier,  1989, Pelletier et al  1995).  Papachristou et al (1997),  however,  showed that 
intra-articular  injections  of  hydrocortisone  alters  the  shape  of  articular  cartilage 
chondrocytes, producing abnormal changes in the cytoplasm and nucleus, leading to cell 
degeneration.
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Viscosupplementation
Treatment  with  viscosupplementation  consists  of  intra-articular  injections  of 
elastoviscous solutions of hyaluronan to augment the elastoviscosity of the synovial fluid 
and the matrix of the cartilage. The injected elastoviscous solution, however, has only a 
short residence time in the joint, therefore the injection should be repeated (Scale et al 
1994, Lussier et al  1996). Randomised controlled clinical trials are required to validate 
the efficacy of this method of treatment.
Surgical treatments
These  include  arthroscopic  techniques  of debridement  and  bone  marrow  stimulation, 
corrective osteotomies and resurfacing of the diseased  cartilage  in the early stages of 
osteoarthritis.  These  methods  are  described  in  the  section  on the  Repair  of Articular 
Cartilage  later  on  in  this  chapter.  The  end-stage  treatment  of an  osteoarthritic joint 
remains its replacement with artificial joint components either partially or totally.
o
Gene therapy
The future prospect of identifying disease susceptibility genes that explain a significant 
part of the genetic component of osteoarthritis will make possible primary prevention of 
the disease (Evans and Robbins, 1995). The identification of disease genes also leads to 
identifying pathogenetic pathways, finding targets for new drug therapies. Gene therapy 
directed  at  replacing  defective  gene  products  will  become  the  future  approach  to 
treatment of osteoarthritis, known as disease modification.
With regard to the repair of the damaged articular cartilage, gene therapy and work with 
growth factors and cytokines and genetically modified chondrocytes all offer the promise 
of regenerating cartilage (Bandara et al  1992, Pelletier et al  1997, Doherty et al  1998). 
The possible uses of gene therapy range from the simple delivery of an inhibitor of a 
cartilage-destructive enzyme, to the very complex production of a range of factors that 
reproduce fetal development signals (Gerich et al 1996, Gerich et al 1997).
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INJURIES OF ARTICULAR CARTILAGE 
INJURY TYPES
Acute injuries to articular cartilage can be caused by blunt trauma, penetration, friction 
abrasion, or sharp concentration of weight-bearing forces. Acute chondral lesions of the 
knee have been divided into two groups: osteochondral fractures and chondral fractures / 
separations without bone involvement (Urrea and Silliman, 1995).
Osteochondral fractures
Osteochondral  fractures  in  the  knee  are  generally  restricted  to  the  medial  femoral 
condyle,  lateral  femoral  condyle,  and  patella.  Rarely  do  lesions  occur  on  the  tibial 
articular surface. Osteochondral fractures are caused by impaction or avulsion and can be 
produced by direct blow, by twisting shearing forces on a nearly fully extended knee, 
and  by  subluxation  or  dislocation  of the  patella  (Johnson-Nurse  and  Dandy,  1985). 
Because of the mechanism of injury, these lesions are often associated with soft tissue 
injuries  including  anterior  cruciate  ligament  tears,  meniscal  tears,  and  parapatellar 
ligament tears (Terry and Flandry, 1988, Butler and Andrews, 1988).
Osteochondral fractures tend to occur mainly in adolescents (Bradley and Dandy, 1989). 
In this  younger age group, the tidemark has  not yet developed.  The hyaline  articular 
cartilage has firm attachment to subchondral bone through directly connecting collagen 
fibres. The shearing forces are transmitted deep to the osteochondral junction,  and the 
fracture line passes through the relatively weaker subchondral cancellous bone (Bauer 
and Jackson, 1988).
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Chondral fractures / separations
These were first described by O'Donoghue in 1966. Usually there is a history of blunt 
trauma, twisting, shearing weight-bearing type of injury, impaction or direct blow on a 
flexed or extended knee (Terry and Flandry, 1988).
Chondral fracture tend to occur in skeletally mature individuals. The fracture line occurs 
at  the  tidemark  (Bradley  and  Dandy,  1989).  The  tidemark  represents  a  weak  zone 
between calcified and uncalcified tissue marking the junction of two biomechanically 
dissimilar materials.  This junction  provides  a cleavage  plane  where  shear  stress  can 
produce a purely cartilaginous fracture leaving the subchondral plate undisturbed.
DIAGNOSIS OF ARTICULAR CARTILAGE DEFECTS 
Clinical
Patients with osteochondral fractures will experience sudden pain aggravated by weight­
bearing. Usually there is swelling. The symptoms often mimic tom meniscus, the knee 
may lack full extension and may be locked. The involved femoral condyle may be tender 
to  palpation.  Patellar  stability  assessment  and  tenderness  of  the  medial  patellar 
retinaculum fibres may indicate lateral patella dislocation (Johnson-Nurse and Dandy, 
1985).  Hemarthrosis with fat globules  seen on aspiration  is  of significant importance 
(Sanberg and Balkfors, 1986, Butler and Andrews, 1988).
In  chondral  fractures  /  separations  pain  and  swelling  are  common.  Isolated  chondral 
fractures may mimic torn menisci with mechanical symptoms of locking, catching and 
giving way and joint line tenderness  (Terry and Flandry,  1988).  Hemarthrosis  is rare 
because  the  subchondral  plate  is  not  penetrated.  A  bloody  effusion  means  that  an 
associated injury has been sustained (De Haven, 1980, Butler and Andrews, 1988).
Although  the  cartilage  itself  has  no  nerve  ends,  the  subchondral  bone  is  often 
compromised,  resulting  in  pain.  Partial-thickness  defects  allow  more  pressure  to  the 
subchondral  bone  when the  weight load passes through the  defect area.  This  is more
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pronounced  during  athletic  activities  when  increased  stress  is  applied  to  the  joint 
surfaces. In these cases the pain is intermittent and often relieved by rest. Full-thickness 
defects, however, where the subchondral bone is directly affected, present with more or 
less continuous pain. Differential diagnosis from a meniscal injury is often necessary. 
During clinical examination, a knee with a damaged meniscus is tender at the joint line 
level. A knee with an articular cartilage defect in the femoral condyle is tender above the 
joint line level. Often there is a false positive McMurray's test. Anterior knee pain with 
positive  patello-femoral  grinding  test  are  also  common  when  the defect  lies  on  the 
articular surface of the patella.
Imaging
Various  imaging methods have been applied for the assessment of articular cartilage. 
These  include  standard  radiography,  arthrography,  computerized  tomography,  CT 
arthrography,  ultrasonography,  and magnetic resonance  imaging (Hodler and Resnick, 
1996).  Plain radiographs  of the  injured  knee  may not show the  loose  or undisplaced 
cartilaginous  fragment.  It  is  important  to  obtain  multiple  views  including  antero­
posterior,  lateral,  right  and  left obliques,  tunnel,  and patellar  views  (Mathewson  and 
Dandy,  1978).  Castriota-Scanderbeg  et  al  (1996)  described  that  sonographic 
measurement of articular cartilage is precise enough to be used in clinical practice. MRI 
is  a promising  tool  of investigation  for the  articular cartilage.  Its  modalities  are  still 
imprecise and debated, but, because of its non-invasiveness, it is destined to be preferred 
over arthro-CT (Drape et al 1998). Specialized magnetic resonance imaging techniques 
such as fast-spin-echo  MR imaging  (Potter et al  1998),  magnetic resonance  chondro- 
crassometry  (Eckstein  et  al  1996),  three-dimensional  computerized  representations 
(Marshall et al 1995, Lavid et al 1996, Tebben et al 1997) as well as magnetic resonance 
microscopy (Goodwin et al 1998, Cova et al 1998) provide more accurate assessment of 
lesions of articular cartilage.
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Arthroscopy / Classification systems
Arthroscopy is the best procedure to establish the diagnosis and also to determine the 
extent and depth of lesion. (De Haven, 1980, Hopkinson et al 1985, Dzioba, 1988). This 
is reflected in the development of a number of classification systems that define the 
lesions arthroscopically:
O uterbridge, 1 9 6 1 grade I: softening and sw elling
grade II: partial thickness, early fissuring
grade III: full thickness, fissuring to subchondral bone
grade IV : subchondral bone exposed
Insall et al 1 9 7 6 grade I: softening and sw elling 
grade II: deep fissures to subchondral bone 
grade ID : fibrillation - ‘crab m eat’ 
grade IV : thinning, course granular appearance, 
exposure of subchondral bo n e
B entley and D ow d, 1 9 8 4 grade I: fibrillation or fissuring, < 0 .5 cm  
grade II: fibrillation or fissuring, 0 .5  - 1 cm  
grade III: fibrillation or fissuring, 1 - 2cm  
grade IV : fibrillation or fissuring, > 2cm
B auer and Jackson, 1 9 8 8 A cute traum atic 
type I: linear crack 
type II: stellar fracture 
type III: flap  
type IV : crater 
D eg en erativ e
type V : fibrillation 
type V I: degrading
D zioba, 1 9 8 8 age of lesion: acu te, subacute, ch ro n ic
diam eter: sm all (< lcm ), m ed iu m  (l-3cm ), large (> 3cm )
depth: superficial, partial, co m p lete
cartilage defect localization: w eightbearing zone, fem ur, condyle,
su b m eniscal, tibial, intercondylar region, 
non-w eight-bearing zone
N ojes and Stabler, 1 9 8 9 grade I: cartilage surface intact 
grade IA : softening, < 1 0 m m  
grade IB : softening (deform ation), > 15m m  
grade II: cracks, fissuring, fibrillation, fragm entation 
grade IIA : < 1 /2  thickness 
grade IIB : > 1/2 thickness 
grade III: bone ex posed
grade IIIA : bone surface intact 
grade IIIB : bone surface excavation
A number of systems have been described in the recent years which take into account 
more  variables  (Koshino  and  Machida,  1993,  Lewandrowski  et  al  1996)  and  also 
statistical  analysis  as in the  SFA  [Societe Francaise d’Arthroscopie]  Score (Dougados 
andAyral, 1994).
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REPAIR OF ARTICULAR CARTILAGE 
THE ‘NATURAL’ REPAIR
The  type  of cartilage  injury,  including  its  depth  and  size  and  whether  it  is  acute  or 
chronic,  distinctly affects  the healing process  (Suh et  al  1995).  Acute  injuries  to  the 
articular cartilage have been biologically distinguished into two types: the injuries with 
loss of matrix macromolecules without mechanical damage to cells or the collagen fibril 
meshwork and the lesions with mechanical disruption of cells and matrix (Buckwalter et 
al 1988).
In partial-thickness injury, because cartilage is avascular, it is up to the chondrocytes to 
mount the entire healing process. Cells near the defect are able to increase their synthesis 
of matrix elements.  Chondrocyte multiplication and cell proliferation which can form 
abnormal multicellular clusters of chondrocytes was shown by Meachim in  1963. The 
increased metabolic activity has been also shown through autoradiographic studies using 
tritiated thimidine (Rothwell and Bentley,  1973) and also during ultrastructural studies 
(Ghadially,  1977). A non-osseous cartilage formation has also been described deriving 
from juxta-articular or  synovial  tissue  that  applies  to  the  defects  at the joint  margin 
(Stockwell  and  Meachim  1979).  The  dense  extracellular  matrix,  however,  keeps  the 
newly synthesized macromolecules from reaching the defect area and the healing of the 
defect cannot be completed (Buckwalter et al  1988).  Partial-thickness injuries healing 
depends  on  the  size  of the  lesion,  its  location  within  the joint  and  the  age  of the 
individual.  Generally,  however,  partial-thickness  injuries  do  not  heal,  although  they 
seldom progress (Suh et al 1995).
Full-thickness  injuries  affect  the  vascularized  and  innervated  subchondral  bone  and 
therefore  activate the  inflammatory response.  Reparative  mesenchymal  cells  originate 
from the undifferentiated bone marrow cells. Within a few weeks, a good proportion of 
the  mesenchymal  cells  in  the  chondral  portion  of  the  defect,  differentiate  into 
chondrocyte-like  cells  and  secrete  proteoglycans  and  collagen  type  II.  In  the  bony 
portion of the defect, endochondral and intramembranous bone formation reconstructs 
the bone defect. By 6 to 8 weeks, some of the repair tissue exhibits an hyaline cartilage 
appearance, while the remainder resembles fibrocartilaginous or fibrous tissue containing
45Chapter I
predominantly  collagen  type  I  (Stockwell,  1987,  Shapiro  et  al  1993).  By  1   year, 
however, the majority of the chondrocyte-like cells transform to fibroblasts and there is 
depletion of matrix proteoglycans.  Fibrillation,  Assuring and thinning of the chondral 
tissue follow. This fibrocartilage usually degenerates in a relatively short time (Furukawa 
etal 1980).
Full-thickness injuries' healing depends on the size, the location and possibly the age of 
the  individual.  Smaller  defects  heal  more  consistently  and  effectively.  In  younger 
patients the chondrocyte response to stimuli is more effective (Buckwalter et al  1988). 
Osteochondral  defects  in  weight-bearing  areas  that  articulate  with  another  cartilage 
surface are less likely to heal than those that do not articulate (Stover et al 1987).
REGULATION OF CARTILAGE BREAKDOWN AND REPAIR
Breakdown and repair of articular cartilage can be regulated mechanically (Caterson and 
Lowther,  1978,  Radin et al  1984, Helminen et al  1992)  and biologically  by growth 
factors (Morales and Hascall,  1989) and other biologial factors (Cawston and Rowan, 
1998).
Mechanical load
Immobilization  or  reduced  loading  of  a joint  results  in  a  decrease  in  proteoglycan 
synthesis,  whereas  moderate  exercise  leads  to  an  increase  in  proteoglycan  synthesis 
(Caterson and Lowther,  1978)  and thickening of the  cartilage matrix  (Helminen et al
1992).  Severe  mechanical  loading  causes  thinning  of  the  matrix  and  leads  to 
degenerative changes (Radin et al  1984). In vitro cartilage explant studies showed that 
dynamic compression forces at frequencies of 0.01 to  1.0 Hz stimulate the synthesis of 
matrix macromolecules (Palmoski and Brandt, 1984, Sah et al 1989, Hall et al 1991), but 
dynamic compression forces of large magnitude appear to accelerate the loss of matrix 
macromolecules and destroy the matrix (Sah et al  1991). It seems that early controlled 
loading and motion can promote healing  (Buckwalter,  1996).  Torzilli  and Grigiene in
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1998 presented results that indicated that proteoglycan release from the cartilage matrix 
is inhibited by continuous cyclic mechanical loading.
Growth factors
Biological  regulation  has  been  shown  to  take  place  through  polypeptides  known  as 
growth  factors  such  as  the  Transforming  Growth  Factor-P  [TGF-p],  the  Insulin-like 
Growth Factor-1   [IGF-1] and the basic Fibroblast Growth Factor [bFGF] (Morales and 
Hascall, 1989). The source of growth factors varies; they may be produced remote from 
the cartilage and diffuse in, they may be sunthesized by the chondrocytes or they may be 
released from the matrix as it is broken down (Cawston and Rowan, 1998).
TGF-p  stimulates  the  synthesis  rate  of matrix  macromolecules  such  as  decorin  and 
biglycan  (Morales  and  Roberts,  1988).  TGF-p  also  promotes  the  repair  of damaged 
cartilage  (Joyce  et  al  1990).  TGF-p  upregulates  plasminogen  activator  inhibitor  and 
TIMP  production  whilst  down-regulating  production  of  MMP-1;  however,  recent 
evidence suggests that it can also up-regulate MMP-13 in normal cartilage (Moldovan et 
al 1997). IGF-1 has the capacity to stimulate chondrocyte proliferation and the synthesis 
of aggrecan and hyaluronic acid (Guenther et al 1982, McQuillan et al 1986, Schalkwijk 
et  al  1989).  IGF-1  also  can  decrease  the  cartilage  degradation  by  anatagonizing 
Interleukin-1   [IL-1]  action  (Tyler,  1989).  bFGF  is  a  potent  mitogenic  agent  for 
chondrocytes  and  can  stimulate  synthesis  of  cartilaginous  matrix  (Kato  and 
Gospodarowicz, 1985).
Other biological factors
Other factors may also have protective effects under certain circumstances.  IL-4, IL-13 
and  IL-10  oppose  the  effects  of  pro-inflammatory  agents  by  blocking  proteinase 
secretion,  increasing  inhibitor production and  synthesis  of new matrix  in many cells. 
Both  IL-4  and  IL-13  can  prevent  IL-1-stimulated  matrix  resorption.  Platelet-derived 
growth  factor  (PDGF)  has  a  mitogenic  effect  on  chondrocytes  and  also  stimulates 
collagenase production in synovial fibroblasts (Cawston and Rowan, 1998).
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METHODS OF ARTICULAR CARTILAGE REPAIR
Methods for articular cartilage repair have become popular in clinical practice.  In the 
past, defects of the articular cartilage used to remain untreated causing severe pain and 
disability  to  the  patients.  The  older  patient  used  to  proceed  earlier  to  corrective 
osteotomy  [high  tibial  or  distal  femoral]  to  reduce  the  weight  stress  on  the  area  of 
cartilage repair (Tippet, 1991) or to total joint replacement. The young and active patient 
used to have to refrain from sporting activities as these would aggravate the symptoms. 
The  clinical  application  of methods  for the resurfacing  of chondral  defects  has  been 
brightening the prognosis of the repair of the articular cartilage. The early identification 
of the symptoms is essential for the future management.
Arthroscopy of the joint is still indispensable in order to identify the grade, the size and 
the location of the defect. This arthroscopic information in conjunction with the patient's 
expectations  and  compliance  with  rehabilitation,  will  dictate  the  choice  of  the 
appropriate method of treatment. A number of treatments have been explored. The goal 
of articular cartilage repair is to restore the integrity of the joint surface and to provide 
full range of pain-free motion, preventing further tissue deterioration.
Arthroscopy and debridement
Arthroscopic  lavage  and  debridement  clears  the  joint  of  loose  articular  debris  and 
inflammatory mediators generated by the synovial lining of damaged joints. It may offer 
temporary relief of pain, but no prospect of long-term cure (Jackson, 1991).
Bone marrow stimulation
In  marrow-stimulation  techniques  [arthroscopic  abrasion,  subchondral  drilling, 
microfracture]  the  subchondral  bone  is penetrated  to  reach  a zone  of vascularization, 
stimulating  the  formation  of  a  fibrin  clot  containing  stem  cells.  This  clot  then 
differentiates and remodels, resulting, however, in fibrocartilage repair tissue (Johnson, 
1991,  Rodrigo  et  al  1994).  If  the  surface  is  protected  from  excessive  loading,
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undifferentiated mesenchymal  cells migrate into the clot, proliferate,  and differentiate 
into cells with the morphological features of chondrocytes (Shapiro et al 1993).
Ficat et al (1979) reported good or excellent results in 79% of their patients (85 patients 
in total) following spongialization (excision of damaged cartilage along with underlying 
subchondral bone). Johnson (1986) examined joint surfaces after arthroscopic abrasion 
and  found  that  in  some  individuals  this  procedure  resulted  in  the  formation  of  a 
fibrocartilaginous articular surface that varied in composition. Baumgaertner et al (1990) 
reported less successful results following arthroscopic abrasion in 44 patients.
The formation of a new articular surface after penetration of the subchondral bone or 
after abrasion does not necessarily relieve pain. The lack of beneficial clinical outcome 
may be attributable to the inability of the newly formed tissue to replicate the properties 
of articular cartilage.  It does not have the  structure,  the  composition,  the  mechanical 
properties  and the  durability of articular  cartilage.  Therefore,  even though this  tissue 
covers the subchondral bone, it may fail to distribute loads across the articular surface in 
a way that avoids pain with loading and additional degeneration of the joint (Mitchell 
and Shepard, 1976, Buckwalter and Lohmander, 1994). A clinical study by Akizuki et al 
(1997) comparing the results of high tibial osteotomy alone with osteotomy and abrasion 
arthroplasty showed no  difference  in the  clinical  outcome  at 2  to  9  years.  Favorable 
results were reported also by Blevins et al (1998)  following microfracture treatment of 
178 athletes at mean follow-up 3.7 years.
Continuous passive motion [CPM]
Salter et al (1980) found no beneficial effect of continuous passive motion on the repair 
of cartilage injuries although in defects that penetrated the subchondral bone, continuous 
passive motion accelerated repair.  O’  Driscoll et al  (1984,  1986)  showed evidence of 
improving  cartilage  repair  with  periosteal  grafts  when  CPM  is  used.  The  forced 
circulation  of  interstitial  fluid  during  cyclic  compression  might  benefit  cartilage 
metabolism  by  promoting  the  transport  of various  macromolecules,  such  as  growth 
factors, cytokines, and other enzymes necessary for cartilage metabolism (O’Hara et al
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1990). Rodrigo et al (1994) also reported improvement of full-thickness chondral defects 
in the human knee after debridement and microfracture using CPM.
Corrective osteotomy
An  osteotomy  is  planned  in  order  to  decrease  loads  on  the  most  severely  damaged 
regions of the joint surface, to bring regions of the joint surface that have remaining 
articular cartilage into opposition with regions that lack articular cartilage, or to correct 
malalignment that may contribute to  symptoms  and dysfunction of the joint.  Clinical 
experience has shown that osteotomies of the hip and the knee can decrease symptoms 
and stimulate the formation of a new articular surface. Osteotomy leads to a decrease in 
the  radiographic  signs  of joint  degeneration,  with  the  improvement  including  the 
resolution of subchondral  cysts or radiolucent lines,  decreased density of subchondral 
bone, and increased radiographic joint space (Buckwalter and Lohmander,  1994). Long 
term follow-up of patients who were managed with osteotomy for osteoarthrosis of the 
hip  and the knee have  shown,  however,  that the  clinical results deteriorate with time 
(Insall et al,  1984, Reigstad and Gronmark,  1984, Matthews et al  1988, Berman et al
1991).
Periosteal and perichondrial grafts [Soft tissue arthroplasty]
Studies have shown that perichondrial and periosteal grafts placed in articular cartilage 
defects can produce new cartilage (Engkvist and Johansson, 1980, Rubak 1982, Rubak et 
al 1982, Homminga et al 1990, Billings et al 1990). O’Driscoll and Salter (1984) showed 
that  neochondrogenesis  in  free  periosteal  autografts  was  facilitated  with  continuous 
passive motion.  Synovium-fat-periosteum autograft taken from the medial  side  of the 
femoral condyle and sutured into the defect of the knee of mature sheep showed failure 
of  the  graft  two  years  later  (Rothwell,  1990).  Perichondrial  graft  taken  from  the 
cartilaginous covering of a rib can be placed in a joint where it develops into hyaline 
cartilage (Kon, 1981, Woo et al 1987, Coutts et al 1992). The graft size is limited by the 
rib size, and several ribs often must be used to harvest sufficient perichondrium to graft
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large joints. These techniques are also limited by the tendency towards ossification of the 
repair tissue (Ritsila, 1994).
A study in sheep, where osteochondral lesions were filled with rib perichondrial grafts 
secured by either collagen sponges or fibrin glue, showed sufficient filling of the defects 
and ingrowth to the surrounding cartilage up to 16 weeks post-transplantation (Bruns et 
al  1997). Another study on 88 patients with up to 52 months mean follow-up reported 
91% good results (Bouwmeester et al  1997). However, an 1-year study in rabbits using 
allogenic  perichondrium  cell  polylactic  acid,  although  it  showed  grossly  successful 
repairs it also revealed inconsistent subchondral bone formation  suggesting that these 
repairs may not represent structurally normal articular cartilage (Chu et al 1997).
Bone and Meniscal grafts
Bone grafting with callus or cortical bone performed in rats showed hyaline-like repair 
tissue,  although hypocellular and  fibrillated  (Goransson et  al  1995).  Frozen meniscal 
allografts transplanted in rabbits showed good cellular response and matrix synthesis in 
24 weeks (Sumen et al 1995).
Osteochondral grafts [Transplantation of articular cartilage]
Osteochondral autografts
This method introduces a new cell population that participates in the repair of articular 
cartilage.  The  small  number  of donor  sites  limits  this  method  to  selected  regions  of 
cartilage defect. Clinical studies have shown that this technique can restore the articular 
surface (Campanacci et al  1985, Yamashita et al  1985, Outerbridge et al  1995, Bobic,
1996). The use of osteochondral plugs derived from the intercondylar notch or femoral 
trochlea  has  demonstrated  satisfactory  repair  of cartilage  defects  with  good  clinical 
outcome.  This  is  a technique which also  allows the transplantation of multiple  grafts 
(mosaicplasty) and therefore the cover of large defects (Outerbridge et al  1995, Bobic, 
1996, Hangody et al 1998).
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Osteochondral allografts
Clinical experience with fresh and frozen osteochondral allografts has shown that they 
can heal to the host tissue and restore articular surface (Bayne et al  1985, Aston and 
Bentley,  1986, Convery et al  1991, Beaver et al  1992, Garett,  1994, McDermott et al 
1985, Mahomed et al 1992, Meyers et al 1989). Gross et al (1992) used fresh allografts 
for the repair of post-traumatic osteoarticular defects and reported 75% successful results 
in five years,  64% at ten years and 63% at fourteen years.  Frozen allografts are more 
available and can be prepared in any size. They permit elective reconstruction and allow 
time  for more  extensive testing  for viral  and  bacterial  infections  (Flynn  et  al  1994). 
Frozen  storage  of  osteochondral  allografts  appears  to  maintain  the  viability  of 
chondrocytes  (Schachar et al  1989)  and not to  alter the viscoelastic properties of the 
tissue (Kiefer et al  1989). Larger grafts seem to have higher rate of failure than smaller 
ones  (Lord  et  al  1988).  Stevenson  et  al  (1991)  showed  that  frozen  grafts’  structure 
deteriorated and proteoglycan concentration was  lower  in comparison to  fresh  grafts. 
Flynn et al (1994), however, reported results with frozen osteochondral allografts that 
compared  favourably  with those  using  fresh  allografts.  Toolan  et  al  (1998)  reported 
improved healing up to 12 weeks post-implantation of a chimeric xenograft.
Electrical and sonic stimulation
Enhanced healing has been demonstrated with the use of implanted electrodes in animal 
models (Lippiello et al  1990).  Huang et al (1997)  suggested that ultrasound enhances 
cartilage repair in early  stages  of degenerative disease and has the  effect  of arresting 
further deterioration in the later stages.
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Laser Stimulation
Schultz et al (1985) found that superficial cartilage defects exposed to low-dose laser 
energy demonstrated a reparative process superior to that found in untreated injuries and 
in injuries treated with higher doses of laser energy. Carbon dioxide experimental laser 
surgery  showed  fibrous  repair  in  deep  lesions  at  early  assessment  and  in  superficial 
lesions  at  later  6  to  12  months  assessment  (Vangsness  et  al  1995).  The  effects  of 
holmium:  yttrium-aluminium-gamet  [Ho:YAG]  laser  energy  on  cartilage  have  been 
studied showing no difference between treated and control lesions in horses (Pullin et al
1996).  Chondral  damage  and  cartilage  slough  secondary  to  Ho:YAG  laser  following 
knee arthroscopy has been reported by Thai et al (1996). Reduction of cell viability and 
the  expression of proteoglycans  in the repaired  articular cartilage  and  damage  in the 
architecture and histology of the subchondral bone have also been reported (Lane et al
1997).
Chondrogenesis  stimulated  with  Bone  Matrix  Protein,  Growth  Hormone  and 
Growth Factors.
Syftestad and Caplan (1986) showed enhanced experimental  chondrogenesis following 
stimulation  with  bone  matrix  protein.  Growth  hormone  enhances  osteogenesis  and 
chondrogenesis  in cells  in culture;  some  of these  effects  are mediated by Insulin-like 
Growth Factor-I  [IGF-I] which also affects bone matrix formation and cell replication 
(Hock et al 1988, Slootweg et al 1988, Kassem et al 1993).
Local  treatment  of  chondral  or  osteochondral  defects  with  growth  factors  has  the 
potential  to  stimulate  the  restoration  of the  damaged  articular  surface.  Hunziker  and 
Rosenberg  (1994,  1996)  treated  partial-thickness  cartilage  defects  with  transforming 
growth  factor-p  [TGF-p]  and  showed  that  it  can  stimulate  cartilage  repair.  The 
responsiveness of cells to growth factors may decline with age (Pfellschifter et al 1993, 
Martin  and  Buckwalter,  1996).  For  the  younger  patient  with  isolated  chondral  or 
osteochondral defects growth factor based treatment appears promising.
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Cell transplantation
A number of experimental studies has shown that transplantation of chondrocytes  can 
promote the restoration of articular cartilage  (Bentley  and  Greer,  1971,  Bentley et al 
1978, Itay et al 1988, Wakitani et al 1989, Robinson et al 1990, Kamade and Yoshimao, 
1991, Brittberg et al  1994, Noguchi et al  1994,  Brittberg et al  1996,  Shortcroff et al
1996). Brittberg et al (1994) described the use of transplants of autologous chondrocytes 
for the treatment of localized cartilage defects of the femoral condyle or the patella in 
twenty  three  patients.  Autologous  chondrocyte  implantation  involved  harvesting  of 
chondrocytes  from  the  upper  medial  femoral  condyle  of  the  affected  knee.  The 
population of the chondrocytes was cultured in vitro for 5 weeks and was expanded ten­
fold. During a second procedure, the defect was covered with a periosteal patch from the 
proximal  tibia,  and  the  cultured  chondrocytes  were  injected  beneath  the  patch.  The 
resulting cartilage was of the hyaline type in twelve of the twenty-three patients and the 
method showed good or excellent clinical results in sixteen patients.
Some studies have also shown that mesenchymal cells aspirated from bone can produce 
cartilaginous tissue in goats (Butnariu-Ephrat et al  1996) and that these mesenchymal 
cells can also repair large osteochondral defects in rabbits (Wakitani et al 1994).
Synthetic materials
A number of synthetic biological and non-biological materials has been developed in the 
recent years for the repair of articular cartilage defects. Most of these have been trialed 
as carrier matrices for the delivery  and stabilization of growth factors or chondrocytes in 
the  defects  (Peppas  and  Langer,  1994,  Parsons,  1985).  An artificial  matrix,  however, 
may allow, and in some instances stimulate ingrowth of host cells, matrix formation, and 
binding of new cells and matrix to host tissue (Paletta et al 1992).
Fibrin has been used to implant and allow timed release of a growth factor (Hunziker and 
Rosenberg, 1994). Fibrin has also been used as an adhesive (Kaplonyi et al 1988) and as 
chondrocyte carrier (Hendrickson et al  1994).  Collagen matrices have been trialed on 
their own (Speer et al  1979) or as scaffolds for chondrocytes (Sams and Nixon,  1995,
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Frenkel et al  1997). Silastic sheet spacers showed no beneficial results (Engkvist and af 
Ekenstam, 1982). An aromatic porous polyurethane material has also been used  with the 
formation, however, of fibrocartilage as a result (Klompmaker et al 1992). Corkhill et al 
(1990,  1993)  studied  in  vitro  hygrogel  gels.  Bioactive  glasses,  hydroxyapatite  and 
hydroxyapatite-glass have also been tried (Suominen et al 1996).
Carbon fibre patches have been used in rabbits (Minns et al  1982, Minns and Muckle, 
1989) and then in clinical practice to fill large osteochondral defects. The patch is used 
as  a support to the fibrocartilaginous matrix.  Seventy five per cent excellent or good 
results were reported three years later (Muckle and Minns,  1990). Encouraging results 
were also reported by Brittberg et al (1994) in 36 patients and by Bentley et al (1998) in 
78  patients  followed  for 6  years.  Hemmen et al  (1991)  also  used  carbon  fibre  plugs 
loaded with chondrocytes.  However,  Meister et al  (1998)  in 27  patients  with patellar 
defects, reported discouraging results with low patient satisfaction and with carbon-fibre 
debris and histiocytic giant-cell reaction in the synovium.
The  resorbable  polymers  polyglycolic  acid  and  polylactic  acid  have  been  tried  as 
chondrocyte  delivery  systems  (Freed  et  al  1993)  and  in  cartilage  tissue  engeneering 
attempts (Sittinger et al  1996, Cao et al  1998, Vacanti and Upton,  1994, Grande et al
1997).  Although promising in their applications,  sterilization and tissue  inflammation 
remain problematic with these biomaterials (Athanasiou et al  1996). No cartilage was 
found  formed  in  defects  which  received  polyglycolic  acid  polymer  alone  without 
carrying cells (Vacanti et al 1994).
New  biomaterials  for  resurfacing  articular  cartilage  defects  are  constantly  under 
continuing investigations. Of these, the new poly-ethyl-methacrylate/tetra-hydro-fiirfuryl 
methacrylate polymer [PEMA/THFMA]  has been experimentally tested in preliminary 
studies  up  to  6  weeks  post-implantation  with promising  results  (Reissis  et  al  1994a, 
Reissis  et  al  1994b,  Reissis  et  al  1995).  This  thesis  will  present  results  on  the 
PEMA/THFMA polymer’s in vivo toxicity and comprehensive evaluation of the repair 
tissue following PEMA/THFMA implantation in articular cartilage defects in rabbits up 
to 1  year. The efficacy of PEMA/THFMA to repair articular cartilage defects will also be 
trialed in different rabbit age groups and in comparison to conventional bone cement. 
Finally, the new polymer will be tested as a drug delivery system for growth hormone.
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CHAPTER II
THE NEW POLY-ETHYL-METHACRYLATE / TETRA-HYDRO-FURFURYL- 
METHACRYLATE (PEMA/THFMA 1 POLYMER
Introduction to PEMA/THFMA 
In vivo toxicity test of THFMA
OBJECTIVE
MATERIALS
•  2 young, 2 adult, 2 old rabbits
•  THFMA vs MMA monomer
METHOD
•  Intravenous administration of monomer concentrations
•  Evaluation of heart rate, arterial blood pressure, O2 saturation
RESULTS
DISCUSSION
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INTRODUCTION TO PEMA/THFMA
PEMA/THFMA is an heterocyclic methacrylate polymer system that had originally been 
developed for use as hearing aid and temporary crown and bridge materials in dentistry. 
It  is  based  on  poly-ethyl-methacrylate  (containing  0.6%  benzoyl  peroxide)  powder 
polymer  and tetra-hydro-furfuryl-methacrylate  (containing  2.5%  v/v N,N,-dimethyl-p- 
toluidine) liquid monomer.
The  conventional  poly-methyl-methacrylate/methyl-methacrylate  [PMMA/MMA] 
system  that  is  used  as  bone  cement  in  orthopaedic  surgery,  for  denture  bases,  for 
artificial teeth and orthodontic appliances and for moulds for hearing aid devices, has a 
number  of disadvantages,  mainly  high  exothermic  reaction  and  high  polymerisation 
shrinkage.  Various  other  methacrylate  esters  have  been  studied  to  overcome  these 
problems. Low shrinkage is obtained with high molar volumes, i.e. big molecules. Above 
C6, however, alkyl-methacrylates are rubbers. Hence, cyclic methacrylates must be used. 
The  heterocyclic  monomer  tetra-hydro-furfuryl-methacrylate  [THFMA]  emerged  as  a 
suitable candidate. THFMA is a 5 membered ring with a hetero atom. It is a colourless, 
transparent, odourless liquid insoluble in water.
The  new  PEMA/THFMA  system,  compared  to  existing  poly-methyl-methacrylate 
[PMMA] based materials, exhibitis much lower shrinkage (Bhusate and Braden,  1985, 
Patel  et  al  1987),  lower  exotherm  during  polymerisation  (Patel  and  Braden,  1991ii), 
excellent biological properties  (Pearson et al  1986),  reasonable mechanical  properties 
with good flexural strengths and exhibited ductile fracture (Patel and Braden, 1991i) and 
hydrophilicity (Patel and Braden, 1991iii).
The  extent  of  the  exothermic  reaction  during  polymerization  is  of  great  clinical 
importance.  Tetra-hydro-furfuryl-methacrylate  gives  lower  exotherm  with  poly-ethyl- 
methacrylate  than  with  conventional  poly-methyl-methacrylate  systems.  The 
PEMA/THFMA system polymerizes at room temperature. N,N-dimethyl-p-toluidine is 
satisfactorily used as activating amine (Patel and Braden, 1991ii).
Tetra-hydro-furfuryl-methacrylate  is  potentially  useful  because  it  does  not  have  the 
unpleasant  odour  of n-butyl-methacrylate  and  has  been  shown  to  be  relatively  non­
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irritant in dental use (Pearson et al 1986). PEMA/THFMA is biocompatible in bone and 
cartilage although not biodegradable (Patel et al 1994). This is probably the reason why 
it elicits no inflammatory or foreign body response in the host tissues.
An  interesting  and  important  feature  of this  polymer  is  that  it  exhibits  high  water 
absorption -up to 34%- in vitro (Patel and Braden, 1991iii), not reaching equilibrium for 
several  months.  In vivo this  polymer  should  absorb tissue  fluids that contain  growth 
factors and hence gain similar biological properties to those of the host tissue. This may 
create an environment which encourages cartilage overgrowth. The high water content of 
this polymer is a charcteristic property of normal hyaline articular cartilage. The water 
uptake process is protracted.  Hydration of cartilage is essential  because  chondrocytes 
rely upon diffusion for the supply of nutrients. The material swells due to water uptake 
after  polymerization  and  a  tight  bond  occurs  between  the  polymer  and  the  bone, 
providing a mechanically stable implant (Downes et al 1994). The high water uptake of 
the  PEMA/THFMA  polymer  system  is  also  the  key to  its  success  as  a  drug  release 
polymer (Patel et al 1994).
Early results of the new polymer’s effect on cartilage repair have been published with 
regard  to  macroscopic,  histological,  immonohistochemical,  and  ultrastructural 
characteristics of the repair tissue (Reissis et al 1994a, 1994b, Reissis et al 1995). These 
results showed that PEMA/THFMA is biocompatible and it encourages the formation of 
hyaline-like cartilage tissue in full-thickness articular cartilage defects. The present thesis 
provides equally encouraging long-term results.
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Poly-ethyl-methacrylate ( PEMA) powder
Fig.II.A .l
Tetra-hydro-ftirfuryl methacrylate (THFMA) monomer
Fig.II.A .2
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IN VIVO TOXICITY TEST OF THFMA 
OBJECTIVE
This  study  tests  the  in  vivo  toxicity  of  the  new  monomer  tetra-hydro-furfuryl- 
methacrylate  [THFMA]  compared  to  methyl-methacrylate  monomer  [MMA].  The 
monomers were administered intravenously in rabbits of three different age groups.
MATERIALS
Two  young  [6 months old], two  adult  [12 months  old]  and two  old  [18  months old] 
female Sandy-Lop rabbits were used. The young rabbits weighed 4.859 kg and 4.880 kg, 
the adult 5.100 kg and 5.120 kg, and the old rabbits 5.150 kg and 5.180 kg. One rabbit in 
each age group was injected with THFMA monomer and the other with MMA monomer.
METHOD
The  rabbits  were  anaesthetised  with  oxygen  llitre/min,  nitrous  oxide  llitre/min  and 
halothane 0.5-1.5%, breathing spontaneously via a mask throughout the course of the 
experiment.  The  injections  were  performed  intravenously  via  a  23G  butterfly  in  a 
marginal ear vein.  In the THFMA group,  1   ml bolus injection of 60/40 alcohol/saline 
was  followed by injection of 1   ml  boluses  of 2%  [4mg/kg],  4%  [8mg/kg],  and  10% 
[20mg/kg]  THFMA  diluted  in  60/40  alcohol/saline.  In the  MMA  group,  1  ml  bolus 
injection  of 60/40  alcohol/saline  was  followed  by  injection  of  1  ml  boluses  of 2% 
[4mg/kg], 4% [8mg/kg] and 10% [20mg/kg] MMA also diluted in 60/40 alcohol/saline. 
The  injections  were  given every  10  minutes  and measurements  of heart rate,  arterial 
blood pressure [systolic and diastolic]  and O2 saturation [using a pulse oximeter] were 
recorded every 1  minute using a standard AS3 anaesthesia monitor [Datex, Finland].
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RESULTS
The results of the monitoring of the vital signs of heart rate, blood pressure and oxygen 
saturation are  demonstrated in tables  II. 1,  II.2,  II.3  and  II.4  and  graphically for both 
monomers.
Table II.1:
In vivo toxicity assay.
Heart rate monitoring following intravenous injections of 
THFMA vs MMA monomer
Heart rate THFMA Heart rate MMA
Young Adult Old THFMA
mean
Young Adult Old MMA
mean
Obs 2 174 154 160 163 176 176 152 168
Obs3 186 153 156 165 174 163 152 163
Obs 4 184 151 158 164 188 156 160 168
Obs 5 182 158 156 165 193 168 152 171
Obs 6 194 156 148 166 196 163 160 173
Obs 7 185 163 162 170 182 162 162 169
Obs 8 180 168 160 169 189 158 151 166
Obs 9 190 165 158 171 184 159 156 166
Obs 11 182 165 152 166 182 153 150 162
Obs 12 186 168 156 170 186 162 151 166
Obs 13 183 172 152 169 192 158 156 169
Obs 14 189 168 140 166 193 166 152 170
Obs 15 198 164 138 167 201 163 153 172
Obs 16 201 160 146 169 186 162 156 168
Obs 17 190 152 148 163 201 171 162 178
Obs 18 186 160 146 164 192 173 153 173
Obs 19 182 163 152 166 193 168 160 174
Ob’ s ?&   ‘ 186 W  156  .171  ■ ■  2% monomer  190  169 158  •   172  V
Obs 21 180 152 143 158 180 160 146 162
Obs 22 176 156 149 160 178 173 142 164
Obs 23 172 158 158 163 180 174 160 171
Obs 24 179 159 162 167 186 169 154 170
Obs 25 184 158 151 164 196 173 156 175
Obs 26 189 168 143 167 192 182 158 177
Obs 27 185 162 148 165 198 181 160 180
Obs 28 178 153 148 160 206 168 153 176
Obs 29 178 163 146 162 202 173 156 177
Obs'30 •  ^ 183 160 152 lS5}vr 4% monomer 193 182 150 175
Obs 31 165 148 133 149 180 186 133 166
Obs 32 163 143 138 148 178 182 138 166
Obs 33 172 148 133 151 180 176 146 167
Obs 34 178 156 136 157 163 159 152 158
Obs 35 183 159 148 163 184 168 162 171
Obs 36 186 163 146 165 193 173 160 175
Obs 37 184 166 151 167 194 172 168 178
Obs 38 192 162 156 170 195 156 172 174
Obs 39 204 163 152 173 198 162 160 173
Obs 40 189 165 148 167 10% monomer 201 182 152 178  -   '
Obs 41 157 138 126 140 186 153 143 161
Obs 42 162 133 123 139 183 158 140 160
Obs 43 159 139 128 142 192 168 146 169
Obs 44 168 146 124 146 196 163 150 170
Obs 45 178 158 141 159 190 172 150 171
Obs 46 191 162 148 167 192 176 152 173
Obs 47 186 168 140 165 186 173 162 174
Obs 48 185 162 152 166 182 168 150 167
Obs 49 182 160 158 167 201 190 148 180
Obs 50 183 159 162 168 186 186 152 175
61Chapter II
Table II.2:
In vivo toxicity assay.
Systolic blood pressure monitoring following intravenous injections of 
THFMA vs MMA monomer
BP  Systolic THFMA BP Systolic MMA
Young Adult Old THFMA
mean
Young Adult Old MMA
mean
Obs 2 96 92 106 98 99 106 106 104
Obs 3 98 99 104 100 86 102 103 97
Obs 4 98 100 100 99 89 104 98 97
Obs 5 94 102 98 98 92 102 % 97
Obs 6 93 108 96 99 96 96 99 97
Obs 7 90 93 100 94 98 98 102 99
Obs 8 92 96 102 97 98 93 102 98
Obs 9 92 98 98 96 90 92 
IT *  *  91®
99 94
Obs 11 88 92 99 93 92 89 98 93
Obs 12 86 90 100 92 96 92 99 96
Obs 13 89 96 100 95 92 96 102 97
Obs 14 96 98 106 100 96 96 102 98
Obs 15 94 94 104 97 99 92 102 98
Obs 16 % 98 102 99 101 93 100 98
Obs 17 94 94 106 98 102 94 100 99
Obs 18 96 96 102 98 98 96 100 98
Obs 19 93 98 106 99 96 98 98 97
Sbti3SS$$ ' x e m m m ....
Obs 21 85 88 84 86 72 68 *73 71
Obs 22 86 86 86 86 76 63 76 72
Obs 23 83 88 82 84 78 82 73 78
Obs 24 89 83 89 87 76 86 76 79
Obs 25 86 89 100 92 79 85 78 81
Obs 26 92 96 106 98 86 91 73 83
Obs 27 93 98 94 95 84 92 83 86
Obs 28 98 101 98 99 83 86 88 86
Obs 29 95 106 92 98 89 88 86 88
M l 1 - ^ 9 8
Obs 31 82 80 76 79 71 72 60 68
Obs 32 86 83 78 82 68 78 58 68
Obs 33 83 86 76 82 69 68 54 64
Obs 34 85 74 74 78 73 69 60 67
Obs 35 86 82 86 85 78 70 62 70
Obs 36 82 89 82 84 72 76 68 72
Obs 37 89 94 89 91 81 78 63 74
Obs 38 94 98 96 96 86 76 67 76
Obs 39 96 93 99 96 91 82 69..... 81
■ •< > 3   • m  * • IQ 2 10% monomer 90 89 76 85
Obs 41 81 73 64 73 62 53 48 “ 54*
Obs 42 76 78 68 74 68 58 43 56
Obs 43 74 74 69 72 63 52 48 54
Obs 44 78 79 85 81 66 50 43 53
Obs 45 76 76 86 79 69 51 43 54
Obs 46 82 84 81 82 63 50 40 51
Obs 47 86 89 78 84 72 61 49 61
Obs 48 91 92 89 91 76 68 52 65
Obs 49 96 81 99 92 78 73 68 73
Obs 50 93 91 103 96 86 81  • 69 79
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Table II.3:
In vivo toxicity assay.
Diastolic blood pressure monitoring following intravenous injections of
THFMA vs MMA monomer
BP Diastolic THFMA BP Diastolic MMA
Young Adult Old THFMA
mean
Young Adult Old MMA
mean
menthffiSM HHBHH |§ § ^ |§ § j| umummmum
w t u m m m m m tr n
Obs 2 72 65 52 63 56 49 56 54
Obs 3 6 8 52 56 59 54 53 53 53
Obs 4 62 53 58 58 62 56 54 57
Obs 5 52 56 53 54 54 62 46 54
Obs 6 50 53 54 52 59 61 48 56
Obs 7 63 61 54 59 62 58 46 55
Obs 8 64 62 58 61 6 8 60 43 57
Obs 9 59 51 59 56 64 49 48 54
w m m a m ■ ■ I ■ m m m o m
Obs 11 58 51 54 54 30 52 50 44
Obs 12 61 50 56 56 53 56 48 52
Obs 13 62 56 59 59 52 58 46 52
Obs 14 60 62 61 61 54 60 43 52
Obs 15 62 62 62 62 56 62 46 55
Obs 16 59 63 60 61 58 6 6 46 57
Obs 17 56 51 58 55 60 64 43 56
Obs 18 59 56 53 56 62 62 48 57
Obs 19 6 8 61 61 63 6 8 60 52 60
tfQbs&ftli .  * ,2% monopier^ HM Mr v
Obs 21 58 38
.... ^
45 46 46 42 45
Obs 22 56 42 43 47 43 48 40 44
Obs 23 62 40 48 50 43 43 40 42
Obs 24 6 8 46 46 53 48 48 38 45
Obs 25 62 49 51 54 52 52 48 51
Obs 26 59 53 52 55 58 56 48 54
Obs 27 59 62 53 58 64 58 46 56
Obs 28 63 6 8 56 62 63 60 52 58
Obs 29 72 59 58 63 6 6 62 50 59
r ** 4*60# 1#!*  itt:'* *-*~-£$9C€l
Obs 31 52 33 38 41 38 "*33 24 32
Obs 32 56 38 36 43 36 38 24 33
Obs 33 50 31 38 40 32 36 2 2 30
Obs 34 48 32 43 41 38 33 24 32
Obs 35 61 31 42 45 39 40 28 36
Obs 36 62 30 34 42 39 48 30 39
Obs 37 62 46 46 51 46 43 36 42
Obs 38 59 48 49 52 48 49 36 44
Obs 39 61 49 58 56 46 ..........52  ^ 32 43
Ob»40 6 8 53- *   ;53 58 IQ% monomer- :  51 .  56 •41
Obs 41 60 31 28 40 30 28 2 2 27
Obs 42 54 30 26 37 31 26 2 2 26
Obs 43 43 29 30 34 38 28 2 0 29
Obs 44 46 27 36 36 36 30 2 2 29
Obs 45 49 31 28 36 34 40 2 0 31
Obs 46 52 36 36 41 41 42 18 34
Obs 47 46 39 48 44 38 42 18 33
Obs 48 56 48 53 52 42 48 2 0 37
Obs 49 59 39 43 47 64 46 28 46
Obs 50 64 52 42 53 62 46 31 46
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Table II.4;
In vivo toxicity assay.
Oxygen saturation monitoring following intravenous injections of 
THFMA vs MMA monomer
0 2 Saturation THFMA 0 2 Saturation MMA
Young Adult Old THFMA
mean
Young Adult Old MMA
mean
Obs 2 98 98 99 98 98 98 98 98
Obs 3 97 % 99 97 96 1 0 0 99 98
Obs 4 96 99 98 98 96 99 98 98
Obs 5 94 99 96 96 98 99 99 99
Obs 6 96 99 96 97 99 98 99 99
Obs 7 98 99 95 97 98 96 98 97
Obs 8 99 98 96 98 94 96 96 95
Obs 9 99 98 95 97 96 94 98 96
w w m o f o
Obs 11 99 98 95 97 99 % 94 96
Obs 12 98 99 98 98 99 94 94 96
Obs 13 99 96 95 97 96 98 98 97
Obs 14 94 98 96 % 96 99  . 98 98
Obs 15 98 96 97 97 96 99 98 98
Obs 16 98 98 96 97 96 98 98 97
Obs 17 99 98 98 98 98 96 99 98
Obs 18 99 99 99 99 96 98 99 98
Obs 19 98 99 96 98 98 99 98 98
*   QttSft'# v  - -A n M -97,;/'?
Obs 21 94......” 97 94 95 96 9 3 95 95
Obs 22 96 98 95 % 98 96 95 96
Obs 23 99 98 96 98 99 93 94 95
Obs 24 99 98 94 97 99 99 96 98
Obs 25 98 98 96 97 99 99 98 99
Obs 26 99 99 96 98 98 99 98 98
Obs 27 98 98 97 98 96 98 99 98
Obs 28 99 99 99 99 98 98 98 98
Obs 29 99 99 98 99 96 98 99 98
Obs 30  ; 99  98  -
Obs 31 96 98 92 95 **93 90 93 92
Obs 32 94 96 94 95 96 94 96 95
Obs 33 94 94 94 94 96 98 96 97
Obs 34 93 98 94 95 98 99 98 98
Obs 35 96 98 94 96 99 99 96 98
Obs 36 96 98 96 97 99 99 94 97
Obs 37 99 % 98 98 98 98 96 97
Obs 38 99 98 98 98 98 98 98 98
Obs 39 99 99 98 99 96 98 98 97
Obs 40 -   99  m   '* > 8  » 99, 10% monomer -   99 97 98
Obs 41 90 93 92 92 *   92 93 93 93
Obs 42 92 92 92 92 92 92 92 92
Obs 43 91 99 94 95 96 93 93 94
Obs 44 98 96 94 96 99 94 94 96
Obs 45 98 92 96 95 99 98 92 96
Obs 46 98 96 96 97 99 98  ' 90 96
Obs 47 96 98 96 97 98 93 98 96
Obs 48 98 99 98 98 96 98 97 97
Obs 49 99 98 98 98 94 99 95 96
Obs 50 98 99 97 98 98 99 98 98
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In vivo toxicity - heart rate
THFMA
MMA
200
180
r  160
X
140
120
I  3  5  7  9  11  13  15  17  19  21  23  25  27  29  31  33  35  37  39  41  43  45  47  49
observations (10/min)
In vivo toxicity - Blood pressure
140
120
I
100 1
1 80
a.
1 60 -
5
40
20
0 1
'THFMA systolic 
'MMA systolic 
THFMA diastolic 
MMA diastolic
I  3  5  7  9  11  13  15  17  19  21  23  25  27  29  31  33  35  37  39  41  43  45  47  49
observations (10/min)
In vivo toxicity - 02  saturation
THFMA
MMA 105  t
100
95
90
observations (10/min)
Graphic presentation of vital sings /mean values1 following intravenous 
administration of THFMA vs MMA monomers:
observations 1-10:baseline, observations 11-20: 60/40 alcohol/saline, 
observations 21-30: monomer 2%, observations 31-40: monomer 4%, 
observations 41-50: monomer 10%.
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The tables show that there is a decrease in the heart rate following each injection of the 
monomers and the decrease is proportionate to the monomer concentration.  The heart 
rate remains within normal range following administration of THFMA monomer in all 
concentrations. The oxygen saturation also shows a fall that is more pronounced in the 
higher  concentrations  of the  monomers.  This  fall  reaches  91%  and  92%  in  the  10% 
concentration  of the  THFMA  and  MMA  respectively,  but  recovers  spontaneously  to 
normal  values  within  a  few  minutes.  The  blood  pressure  also  drops  following  the 
injection of the monomers with the effect of the MMA monomer being more pronounced 
in all dilutions. Hypotension recovers relatively quicker in the THFMA than the MMA 
injected rabbits. In all parameters recovery was faster in the young and the adult rabbits 
compared to the old ones.
DISCUSSION
Cardiorespiratory  effects  at  the  time  of  implantation  are  described  in  man  and 
experimental  models  and  considered  to  be  mainly  due  to  the  effects  of circulating 
monomer (Homsy et al  1972, Ellis and Mullvein,  1974), although embolism of fat and 
air to the lung may also play a role (Orsini, et al 1987).
Cardiac  effects  following  implantation  with  biomaterials  may  be  due  to  a  direct 
vasodilator effect on the  coronary circulation (Mir et al  1973).  It is  known that bone 
cements currently used in clinical practice may cause hypotensive episodes during the 
implantation procedure (Gresham et al 1971, Phillips et al 1971, Homsy et al 1972, Ellis 
and  Mullvein  1974).  In  more  recent  studies,  however,  it  is  shown  that  there  is  no 
evidence  that  methyl-methacrylate  monomer  released  from  the  conventional 
PMMA/MMA  bone  cement  was  responsible  for  the  cardiorespiratory  changes  when 
cemented and uncemented femoral implants were compared (Orsini et al 1987).
Revell  et  al  (1992)  when  testing  the  toxicity  of  MMA  and  n-butyl-methacrylate 
monomers,  reported dose-related hypotensive response  when injected  intravenously in 
rabbits.  In our  study  intravenous  injection of the  THFMA  and MMA  monomers  also
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caused reduction in heart rate, blood pressure and oxygen saturation which seems to be 
dose-related.  These  effects  on  the  vital  sings,  however,  showed  recovery  to  normal 
values within a very short time. THFMA had the less dramatic effects in all dilutions and 
thus it appears to be the safer of the two in its effects on the cardiovascular / respiratory 
system.
Homsy et al (1972) reported blood levels of MMA following hip arthroplasty at 2 mg/kg. 
This is a level considerably below that administered to the rabbits in our study. It seems 
that THFMA is no more toxic in rabbits than MMA in all three age groups studied and, 
since  MMA  levels  in  clinical  practice  produce  no  apparent toxic  effects,  it  is  highly 
unlikely that THFMA monomer released from the PEMA/THFMA polymer will have 
any toxic side effects in humans.
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CHAPTER III
PEMA/THFMA POLYMER IN THE REPAIR OF FULL-THICKNESS 
ARTICULAR CARTILAGE DEFECTS
A.  Scoring System for the assessment of articular cartilage repair
B.  Macroscopic and Histolocical/Histochemical assessment of repair tissue
C.  Immunohistochemical assessment of repair tissue
D.  Electron Microscopy of repair tissue
E.  Image Analysis of repair tissue
68Chapter III
CHAPTER III.A
SCORING SYSTEM 
FOR THE ASSESSMENT OF ARTICULAR CARTILAGE REPAIR
A  scoring system for the  assessment of the repair tissue  in articular cartilage  defects 
should be simple to use and should take into consideration characteristics of the articular 
cartilage that have been proven to  be  of clinical  significance.  O’Driscoll  et al  (1988) 
have developed a grading scale for the histochemical and histological assessment of the 
repair  tissue  in  full-thickness  articular  cartilage  defects.  The  scale  included  no 
macroscopic criteria i.e. evaluation of the total area of the defect resurfaced, which is of 
paramount clinical importance. The grading scale applied was different for each criterion 
depending  on  the  number  of  sub-groups  noted  rather  than  the  consistency  of  the 
particular parameter throughout the repair or its clinical significance.  In 1992, Pineda et 
al  developed  a  semiquantitative  scale  for  histological  grading  of the  natural  healing 
process  of  defects  drilled  into  articular  cartilage.  Their  scale  composed  of  four 
paramenters:  percent filling of the defect, reconstitution of the osteochondral junction, 
matrix staining and cell  morphology.  This  grading  scale  is  also  based on histological 
only criteria up to 4 months of observations and, as the authors addressed,  it may not 
necessarily correspond to clinical pathology.
The scoring system that has been developed for this study is numerical, based on seven 
macroscopic  and  histological/histochemical  criteria.  These  can  be  assessed  during 
experimental  studies  for  evaluation  and  comparison  between  treatments  and  also  in 
clinical applications in humans by using arthroscopy and simple histology. When applied 
in humans, this scoring system may also be complemented with clinical criteria that will 
monitor the patient’s progress.
The seven criteria of the scoring system include:
1.  Area
The  total  area of the  defect that has  been resurfaced  is  of paramount  importance. 
Complete resurfacing of the defect allows more physiological use of the joint and 
inevitably reduces the amount of inflammation and pain. The larger the percentage of
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the defect resurfaced, the larger the area score of the repair,  keeping in mind that 
wider lesions can also cause abrasion of the articular cartilage that articulates with 
the defect.
2.  Level
The ideal repair comprises repair tissue that grows at the same level as the adjacent 
normal  articular  cartilage.  Minimal  depression/elevation  do  no.t  appear  to  cause 
significant functional disability, although gross depression of the repair tissue leads 
to  formation  of  intra-articular  ‘steps’  that  can  cause  secondary  damage  to  the 
opposing  articular  cartilage  and  to  the  normal  articular  cartilage  adjacent  to  the 
defect.
3.  Surface
The smooth and glistering surface of the repair tissue allows frictionless movement 
to  occur  in  the joint  and  causes  no  damage  to  the  opposing  articular  cartilage. 
Moreover, the more irregular the repair tissue surface is, particularly when disrupted 
by fissures, the less resilient the tissue can be to mechanical loading.
4.  Cells
Predominance  of  chondrocytes  in  the  repair  tissue  is  of paramount  importance, 
although a percentage of fibroblast-like cells has been noted in all methods of clinical 
and experimental repair of articular cartilage reported to date. However, the presence 
of other cells,  such as fat cells and osteoblasts can compromise the biological and 
mechanical properties of the repair tissue and can lead to early degenerative changes.
5.  Proteoglycans [PGs]
The amount of proteoglycans  in the repair tissue characterises the total  amount of 
water that can be retained in the tissue, thus reflecting the ability of the repair tissue 
to  sustain  compression  loading.  Low  concentration  of proteoglycans  can  lead  to 
earlier degeneration of the repair tissue in the long-term.
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6.  Structure
Hyaline-like  appearance  of the  repair tissue,  comprising  of high  concentration  of 
proteoglycans  in  the  deeper  layers  of  the  repair  tissue,  combined  with  even 
distribution of chondrocytes throughout the whole of the repair tissue, promises more 
physiological  function  of  the  repair  tissue  in  the  joint.  Reversely,  grossly 
disorganized matrix and the presence of clusters of chondrocytes will score lower in 
the repair tissue.
7.  Bonding
Complete  bonding  of the  repair  tissue  to  the  adjacent  normal  articular  cartilage 
creates  a  stable  foundation  that  helps  in  the  even  distribution  of the  mechanical 
loading on the repair tissue, thus protecting the repair tissue and the adjacent to the 
defect normal articular cartilage from early degeneration. On the contrary, minimal 
or incomplete bonding results in abnormal micro-movement between the repair tissue 
and  the  adjacent  normal  articular  cartilage  with  subsequent  degeneration  in  both 
areas.
In a pilot study conducted prior to formulating this scoring system, macroscopic and 
histological/histochemical  assessments  were  performed  on  sections  from  different 
sites  of the  repair  tissue.  It  was  noted  that  the  level  of resurfacing,  the  surface 
appearance  of  the  repair  tissue  and  its  structure  as  well  as  the  amount  of 
proteoglycans  in the  newly  formed  tissue  can  vary  significantly  from  one  site  to 
another in the  same repair tissue.  A solution could have been to  assess  separately 
numerous sections in the same defect taken from different sites and to calculate mean 
values.  This  method,  however,  would  have  introduced  new  variables,  the  most 
important being the different diameter of the defect in different sites and would have 
complicated  the  scoring  system.  Thus,  it  was  decided  to  score  all  criteria  from 
sections taken from the centre of the defect where the diameter of the repair is at its 
maximum length, and to score these four criteria [level, surface, PGs and structure] 
with lower maximum points [10 points].
By contrast, the total area of the defect resurfaced, the quality of the bonding of the 
repair tissue to the adjacent normal articular cartilage and the predominant type of 
cells in the repair tissue scored similarly throughout the whole of the repair tissue and
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therefore  it was hypothesised that the score in the centre of the repair represented 
more accurately the mean score in the whole repair.  Thus,  it was decided to score 
these three criteria [area, cells and bonding] with higher maximum points [20 points].
The total maximum points that the repair tissue  can  score  are  100  and the  lowest 
score is 0. The repair tissue can be poor [total score 0-45], good [total score 50-80] or 
excellent [85-100]. The articular cartilage repair scoring system has as follows:
Articular C artilage R epair S coring System.
AREA Score
100% resurfacing 20
'50% resurfacing
•   50% resurfacing 
!   LEVEL
Normal cartilage level
K)
"
Score
10
Minimal depression / elevation 5
Gross depression
!   's u r f a c e
Smooth, glistering 
Irregular, opaque
__________ 0  ___
Score
.........  10
5
Disrupted by fissures 0
CELLS Score
Chondrocytes
Fibroblasts
20
10
Other 0
PCs Score
Normal 10
Moderate 5
Low 0
STRUCTURE Score
1lyaline-like tissue 10
Moderately disorganised 5
Grosslv disoruanised 0
BONDING Score
Complete 20
Incomplete 10
Minimal 0
ARTICUI AR CARHLAGE 
REPAIR
TOTAL SCORE
Excel len t
©
c
O
Good 50-80
Poor o-45
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CHAPTER III.B
MACROSCOPIC AND HISTOLOGICAL/HISTOCHEMICAL ASSESSMENT
OF THE REPAIR TISSUE 
FOLLOWING IMPLANTATION OF PEMA/THFMA POLYMER 
IN FULL-THICKNESS ARTICULAR CARTILAGE DEFECTS
OBJECTIVE
MATERIALS
•  120 adult rabbits
•  PEMA vs CONTROL
METHOD OF IMPLANTATION 
METHODS OF ASSESSMENT
•  Macroscopic evaluation at 6 weeks, 3 months, 6 months and 1  year
•  Histological/Histochemical evaluation at 6 weeks, 3 months, 6 months and 1 year
RESULTS
DISCUSSION
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OBJECTIVE
This study aims to assess the chondrogenic potential of PEMA/THFMA polymer in large 
full-thickness articular cartilage defects in the weight-bearing area of the knee joint.
MATERIALS
One hundred and twenty female Sandy-Lop adult rabbits (10-12 months of age and 3.6- 
4.7 [mean 4.1] kg of weight) were used for the experiment. Both knees were operated on 
in each animal, the one knee receiving the new biomaterial [PEMA] and the contralateral 
knee receiving no biomaterial and allowed to repair ‘naturally’ [CONTROL].
METHOD OF IMPLANTATION
Anaesthesia was  induced  by intravenous  injection of Methohexitone  Sodium  (Brietal, 
lOmg/kg)  and maintained  by 2%  Halothane  and  a 3:2  mixture  of Nitrous  Oxide  and 
Oxygen, through a fixed face mask. The knee joint was exposed through a 2cm straight 
midline skin incision and a medial parapatellar approach. The osteochondral defect was 
created in the femoral trochlea,  10mm proximal to the level of insertion of the anterior 
cruciate ligament into the distal femur. The femoral trochlea articulates directly with the 
patella throughout the  whole  range  of movement of  the knee joint,  and  is  a heavily 
loaded area of  articular cartilage with significant shear forces applied by the articulating 
patella.  A circular articular cartilage and subchondral bone defect was created by hand, 
using a 4.5mm drill bit. The depth of drilling was carefully controlled to be 4mm in the 
biomaterial group and 2mm in the control group. All osteochondral debris from the drill 
holes were thoroughly washed with normal saline prior to polymer implantation.
Preparation of the polymer system was made at room temperature using a sterile spatula 
(Patel  and  Braden,  1991ii)  by  mixing  by  hand  lgr  PEMA  (powder  containing  8% 
Barium Sulphate) with 0.6ml THFMA (liquid containing 2.5% V/V N,N - dimethyl  -  p 
-  toluidine)  for  two  minutes.  The  resulting  paste  was  then  sucked  into  a  1ml  sterile 
syringe and 0.1ml of this was injected into the created osteochondral defect of one knee
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[PEMA  group].  This  polymer  volume  forms  a  2mm  deep  plug  and  therefore, 
subsequently,  a  2mm  deep  by  4.5mm  wide  osteochondral  defect  was  left  to  be 
biologically repaired in both the biomaterial and the control groups.
Polymerisation occurred in situ.  In most cases bleeding from the defects was minimal, 
not interfering with accurate positioning of the polymer plugs and setting of the polymer. 
During  polymerisation,  using the  flat  end  of a  4.5mm  wide  cylindrical  metallic  rod, 
constant pressure was applied at the top surface of the plugs, thus carefully controlling 
the level of implantation into the subchondral bone, 2mm below the level of the adjacent 
articular cartilage in order to allow full-thickness repair tissue to form on top. At this part 
of the joint the thickness of the articular cartilage is 1.4mm (range 1.3mm -  1.6mm). The 
positioning of the polymer plug is illustrated in the scheme below:  f
Bleeding  was  carefully controlled  and wounds were closed using absorbable sutures. 
The operated limbs were not immobilised. The rabbits were group-housed  in floor-pens 
(Batchelor,  1991).  Full  range  of  movement  and  full  weight bearing  were  allowed 
immediately  post-operatively allowing maximum loading on the defect area.
Articular 
cartilage
PEMA/THFMA
Subchondral
bone
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METHODS OF ASSESSMENT
Macroscopic and Histological/Histochemical assessment was done at 6 weeks, 3 months, 
6  months  and  1   year  post-implantation.  Thirty  rabbits  were  assigned  in  each 
observational period. General clinical observations were made and the assessment of the 
repair tissue  in the  PEMA/THFMA biomaterial  group and the  CONTROL  group  was 
based  on  the  seven  criteria  of the  Articular  Cartilage  Repair  Scoring  System.  Three 
examiners assessed all  specimens independently and blindly.  The score  given to  each 
criterion  for  each  specimen  represents  the  score  given  by  at  least  two  of the  three 
independent examiners.  In 86% of the specimens the score given was the same by all 
three examiners, and in 14% the score was given the same by two examiners. During this 
study,  none  of the  specimens  was  given  a  different  score  by  each  one  of the  three 
examiners.
Macroscopic evaluation
The rabbits were sacrificed by  intravenous injection of pentobarbitone sodium (Euthatal 
600mg). The presence or absence of knee swelling and/or contractures was recorded. The 
knee joints  were  exposed and the presence  of excessive  synovial  fluid,  intra-articular 
adhesions or degenerative changes was also noted. Samples of the adjacent to the defect 
synovium  were  placed  in  10%  neutral  buffered  formalin  and  sent  for  histology,  to 
investigate  an  inflammatory  or  foreign  body  reaction  to  the  biomaterial 
[biocompatibility]. The total resurfaced area of the defect [AREA criterion in the Scoring 
System],  the  repair tissue  level  in relation to  the  adjacent  articular  cartilage  [LEVEL 
criterion] and the repair surface appearance [SURFACE criterion] were assessed.
Histological and histochemical evaluation
Distal femora, including the resurfaced defect area, were fixed in 4% paraformaldehyde 
and 0.3% glutaraldehyde in 0.1M sodium cacodylate for seven days at 4°C.  Excessive 
bone of the distal femur was removed and specimens were decalcified in neutral EDTA 
(14%  solution  in  distilled  H2O)  at  4°C,  until  mineral  (calcium)  could  no  longer  be 
detected radiographically.
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Specimens  were  washed  in  0.1M  sodium  cacodylate  for  two  days  and  dehydrated 
through a graded series of ethanols (70%, 90%,  100%) and xylene for 24 hours at room 
temperature, with three changes of fresh xylene. Specimens were then impregnated into 
wax over 24 hours at 60°C, with three changes of fresh wax, before being embedded into 
wax blocks and stored at room temperature.  Sagittal sections, 5 pm thick, cut from the 
central part of the defect and including the whole of the repair tissue and part of the 
adjacent to the defect normal articular cartilage, were stained with haematoxylin/eosin 
and safranin-0 stains.
The haematoxylin/eosin and safranin-0 stained sections were assessed by means of the 
predominant type of cell in the repair tissue [CELLS criterion in the Scoring System], the 
concentration of extracellular proteoglycans [PGs criterion], the structural characteristics 
of the repair tissue in terms of cell/matrix organisation [STRUCTURE criterion] and the 
quality of bonding between the repair tissue and the adjacent normal articular cartilage 
[BONDING criterion].
Sagittal sections,  1  pm thick were cut with a diamond knife from 16 randomly selected 
specimens [2 from the PEMA group and 2 from the control group at 6 weeks, 3 months, 
6 months and  1   year] and were stained with  1% toluidine blue in 1% borax (Robinson 
and Gray,  1990). These sections were later prepared for electron microscopy according 
to the method described in Chapter III.D.
RESULTS
Clinical observations
•  Deaths and excluded animals
The rabbits lived happily in the open pens during the experimental period. Five rabbits 
died unexpectedly and two other rabbits were culled as a result of continuing otitis media 
that was impossible to be controlled on antibiotics. The incidents happened at 5 weeks [3 
rabbits, 2 died and I was culled, finally assigned in the 6 week experimental period], at 7 
months [1 rabbit died, assigned in the 6 month experimental period] and at 11 months [3
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rabbits, 2 died and  1   was culled, assigned at the  1  year experimental period]. All seven 
rabbits were replaced in their original groups.
•  Contractures
Twenty  seven  knees  were  detected  with  fixed  flexion  deformity  [21  (17.5%)  in  the 
control group and 6 (5%) in the biomaterial group]. The deformities consisted of loss of 
extension in the knee joint although flexion was complete. The fixed flexion deformity 
ranged between 25 and 50 degrees in the control group and between 30 and 40 degrees in 
the biomaterial group.
•  Intra-articular adhesions
Twenty-eight (23.3%) knees in the control group and 7 (5.8%) knees in the biomaterial 
group  were  found  to  have  intra-articular  adhesions.  Twelve  of these  knees  from  the 
control group were also found to have fixed flexion deformity while none of the knees 
with  intra-articular  adhesions  demonstrated  fixed  flexion deformity in the  biomaterial 
group.  All intra-articular adhesions were primarily in the anterior compartment of the 
knee although additional adhesions in the medial compartment were noted in 7 knees in 
the control group.
•  Effusion
Four (3.3%) knees in the control group and three (2.5%) in the biomaterial group were 
noted to have significantly increased amount of synovial fluid which was cultured and 
was found sterile in all cases.
•  Osteoarthritic changes
Moderate/advanced osteoarthritic changes were noted in 2  (3.3%)  of the  knees  of the 
PEMA group at 6 months and in 7 (11.6%) of the knees in the 1-year specimens (5 in the 
control group and 2 in the PEMA group). The changes consisted primarily of destruction 
of the articular cartilage in the femoral condyles (predominantly the medial condyle) and 
formation of peripheral osteophytes.
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•  Non-specific inflammation of the synovium and foreign body reaction
Mild inflammatory response of the synovium was noted in 26  (21.6%)  of the control 
knees  and  in  11  (9.1%)  of the  knees  in  the  biomaterial  group.  The  changes  in  the 
biomaterial group were noted exclusively in the 6-week and 3-month specimens (9 and 2 
knees respectively). In the control group the inflammatory response was more common 
in the 6-month and  1-year specimens (7 and  10 knees respectively) with less reaction 
noted at 6 weeks (4 knees) and 3 months (4 knees). There was no evidence of infection 
or foreign body reaction in the synovial membrane samples. There was prominent vilous 
formation in the synovial tissue with chondroid metaplasia of the stroma with occasional 
incorporated calcified bony particles, some of which were surrounded by multinucleate 
giant  cells,  in  19  of  the  control  knees.  Mild  vilous  formation  without  chondroid 
metaplasia of the stroma was noted in 3 of the knees of the biomaterial group.
Macroscopic and Histological/Histochemical results
All  results  are  demonstrated  in  Tables  III.B.l,  III.B.2,  III.B.3,  III.B.4,  and  III.B.5 
followed by statistical analysis and Figures III.B.l -  III.B.28.
At all observational periods the PEMA group scored higher than the control group in all 
seven criteria.  At 6 weeks,  the highest mean scores in the PEMA group were  for the 
surface (9 out of 10), for the cells (18 out of 20) and for the proteoglycans (9.5 out of 
10). The total mean scores were 80.83 in the PEMA and 42.83 in the control groups. At 3 
months, the highest mean scores in the PEMA group were for the cells (15.33 out of 20), 
for the bonding (15.33  out of 20) and for the proteoglycans (8.67 out of 10). The total 
mean scores in the PEMA group was 73.50 and in the control group 50.00. At 6 months, 
the highest mean scores were for the cells (15.33  out of 20), for the proteoglycans (8.5 
out of 10), for the level (8 out of 10) and for the area resurfaced (15 out of 20). The total 
mean scores in the PEMA group was 73.33 and in the control group 50.33. Finally at 1  
year, the higher mean scores were for the area (16 out of 20), for the cells (15 out of 20) 
and for the level (8.17 out of 10). The total mean scores were 69.33  in the PEMA and 
46.00 in the control groups.
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Table IIIB.l:
M acroscopic and H istological/H istochem ical assessm ent per criterion 
S coring at 6  w eek s. R abbits 1-30 
PEMA vs CONTROL
PEMA 1 2 3 4 J 6 7 8 9 10  11  12  13 14 U.  16  17  18  19  20  n 22 2324252627282930
Area 2 0 2 0 10 2 0 2 0 10 0 2 0 10 2 0 2 0 2 0 2 0 2 0 10 2 0 0 0 2 0 2 0 10 2 0 10 2 0 10 2 0 0 2 0 2 0 2 0
Level 10 5 10 10 10 0 0 10 10 10 10 5 10 10 10 10 0 5 10 10 10 10 10 10 10 5 0 10 10 10
Surface 10 5 10 10 10 10 5 10 10 10 10 10 10 10 10 10 0 5 10 10 10 10 10 10 10 10 5 10 10 10
Cells 2 0 2 0 2 0 2 0 2 0 2 0 10 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0  2 0 10 10 10 2 0 2 0 2 0 2 0 2 0 2 0 2 0 0 2 0 2 0 2 0
PCs 10 10 10 10 10 10 5 10 10 10 10 10 10 10 10 10 5 10 10 10 10 10 10 10 10 10 5 10 10 10
Structure 10 5 5 5 10 5 0 5 5 5 5 10 5 10 10 10 0 0 5 5 10 10 5 5 5 0 0 0 10 5
Bonding 2 0 2 0 2 0 2 0 10 2 0 10 2 0 2 0 2 0 2 0 10 10 2 0 2 0 10 0 10 2 0 2 0 10 2 0 2 0 2 0 10 2 0 0 2 0 2 0 2 0
TOTAL
SCORE
1 0 0 85 85 95 90 75 30 95 85 95 95 85 85 100 90 90 15 40 85 95 80 1 0 0 85 95 75 85 10 90 10 95
CONTROL I 2 3 4 5 6 7 8 9 IQ.  11  12  13 14 15  16  17  18  19  20  21 22 23  24  25  26  27  28  29  30
Area 1 0 0 1 0 1 0 io 20 1 0 1 0 20 0 0 0 1 0 20 1 0 1 0 1 0 1 0 1 020 20 1 0 0 1 0 0 0 0 1 020 0
Level 5 0 5 5 5 1 0 5 1 0 1 0 0 5 0 1 0 5 5 5 5 1 0 1 0 1 0 5 0 0 0 1 0 1 0 0 5 5 0
Surface 0 5 5 5 1 0 1 0 1 0 5 0 0 5 0 1 0 5 5 5 5 5 5 1 0 5 0 5 5 1 0 1 0 5 5 5 0
Cells 10 1 0 1 0 1 0 1 020 1 0 1 0 20 1 0 0 0 1 0 1 0 1 0 1 0 0 1 0 1 020 1 0 0 1 0 1 0 0 0 1 020 1 0 1 0
PCs 5 0 5 1 0 5 1 0 1 0 5 0 5 0 0 1 0 1 0 5 5 0 1 0 5 5 1 0 0 1 0 5 0 5 1 0 1 0 0 5
Structure 0 0 0 0 0 5 0 0 0 5 0 0 0 0 5 5 5 0 0 0 0 0 0 5 0 0 0 5 5 5
Bonding 1 0 1 0 0 0 1 0 1 0 0 1 0 1 0 1 0 0 0 1 0 1 0 20 1 0 1 0 0 0 20 20 1 0 0 1 0 0 0 0 19 1 0 1 0
TOTAL
SCORE
40 25 35 40 50 85 45 50 60 30 10 0 60 60 60 50 35 45 40 85 70 2 0 25 45 2 0 25 25  65 55 30
PEMA MEANS CONTROL MEANS PEMA SD CONTROL SD
Area 15.00 9.00 7.31 7.12
Level 8 .0 0 5.17 3.62 3.82
Surface 9.00 5.17 2.42 3.34
Cells 18.00 9.33 4.84 5.83
PGs 9.50 5.33 1.53 3.92
Structure 5.33 1.50 3.46 2.33
Bonding 16.00 7.33 6 .2 1 6.40
TOTAL 80.83 42.83 24.21 20.33
SCORE
100  -
90
80  --
70
2  60
50  -
40  -
30  -
20  -
10
6  weeks
IPEMA
IControl
Criteria
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Table m.B.2:
M acroscopic and H istological/H istochem ical assessm ent per criterion 
S coring at 3  m onths. R abbits 31 - 60
PEMA vs CONTROL
PEMA U 32  33 34  35  36  37  38  39  40  41  42  43 44 45 46  47  48  49  50  51  52  53 54 55 56 57 58 59 60
Area 2 0 10 2 0 2 0 2 0 2 0 10 2 0 0 2 0 2 0 2 0 10 2 0 0 0 2 0 2 0 10 2 0 2 0 10 0 2 0 0 2 0 2 0 2 0 2 0 10
Level 10 10 10 10 5 10 0 10 0 10 10 10 5 10 0 5 10 10 10 10 5 10 0 10 10 10 5 10 5 10
Surface 10 10 10 5 10 10 5 5 0 10 10 10 10 5 0 0 10 10 10 10 5 5 0 10 10 10 10 5 5 10
Cells 2 0 2 0 2 0 2 0 2 0 2 0 10 10 10 2 0 10 2 0 2 0 10 10 0 10 2 0 2 0 2 0 10 10 10 2 0 2 0 2 0 10 2 0 10 2 0
PGs 10 10 10 5 10 10 10 10 0 10 10 10 10 10 5 0 10 10 10 5 10 5 10 10 10 10 10 10 10 10
Structure 5 5 5 0 5 5 5 5 0 5 5 0 5 5 0 0 0 5 5 5 10 5 5 10 5 10 10 5 5 0
Bonding 2 0 2 0 2 0 2 0 10 2 0 2 0 2 0 10 2 0 2 0 2 0 10 10 10 0 10 10 2 0 2 0 2 0 10 10 2 0 2 0 2 0 10 10 2 0 10
TOTAL 95 85 95 80 80 95 60 80 2 0 95 85 90 70 70 25 5 70 85 85 90 80 55 35 100 75 1 0 0 75 80 75 70
SCORE
CONTROL 31 n 3 3 3 4 i l M i l i l l 2 1 0 4 1   42  43  44  4 5  46 47 48  49  50  5 1   52  5 3 54 5 5 5 6 57 58  59  60
Area 10 10 10 10 0 10 10 10 10 0 0 0 10 2 0 2 0 10 2 0 0 0 10 10 10 2 0 2 0 10 0 10 2 0 10 0
Level 10 5 5 5 0 5 10 10 5 0 5 0 10 5 10 5 10 0 5 10 5 10 5 10 10 0 0 5 10 5
Surface 5 5 10 0 5 5 10 5 0 5 5 0 10 5 10 5 10 5 0 10 5 10 5 10 0 5 0 5 10 5
CeUs 2 0 10 10 0 10 10 10 0 10 10 2 0 2 0 10 10 2 0 10 0 0 10 10 10 10 10 10 0 10 0 10 10 0
PGs 5 5 5 10 10 5 10 0 5 10 10 10 10 5 5 5 5 0 10 5 10 5 5 10 5 0 10 5 10 10
Structure 0 0 5 5 0 . 5 0 5 5 0 5 5 0 0 0 5 5 5 10 10 5 5 5 0 5 5 5 10 10 5
Bonding 10 10 2 0 10 0 10 10 2 0 10 2 0 10 0 10 10 2 0 10 10 10 2 0 10 10 10 2 0 2 0 0 0 10 10 10 10
TOTAL
SCORE
60 45 65 40 25 50 60 50 45 45 55 35 60 55 85 50 60 20 10 65 55 60 70 80 30 20 35 65 70 35
PEMA MEANS CONTROL MEANS PEMA SD CONTROL SD
Area 14.67 9.33 7.76 6.91
Level 7.67 5.83 3.65 6.91
Surface 7.33 5.50 3.65 3.73
Cells 15.33 9.00 5.71 3.56
PGs 8.67 6.67 2.92 6.07
Structure 4.50 4.17 3.04 3.30
Bonding 15.33 1 1 .0 0 5.71 3.24
TOTAL 73.50 50.00 23.86 18.05
SCORE
100
90
80
70
60
50
40
30
20
10
3  months
■ PEMA
■  Control
✓
Criteria
& &
<o A'
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Table III.B.3:
M acroscopic and H istological/H istochem ical assessm ent per criterion 
S coring at 6  m onths. R abbits 61 - 90
PEMA vs CONTROL
PEMA 61 62 63 64 65 66 67 68 69  70 71 72 73 74 75  76 77  78 79  80  81 82 83 84 85 86 87 88 89 90
Area 2 0 10 10 2 0 2 0 2 0 2 0 10 2 0 10 0 2 0 2 0 2 0 2 0 10 2 0 0 2 0 10 2 0 10 2 0 2 0 20 10 0 20 20 1 0
Level 10 5 0 10 10 5 10 10 10 10 5 10 5 10 10 10 5 0 10 10 5 10 10 10 5 10 10 10 10 5
Surface 10 10 5 10 5 5 10 5 10 10 10 5 10 10 5 5 5 0 10 10 5 10 10 5 5 0 10 0 10 5
Cells 2 0 2 0 10 2 0 2 0 2 0 10 2 0 10 10 10 2 0 10 2 0 10 2 0 10 2 0 10 10 2 0 10 10 10 20 2 0 2 0 2 0 10 2 0
PGs 10 10 10 5 10 10 10 10 10 5 5 10 5 10 5 10 5 10 10 10 10 10 10 5 10 5 10 10 10 5
Structure 5 5 5 0 5 10 5 10 5 5 5 5 5 5 5 5 5 5 0 10 5 10 5 10 5 5 5 0 0 5
Bonding 2 0 2 0 10 10 2 0 10 2 0 10 10 2 0 2 0 2 0 2 0 2 0 10 0 2 0 10 0 2 0 10 2 0 10 2 0 10 2 0 2 0 2 0 10 0
TOTAL 95 80 50 75 90 80 85 75 75 70 55 90 75 95 65 60 70 45 60 80 75 80 75 80 75 70 75 80 70 50
SCORE
CONTROL 61 62 63 64 65  66 67 68 69 70 71 72 73 74 75  76  77  78 79  80 81 82 83 84 85 86 87 88 89 90
Area 10 20 10 0 10 10 10 0 10 20 20 10 10 20 10 2 0 0 0 10 10 10 20 10 10 10 10 10 10 10 20
Level 10 5 0 5 10 5 10 5 10 5 0 0 10 5 10 10 5 5 10 10 5 5 10 5 5 5 5 5 5 5
Surface 10 5 5 5 5 5 5 10 10 5 5 0 5 10 5 0 5 0 0 5 0 5 10 5 10 5 0 0 0 5
Cells 2 0 10 10 10 10 2 0 10 10 10 10 2 0 0 10 10 10 10 10 2 0 10 10 10 10 10 0 10 10 10 10 10 10
PGs 10 5 5 10 10 10 5 5 5 5 0 5 0 5 0 5 5 5 10 10 10 5 5 5 5 10 5 5 5 5
Structure 0 0 5 5 0 0 0 5 0 0 5 0 5 10 5 5 5 5 10 0 0 5 5 5 0 0 0 0 0 0
Bonding 2 0 10 2 0 10 10 10 0 0 10 10 10 0 10 0 10 0 10 10 10 10 10 10 10 10 10 10 10f
10 2 0 10
TOTAL 80 55 55 45 55 60 40 35 55 55 60 15 50 60 50 50 40 45 60 55 45 60 60 40 50 50 40 40 50 55
SCORE
PEMA MEANS CONTROL MEANS PEMA SD CONTROL SD
Area 15.00 1 1 .0 0 6.82 6.07
Level 8 .0 0 6.17 3.11 3.13
Surface 7.00 4.67 3.37 3.46
Cells 15.33 10.67 5.07 4.50
PGs 8.50 5.83 2.33 2.96
Structure 5.17 2.67 2.78 3.14
Bonding 14.33 9.33 6.79 5.21
TOTAL 73.33 50.33 12.62 11.29
SCORE
100
90
80
70  + 
60 
50  - 
40  - 
30  -  
20 
10 
0
6 months
IPEMA 
I Control
h k it
Criteria
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Table III.B.4:
M acroscopic and H istological/H istochem ical assessm ent per criterion 
S coring at 1  year. R abbits 91 -120
PEMA vs CONTROL
PEMA 91 92 93 94 95 96 97 98 99  100  101  102  103  104  105 106 107 108  109 110  111  112  113  114  115  116 117 118  119 120
Area 2 0 2 0 10 2 0 10 2 0 10 2 0 10 2 0 2 0 2 0 2 0 2 0 10 2 0 0 2 0 2 0 2 0 2 0 10 2 0 10 2 0 10 2 0 10 2 0 10
Level 10 10 5 10 10 10 10 10 10 10 10 10 5 5 10 10 5 10 0 10 10 5 10 10 5 10 10 10 5 0
Surface 0 5 5 5 10 5 10 5 0 0 5 5 5 10 0 10 10 10 5 5 5 5 5 0 0 10 0 10 5 5
Cells 2 0 10 2 0 2 0 2 0 2 0 2 0 2 0 10 10 10 10 2 0 2 0 0 10 2 0 2 0 10 2 0 2 0 2 0 10 10 10 10 2 0 10 2 0 10
PGs 10 10 5 5 10 10 10 10 10 5 5 5 5 10 5 5 5 5 5 5 10 10 10 5 0 5 5 5 5 5
Structure 5 5 0 0 5 5 0 0 5 0 5 0 0 5 10 5 5 5 10 10 5 5 5 5 0 0 0 5 5 10
Bonding 2 0 10 2 0 2 0 2 0 2 0 10 10 10 10 2 0 2 0 2 0 10 2 0 10 2 0 2 0 10 2 0 2 0 10 10 10 0 10 10 10 2 0 10
TOTAL 85 70 65 80 85 90 70 75 55 55 75 70 75 80 55 70 65 90 60 90 90 65 70 50 35 55 65 60 80 50
SCORE
CONTROL  91  92  93  94  95  96  97  98  99  100  101  102  103  104  105 106 107 108  109 110 111  112  113  114 115  116 117 118  119 120
Area 2 0 10 10 2 0 10 2 0 0 2 0 10 2 0 0 0 10 2 0 10 0 0 0 0 0 10 2 0 10 10 2 0 2 0 2 0 0 0 10
Level 10 10 5 5 5 5 0 5 5 5 5 0 0 5 5 5 5 5 5 5 0 5 0 10 10 5 0 5 0 0
Surface 0 0 5 0 0 0 5 0 0 0 5 10 0 0 5 5 5 5 0 0 5 5 0 10 5 10 5 5 0 0
Cells 10 10 0 10 10 2 0 10 2 0 2 0 10 10 10 2 0 0 2 0 10 10 2 0 10 10 2 0 10 10 2 0 10 10 10 10 0 0
PGs 5 5 5 0 0 5 5 5 5 0 0 5 0 0 10 10 5 10 5 5 5 5 5 0 10 5 5 5 0 10
Structure 0 0 5 5 0 5 5 0 0 0 5 5 5 0 10 5 0 0 0 0 5 0 0 0 0 10 5 5 5 5
Bonding 10 10 10 2 0 2 0 2 0 2 0 10 10 2 0 10 10 0 0 10 10 0 0 10 10 10 10 10 10 10 10 10 10 0 10
TOTAL
SCORE
55 45 40 60 45 75 45 60 50 55 35 40 35 25 70 45 25 40 30 30 55 55 35 60 65 70 55 40 5 35
PEMA MEANS CONTROL MEANS PEMA SD CONTROL SD
Area 16.00 1 0 .0 0 5.63 8.30
Level 8.17 4.33 3.07 3.14
Surface 5.17 3.00 3.59 3.37
Cells 15.00 11.33 5.72 6.29
PGs 6.67 4.50 2.73 3.31
Structure 4.00 2.83 3.32 3.13
Bonding 14.33 1 0 .0 0 5.68 5.87
TOTAL 69.33 46.00 13.94 15.61
SCORE
100
90
80
70
60
50
40
30
20
10
0
1  year
■ PEMA
■  Control
C r?  A®  .  /V S
<r  i?  /
*  < (P
A
Criteria
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Table 1II.B.5:
M acroscopic and H istological/H istochem ical assessm ent.
T O T A L  S C O R E S  at 6  w eek s, 3  m onths, 6  m onths and 1  year. R abbits 1-120
PEMA vs CONTROL.
PEMA MEANS CONTROL MEANS PEMA SD CONTROL SD
6 weeks 80.83 42.83 24.21 20.33
3 months 73.50 50.00 23.86 18.05
6 months 73.33 50.33 12.62 11.29
1 69.33 46.00 13.94 15.61
100  T
6  w eeks  3  m onths  6  months  1  year
Time
There is continuous superiority of the repair in the biomaterial group throughout the  1- 
year period of assessment. This affects all seven criteria and the results are statistically 
significant. It appears that the repair tissue in the control group scores worse results in 
the immediate post-operative period, while it slightly improves at 3 and 6 months. On the 
contrary, the repair tissue in the biomaterial group scores the highest results at 6 weeks 
post-operatively and slowly degrades with time, although it always remains significantly 
superior than the repair tissue in the control group.
Table III.B.6  shows the  assessment of the  repair tissue  in  the PEMA and the  control 
groups  at  all  observational  periods  by criterion  as  well  as  the  overall  grading  of the 
repair.
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Table III.B.6:
M acroscopic and H istological/H istochem ical assessm ent of repair tissue by criterion and 
the overall repair at 6  w eeks, 3  m onths, 6  m onths and 1  year 
PE M A  v s C O N T R O L
6 weeks 3 months 6  months  1 year
C R IT E R IO N PEMA 
n  =30
CONTROL
n-30
PEMA
n-30
COM ROE 
n=30
PEMA  CONTROL  PEMA 
11 "30  n-30  n=30
CONTROL
n-30
AM-: A
100% iGsuriaeing 19  (63.3%) 6  (2U.U>o) 19  (63.3%) 6  (20.0%) 18  (b0.0%)  /  (23.3%)  19  (63.3%) 10  (33.3%)
>50% resurfacing 7  (23.3%) 15  (50.0%) 6  (20.0%) 16  (53.3%) 9  (30.0%)  19  (63.3%)  10  (33.3%) 10  (33 3%)
<-50% resurfacing 4  (13.3%) 9  (30.0%) 5  (16.6%) 8  (26 6%) 3  (10.0%)  4  (13.3%)  1   (3.3%) *10  (35.3"o)
LEVEL
Normal cartilage level 22  (73  1%) 9  (30.0%) 20  (66.6%) 11  (36 6%) 20  (66.6%)  9  (30.0%)  21  (70.0%) 4  (13.t%)
Minimal depression 4  (13.3%) 13  (43.3%) 6  (20.0%) 13  (43.3%) 8  (26.6%)  18  (60.0%)  7  (23.3%) 18  (60.0%)
Gross depression 4  (13.3%) 8  (26.6%) 4  (13.3%) 6  (20.0%) 2  (6.6%)  3  (10.0%)  2  (6.6%) 8  (26.6%)
SURFACE
Smooth, glistering 25  (83.3%) 7  (23.3%) 18  (60.0%) 9  (30.0%) 15  (50.0%)  6  (20.0%)  8  (26.6%) 3  (10.0%)
Irregular, opaque 4  (13.3%) 17  (56.6%) 8  (26.6%) 15  (50.0%) 12  (40.0%)  16  (53.3%)  15  (50.0%) 12  (40.0%)
Disrupted by fissures 1  (3.3%) 6  (20.0%) 4  (13.3%) 6  (20.0%) 3  (10.0%)  8  (26.6%)  7  (23.3%) 15  (50.0%)
CELLS
Chondrocytes 25  (83.3%) 4  (13.3%) 17  (56.6%) 4(1= ' % ) 16  (53.3%)  4  (13.3%)  16  (53.3%) 8  (26.6%)
Fibroblasts 4  (13.3%) 20  (66.6%) 12  (40.0%) 19  (63.3%) 14  (46.6%)  24  (80.0%)  13  (43.3%) 18  (60.0%)
Other
PGs
1   (33.3%) 6  (20.0%) 1   (3.3%) 7  (23.3%) 0  (0.0%)  2  (6.6%)  1   (3.3%)
.
4  (13 3%)
Normal 27  (90.0%) 10  (33.3%) 24  (80.0%) 13  (43.3%) 21  (70 0%)  8  (26 6%)  11  (36.6%) 5  (16.6%)
Moderate 3  (9.9%) 12  (40.0%) 4  (13.3%) 14  (46.6%) 9  (30.0%)  19  (63.3%)  18  (60.0%) 17  (56.6%)
Low 0  (0.0%) 8  (26.6%) 2  (6.6%) 3  (9.9%) 0  (0.0%)  3  (9.9%)  1   (3.3%) 8  (26.6%)
STRUCTURE
I lyaline-like tissue 8  (26.6%) 0  (0.0%) 4  (13.3%) 4  (13.3%) 5  (16.6%)  2  (6.6%)  4  (13.3%) 2  (6/.%)
Moderately disorganised 16  (53.3%) 9  (30.0%) 19  (63.3%) 17  (56.6%) 21  (70.0%)  12  (40.0%)  16  (53.3%) 13  (43.3%)
Grossly disorganised 6  (20.0%) 21  (70.0%) 7  (23.3%) 9  (30.0%) 4  (1.3.3%)  16  (53.3%)  10  (33.3%) 15  (50.0%)
BONDING
Complete 20  (66.6%) 3  (9.9%) 17  (56.6%) 6  (20.0%) 16  (53.3%)  3  (9.9%)  14  (46.6%) 5  (16.6%)
Incomplete 8  (26.6%) 16  (53.3%) 12  (40.0%) 20  (66.6%) 11  (36.6%)  22  (73.3%)  15  (50.0%) 20  (66.6%)
Minimal 2  (6.6%) 11  (36.6%) 1   (3.3%) 4  (13.3%) 3  (9.9%)  5  (16.6%)  1   (3.3%) 5  (16.6%)
ARTICULAR 6  weeks ■  .V :  3; months 6  months  1   year
CARTILAGE
REPAIR
PEMA
n=30
c o \  rum V  >  I  ^   S.  •  A  V  ^  ^
n-30
PEMA
n=30
CONTROL
n-30
PEMA  CONTROL  PEMA 
n-30  n-30  n-30
COM ROE
n-30
EXCELLENT 22  (73.3%) 2  (6.6%) 12 (40.0%) 1   (3.3%) 5  (16.6%)  0  (0.0%)  6  (20.0%) 0  (0.0%)
GOOD 4  (13.3%) 10  (33.3%) 14 (46.6%) 18  (60.0%) 24  (80.0%)  20  (66.6%)  23  (76.6%) 13  (43.3%)
POOR 4  (13.3%) 18  (60.0%) 4  (13.3%) 11  (36.6%) 1   (3.3%)  10  (33.3%)  1  (3.3%) 17  (56.6%)
Table  III.B.6  shows that the  area  of the  defects  in the  PEMA  group  was  completely 
resurfaced by 6 weeks  in 63.3%  and remained so  over time  showing  63.3%  complete 
cover  also  at  1   year.  In  the  control  group  the  majority  of the  defects  (80%)  were 
incompletely resurfaced. In 73.3% in the PEMA group the defects were resurfaced up to 
the level of the surrounding normal articular caritlage by 6 weeks and they remained so 
in 70% up to  1   year. In the control group the majority of the defects (70% by 6 weeks) 
were  found depressed.  This phenomenon in the control group deteriorates  further with 
time (86.7% depressed repairs at 1   year). The surface appearance of the repair tissue in 
both  groups  deteriorated  with  time,  more  severely  in  the  control  group  (50%  of the 
repairs were disrupted by fissures at 1  year).
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Table III.B.6 also shows that there was striking chondrocyte predominance in the repair 
tissue  in  the  biomaterial  group  (83.3%  by  6  weeks)  compared  to  the  fibroblastic 
predominance  (66.6%  by  6  weeks)  in  the  control  group.  The  repair  tissue  in  the 
biomaterial group presented high concentration of proteoglycans  (90% by 6 weeks), 
much higher than that in the control group (33.3% at 6 weeks). There was, however, in 
both groups a gradual decrease in the proteoglycan concentration over time.
In both groups the structure of the cells and the matrix was inferior compared to normal 
articular cartilage. In the biomaterial group the cells of the repair tissue were numerous, 
oriented parallel to the surface of the repair in the superficial layer and more vertical in 
the deeper layers, without the characteristic formation of columns. Collagen fibres were 
scattered and disorganised particularly in the long-term specimens (86.6% in 1  year). In 
the control  group,  however,  there  was  complete  disorganisation of the  cellular/matrix 
components in both the superficial and the deep layers of the repair tissue, particularly in 
the short-term specimens (100% at 6 weeks and 93.3% at 1 year).
There  was  significantly  superior  bonding  of the  repair tissue  to  the  surrounding  the 
defect normal  articular cartilage  in the biomaterial  group at all times post-operatively 
(66.6% complete bonding at 6 weeks and 46.6% at 1   year). The majority of the control 
group specimens, however, showed incomplete/minimal bonding of the fibrous tissue to 
the  adjacent articular  cartilage  (90.1%  at  6  weeks  and  83.4%  at  1  year).  The  overall 
complete  bonding  of the  repair tissue  to  the  surrounding  the  defect  normal  articular 
cartilage in the PEMA group was 55.8% throughout the 1-year period.
Statistical analysis of the results:
The most important aspect of the trial design is the pairing of the PEMA and CONTROL 
knees  within  animals  because  this  automatically  removes  the  inter-animal  variability. 
The measurements are ordinal, rather than scalar, and thus the McNemar’s test was used. 
This test demonstrates the possible asymmetry in the results that would indicate that the 
score was dependent on whether the articular cartilage defect was resurfaced with PEMA 
or not, or that it could be produced at random. This test produces a p-value to quantify 
this effect.
86Chapter III
For each animal, there are seven pairs of scores corresponding to different criteria of 
each knee’s repair. The number of rows/columns (20) is too large and hence McNemar’s 
test  would  have  insufficient  power.  Instead,  we  assume  the  20  point  ordinal  score 
produced is an approximation to a continuous scale. This allows the use of Wilcoxon’s 
rank sum test. This counts how many of the PEMA scores are ‘greater’, ‘equal’ or ‘less 
than’  the  corresponding  control  score.  An  imbalance  between  the  ‘greater’  and  ‘less 
than’ counts indicates that  PEMA/control has an effect on the overall score. Wilcoxon’s 
test also produces a p-value to quantify this.
To surmount multiple testing errors and the inability to detect trends in the ‘size’ of the 
treatment’s effect, a more complex statistical approach is taken, namely polychotomous 
logistic  regression.  Firstly,  the  pairing  is  ignored  and  the  knees  are  assumed  to  be 
individual  units,  independent  from  each  other.  Secondly,  the  knees’  total  score  is 
trichotomised into three categories, excellent, good and poor, and Table III.B.6 for the 
tissue repair is used where the numbers are counts of knees. From this we fit a model 
where the probability of falling into a particular repair category is a function of the time 
and treatment. This allows the detection of any trends or interaction and improves the 
statistical power. The exact details are:
Pr( repair =i | treatment, time) = 0,  i =  poor, good, excellent;
treatment = PEMA, Control;
time = 6 weeks, 3 months, 6 months, 1 year
where,
log(0|) = CCj + Ptreatment  i  Ptime  i
The  data  determines  the  choice  of  a ,p ,  and  we  assess  the  goodness  of fit  using  an 
analysis of deviance table which uses the  difference  between predicted  and  observed 
values  to  test  if the  covariates  should  be  included  in  the  model.  The  values  of the 
coefficients,  a, p , tell us the size and direction of any trends.
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P-values for McNemar’ s and Wilcoxon’ s test
SCORES 6 weeks 3 months 6 months 12 months Using combined 
time groups
Area 0.019 0.011 0.149 0.022 1.5e-6
Level 0.031 0.163 0.039 0.001 7.4e-8
Surface 6.4e-4 0.162 0.055 0.080 8.7e-7
Cells l.le-4 0.011 0.010 0.133 5.1e-10
PGs 0.002 0.006 0.005 0.041 1.4e-8
Structure 0.002 0.749 0.014 0.506 2.6e-4
Bonding 6.7e-4 0.059 0.015 0.079 1.4e-8
Total score 
(Wilcoxon*s)
1.5e-5 0.002 7.8e-6 7.3e-5 2.7e-15
The higher mean scores of the repair tissue in the PEMA group in all time intervals show 
the superior quality of repair in the biomaterial group. This affects all criteria and total 
scores and the results are statistically significant.
It is therefore manifested that the PEMA group is significantly better than the control 
group.  The  effect  of time,  however,  is  not  very  clear.  All  the  6  week  scores  are 
significant while 4 scores at 3 months are non-significant at the 5% level. At 6 months, 2 
scores are non-significant and at  1  year 4 scores are non-significant at the 5% level of 
significance. It is difficult to tell from these tests if there is a trend over time. Using the 
box-plot below,  however,  it is  shown that there  is  a trend  over time  and the  logistic 
regression confirms this:
Total Score
a
12 6 1.5 3
Months
Analysis of deviance for the overall repair is as follows:
V ariable d.f. D eviance residual d.f. residual deviance p-value
T reatm ent 2 79.577 1 2 50 .9 0 9 .0 0 4
T im e 6 42.014 6 8 .8 9 5 .0 4 0Chapter III
The  analysis  of deviance  tells  us  that  both  treatment  with  PEMA  and  time  have  a 
significant effect on the repair. The next question is to show how these factors affect the 
repair.
To interpret the size of the effect of any covariates, we use odds ratios. To systematically 
present the predicted odds of a repair outcome given the type of treatment and time we 
present the odds of all events relative to some arbitrary reference event i.e. P(event of 
interest)/P(reference event). The reference event is an arbitrary bench-mark used for ease 
of interpretation. In this analysis the reference event used is Excellent repair having had 
treatment with  PEMA  and  being  measured  at  6  months.  If we  wish to  compare  two 
events neither of which are the reference event, we use the relationship:
P(A) =  P(A)  Preference) =  P(A)  j   P(C)  oddsjA)
P(C)  Preference)  P(C)  Preference) / Preference)  odds(C)
In fact we present the logarithm of the odds, which converts multiplication into addition 
and division into subtraction. With this we can calculate any odds ratio we desire. The 
first row tells us that:
log ( Pr(Good | PEMA, 6 weeks)  /  Pr(Excellent | PEMA, 6 weeks) ) = -1.3932 ,
which, since it is negative, tells us that with the conditioning factors, PEMA  & 6 weeks, 
having good repair is less likely than having excellent repair. The statistical results are
presented in the table below:
Conditioning Factors Repair Log odds 
coefficient
S.D. p-value
Intercept good -1.3932 0.4212 0.000942
poor -2.2495 0.5136 1.19e-05
Control good 2.9237 0.6632 1.04e-05
poor 4.6189 0.7097 7.61e-ll
Time 3 months good 1.6246 0.5375 0.002507
poor 0.5312 0.6313 0.400098
Time 6 months good 2.9803 0.6344 2.63e-06
poor 1.3226 0.7363 0.072456
Time 1  year good 2.6688 0.6100 1.21e-05
Poor  ....... 1.7690 0.6874 0.010068
The  values  of the  coefficients  indicate  that,  overall,  the  PEMA  enhanced  repairs  are 
significantly superior to  controls and that as  time progresses the  quality  of the repair 
tissue decreases marginally.
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Fig.III.B.l
Macroscopic  appearance  of the  defect  of the  articular  cartilage  in  the  femoral 
trochlea [ft] at operation:
The — ►  indicates the periphery of the defect.
Fig.III.B.2
Macroscopic  appearance  of  the  defect  in  the  articular  cartilage  of  the  femoral 
trochlea [ft] following the implantation of the polymer [p] at operation:
The  polymer plug  is  recessed below the  surrounding  normal  articular cartilage,  at the 
level of the subchondral bone. The — ►  indicates the periphery of the defect.
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Fig.III.B.3
Histological appearance of a sample of synovium of the knee joint in the polymer 
group at 6 weeks:
There is no apparent inflammatory or foreign body reaction around the polymer particles 
[— ► ]. (Haematoxylin/Eosin staining, x 66)
Fig.HI.B.4
Histological appearance of a sample of synovium of the knee joint in the polymer 
group at 1 year:
A polymer particle can be noted  [►]  with no apparent inflammatory or foreign body 
reaction around it. (Haematoxylin/Eosin staining, x 66)
91I
Chapter III
Fig.III.B.3
Fig.III.B.4Chapter III
Fig.III.B.5
Macroscopic appearance of the repair tissue in the polymer group at 6 weeks:
The defect in the femoral trochlea [ft] has been fully resurfaced and the repair tissue [rt] 
is  smooth and  glistering,  fully bonded to  the  surrounding the  defect normal  articular 
cartilage. The ►  indicates the periphery of the defect.
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Fig.III.B.6
Histological appearance of the repair tissue in the polymer group at 6 weeks: 
Complete  integration  of the repair tissue  [rt]  with the  surrounding the  defect normal 
articular cartilage  [c].  The polymer  [p]  has been dissolved through the tissue process 
[b=subchondral  bone].  The  — ►   indicates  the  smooth  transition  between  the  normal 
articular cartilage and the repair tissue. (Haematoxylin/Eosin staining, x 13.2)
Fig.III.B.7
Histological appearance in the centre of the repair tissue in the polymer group at 6 
weeks:
Numerous chondrocytes can be noted both in the supreficial  [s]  as well as the deeper 
layers in the repair tissue. The chondrocytes in the superficial layer are smaller in size 
than those in the deeper layers. (Haematoxylin/Eosin staining, x 66)
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Fig.III.B.8
Histochemical appearance of the repair tissue in the polymer group at 6 weeks:
Abundant concentration of proteoglycans can be noted in the repair tissue [rt] similar to 
the  concentration  in  the  surrounding  the  defect  normal  articular  cartilage  [cj.  The 
subchondral bone [b] does not contain proteoglycans and stained negative. The polymer 
[p] has been dissolved through the tissue process. (Safranin-O staining, x 13.2)
Fig.III.B.9
Histological appearance of the junction between the repair tissue and the normal 
articular cartilage in the polymer group at 6 weeks:
The repair tissue [rt] is fully integrated with the surrounding the defect normal articular 
cartilage [c]. (Ifan thick section, Toluidine blue staining, x 132)
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Fig.III.B.9Chapter III
Macroscopic appearance of the repair tissue in the control group at 6 weeks:
The defect in the femoral trochlea  [ft]  has been partially resurfaced with repair tissue 
[rt]  The star indicates the unresurfaced area of the defect.
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Histological appearance of the repair tissue in the control group at 6 weeks:
The repair has been covered with fibroblastic tissue with irregular superficial layer [s]. 
The — >   indicate large lipid droplets. (Haematoxylin/Eosin staining, x 66)
Fig.III.B.12
Histological appearance of the tissue in the unresurfaced area of the defect in the 
control group at 6 weeks:
Accumulation  of debris  and  undifferentiated  mesenchymal  stem  cells  can  be  noted. 
[s=superficial layer] (Haematoxylin/Eosin staining, x 13.2)
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Fig.III.B.13
Histochemical appearance of the repair tissue of the polymer group at 3 months:
The  repair tissue  [rt]  and the normal  articular  cartilage  [c]  contain  large  amounts  of 
proteoglycans.  The  subchondral  bone  [b]  contains  no  proteoglycans  and  stained 
negative. The — ►  indicates the smooth transition between the repair tissue and the normal 
articular cartilage, [p=polymer]. (Safranin-0 staining, x 13.2)
Fig.III.B.14
Histological appearance of the repair tissue in the polymer group at 3 months:
Numerous  cells  with chondrocytic phenotype  can be  noted in both the  superficial  [s] 
layer and the  deeper  [d]  layers.  The  cells  in the  superficial  layer  appear to  be  more 
flattened, lying parallel to the surface, while the cells in the deep layers are round. (Iftm 
thick section,  Toluidine blue staining, x 132)
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Histological appearance of the repair tissue in the control group at 3 months:
The repair tissue [rt] is disorganised and comprises primarily of cells with fibroblastic 
phenotype. The articular cartilage [c] surrounding the defects has also been replaced by 
fibroblastic tissue [b=subchondral bone] (Haematoxylin/Eosin staining, x 13.2)
Fig.III.B.16
Histological appearance in the centre of the repair tissue in the control group at 3 
months:
Higher magnification in the centre of the repair tissue shown in Fig.II.B.15, illustrating 
the disorganised appearance of the fibroblastic repair.  (Haematoxylin/Eosin staining,  x 
33)
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Macroscopic appearance of the repair tissue in the polymer group at 6 months:
The  defect  in  the  femoral  trochlea  [ft]  has  been  fully  resurfaced  with  smooth  and 
glistering  repair tissue  fully  contoured  to  the  shape  of the  femoral  trochlea.  The  ►  
indicates the periphery of the defect.
Fig.III.B.18
Macroscopic  appearance  of  the  posterior  aspect  of  the  femoral  condyle  of  the 
specimen shown in Fig.III.B.17:
Early osteoarthritic changes can be noted with destruction of the articular cartilage  [c] 
and  ebumation  of the  subchondral  bone  [b],  suggesting  that  the  polymer  enhances 
articular cartilage repair despite the presence of osteoarthritic changes elsewhere in the 
joint. The ►  indicates the periphery of the articular cartilage destruction.
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Fig.III.B.19
Histological appearance of the repair tissue in the polymer group at 6 months:
The repair tissue [rt] is fully integrated with the surrounding the defect normal articular 
cartilage [c]. The — ►  indicates the transition from the repair tissue to the normal articular 
cartilage.  [b=subchondral  bone,  p=space  occupied  by  the  polymer  that  has  been 
dissolved through the tissue process]. (Haematoxylin/Eosin staining, x 13.2)
Fig.III.B.20
Histological appearance of the repair tissue in the polymer group at 6 months:
The picture focuses on the junction between the repair tissue and the normal articular 
cartilage on the opposite edge of the defect shown in Fig.III.B. 19. The repair tissue [rt] 
is  fully  bonded  to  the  normal  articular  cartilage  [c]  and  it  comprises  of cells  with 
chondrocytic  phenotype.  The  —>   indicates  the  transition  from  the  repair tissue  to  the 
normal articular cartilage. [b=subchondral bone]. (Haematoxylin/Eosin staining, x 33)
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Fig.III.B.21
Histological appearance of the repair tissue in the control group at 6 months:
The  repair  tissue  [rt]  comprises  predominantly  of  fibroblasts  arranged  in  a 
multidirectional pattern. The normal articular cartilage [c]  shows signs of degeneration 
with  deep  erosions.  The  — ►   indicates  a  deep  erosion,  [b=subchondral  bone] 
(Haematoxylin/Eosin staining, x 33)
Fig.HI.B.22
Histological appearance of the repair tissue in the control group at 6 months:
The repair tissue  is primarily  fibroblastic with irregular surface and deep  fissures  [f]. 
Chondrocyte  islands  [c]  are  scattered  in  the  repair  tissue.  The  ►   indicate  the  deep 
fissure, splitting the repair tissue. (Haematoxylin/Eosin staining, x 33)
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Fig.III.B.23
Macroscopic appearance of the repair tissue in the polymer group at 1 year:
The  defect  in  the  femoral  trochlea  [ft]  has  been  fully  resurfaced  with  smooth  and 
glistering repair tissue, fully integrated with the surrounding normal articular cartilage. 
The small ►  indicates the periphery of the defect, the large — >  indicates an osteophyte in 
the femoral condyle.
Fig.III.B.24
Macroscopic  appearance  of the  posterior  aspect  of the  femoral  condyle  of  the 
specimen shown in Fig.III.B.23:
The articular cartilage  [c]  is disrupted by advanced degenerative changes with a large 
area of subchondral bone  [b]  being exposed,  indicating that the polymer can enhance 
articular cartilage repair despite the presence of degenerative changes elsewhere in the 
joint. The ►  indicates the periphery of the degeneration of the articular cartilage.
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Fig.III.B.25
Histological appearance of the repair tissue in the polymer group at 1 year:
The repair tissue  [rt]  is fully integrated with the surrounding normal articular cartilage 
[c] and comprises of cells with chondrocytic phenotype. The — >  indicates the transition 
from  the  repair  tissue  to  the  normal  articular  cartilage,  [b=subchondral  bone] 
(Haematoxylin/Eosin staining,  x 33)
Fig.III.B.26
Histochemical appearance of the repair tissue in the polymer group at 1 year:
The repair tissue [rt] and the normal articular cartilage [c] contain abundant amounts of 
proteoglycans.  The  subchondral  bone  [b]  contains  no  proteoglycans  and  stained 
negative.  The — ►   indicates the transition from the repair tissue to the normal  articular 
cartilage, [p=polymer] (Safranin-O staining, x 33)
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Fig.III.B.27
Histological appearance of the repair tissue in the control group at 1 year:
The repair tissue [rt] is fibrocartilaginous, not integrated with the surrounding the defect 
articular cartilage  [c].  The  latter shows signs of degeneration with acellular areas and 
destruction of the superficial layer. [b=subchondral bone] (Haematoxylin/Eosin staining, 
x33)
Fig.III.B.28
Histochemical appearance of the repair tissue in the control group at 1 year:
The repair tissue  [rt] contains very small amounts of proteoglycans, mainly distributed 
around  the  scattered  chondrocyte  aggregations.  Proteoglycan  concentration  is  also 
abnormal at the edge of the normal articular cartilage [c] due to tissue degeneration. The 
subchondral  bone  [b]  contains  no  proteoglycans  and  stained  negative.  (Safranin-O 
staining, x 33)
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DISCUSSION
The  present in vivo  experimental  study utilised the new hydrophilic polymer  system 
PEMA/THFMA as a potential biomaterial to enhance the biological resurfacing of large, 
full-thickness defects, in a weight-bearing area of the articular cartilage. The material has 
been  found to  have  excellent biological  properties  in the  oral  mucosa  (Pearson  et al 
1986). In the present study, no foreign body reaction was noted in neither the synovium 
nor  the  repair  tissue  in  any  of the  specimens.  Foreign  body  responses  are  common 
following implantation of biomaterials in orthopaedic surgery. Such reactions have been 
shown to exist following implantation of poly-propylene-fumarate based materials (Peter 
et  al  1998),  of  polyglycolide,  polylactide  or  glycolide-lactide  based  copolymers 
(Bostman,  1998)  and  also  following  implantation  of hydroxyapatite  coated  materials 
(Morscher et al 1998).
Providing  that  PEMA/THFMA  maintains  high  water  uptake  in  vivo,  similar  to  its 
hydrophilic property in vitro (Patel and Braden, 1991iii), the material may absorb tissue 
fluids and the dissolved proteins, including growth factors, from the synovial fluid, the 
bone  matrix  (Syftestad  and  Caplan,  1986)  and  the  bone  marrow,  thus  creating  an 
artificial environment that encourages cartilage overgrowth. High water concentration is 
characteristic  and determines  the  properties  of articular  cartilage.  The  water  interacts 
with the structural matrix molecules  [particularly the large aggregating proteoglycans] 
and it is loosely bound to them so to be able to maintain hydration of the cartilage and at 
the same time to allow exchange with fluids outside the tissue (Torzilli et al  1998a). It 
seems that the hydrophilicity of the PEMA/THFMA polymer is a major advantage in its 
role in the regeneration of hyaline articular cartilage.
The  resurfaced  defects  in  the  biomaterial  group  in  this  study  were  in  their  majority 
levelled (mean 69.1% throughout the  1   year of assessments) with the adjacent normal 
articular  cartilage,  whereas  the  control  defects  were  resurfaced  with  tissue  depressed 
below the level of the surrounding articular cartilage (mean 20.8% gross depression in 1  
year).  Formation of ‘steps’  in the articular cartilage surface creates  areas  of excessive 
mechanical stress in the adjacent to the repair normal articular cartilage and also in the 
opposing the repair articulating surface, that can lead to early degeneration and damage 
(Minas and Nehrer, 1997).
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In this study, the polymer was positioned into the subchondral bone, with the surface 
level  recessed  just  below  the  level  of the  adjacent  normal  articular  cartilage.  The 
subchondral  marrow cells  have  been  shown to  be  able  to  potentially  differentiate  to 
chondrocytes  (Spom et al  1986, Johnstone et al  1998).  Bone marrow also  contains  a 
multipotential stromal cell known as colony-forming unit-fibroblastic [CFU-F] which is 
capable  of  differentiating  into  chondrocytes,  osteoblasts,  fibroblasts  and  adipocytes 
(Beresford,  1989,  Caplan,  1991,  Wakitani  et al  1994)  and,  therefore,  exposure of the 
subchondral bone could be a biological advantage in articular cartilage repair.
Meachim (1972) as well as Salter et al (1980) reported on the significance of the repaired 
subchondral  plate  in  the  subsequent  healing  of  the  overlying  articular  cartilage. 
Mechanical  loading  has  been  shown  to  influence  the  metabolism  of undifferentiated 
mesenchymal cells with regions under compressive loads becoming cartilaginous (Sah et 
al  1989,  Lee  and  Bader,  1995).  When  the  biomaterial  is  placed  at  the  level  of the 
subchondral bone, it instantly restores the structural integrity of the subchondral plate, 
allowing at early stages the much more physiological mechanical loading onto the repair 
tissue  and  the  adjacent  articular  cartilage  and  this,  may  enhance  formation  and 
maturation  of the  articular  cartilage.  It  is  also  possible  that  the  blood  supply  of the 
subchondral bone plays an essential role in the nutrition of the newly formed articular 
cartilage above, since it has been shown that ischaemia of the underlying bone results in 
degenerative  changes  in  the  articular  cartilage  (Graf et  al  1992,  Hodler  et  al  1992, 
Simank et al 1992).
In  our  study we  observed deterioration  in the  surface  appearance  in  both the  PEMA 
enhanced and the control repairs with time, the surface irregularities being worse in the 
control group. This might be a sign of progressive degradation of the repair tissue in both 
groups or it could reflect the inferior biological or mechanical properties of the repair 
tissue  that become  apparent with time.  The predominance  of fibroblasts  in the repair 
tissue  in  the  control  defects  explains  the  gradual  increase  of fissure  formation  and 
breakdown of the repair tissue in the control group, since fibrous tissue is mechanically 
less  resilient than  articular  cartilage  (Shapiro  et  al  1993).  Although  the  proteoglycan 
concentration is much higher in the biomaterial group compared to the control, in both 
groups  the  proteoglycan  concentration  decreases  with  time.  This. decrease  is  more
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apparent  in  the  PEMA  group  at  1   year  (36.6%  of repairs  have  high  proteoglycan 
concentration compared to 90% at 6 weeks) and may reflect a gradual return to ‘normal’ 
production of proteoglycans from the chondrocytes that were overproducing in the initial 
stages  following  the  implantation  of  the  biomaterial.  Reduction  of  proteoglycan 
formation was mainly noted in the  supreficial  layers  at  1  year,  but not  in the deeper 
layers  of the  repair  tissue  in  the  biomaterial  group.  Hunziker  and  Kafinger  (1998) 
showed that removal of proteoglycans from the surface of defects in articular cartilage 
transiently enhanced coverage by repair cells migrating in the defect.
Bonding  of  the  repair  tissue  to  the  surrounding  normal  articular  cartilage  was 
significantly superior in the PEMA group showing complete bonding in the majority of 
repaired  defects.  This  may  be  explained  by  the  chemical/physical/mechanical 
resemblance between the normal articular cartilage and the repair tissue in the PEMA 
group or may reflect the properties of the PEMA/THFMA polymer. Because the polymer 
swells  slightly during polymerisation (Patel  and  Braden,  1991),  it forms  an  excellent 
bond with the surrounding tissues, thus providing a stable foundation for the growth of 
the repair tissue over it. In the control specimens in the present study, severe trauma was 
noted  at the  edges  of the  surrounding the  defect  'normal'  articular  cartilage,  possibly 
caused by uneven mechanical loading. This could also be one of the etiologic factors, 
responsible  for  the  significantly  inferior  bonding  of the  repair  tissue  to  the  adjacent 
articular cartilage, found in the control group. Shapiro et al (1993) and Newman (1998) 
also noted that the collagen fibrils in ‘naturally’ healing defects were not well integrated 
with those of the surrounding cartilage. They suggested that this leads to vertical shear 
forces, precipitating micromotion and early failure.
In general, the PEMA group showed significantly better results than the control group. 
Particularly  in the  early  stages  the  repair  is  excellent  in the  majority  of the  defects, 
although gradual deterioration is seen with time. The rate of deterioration of the repair 
tissue in the biomaterial group is low and can be safely speculated that the repair tissue 
will continue to function satisfactorily after the first year. On the other hand, the rate of 
improvement of the repair tissue in the control group is very low and it does not appear 
that the repair tissue in this group will score as high as the biomaterial group at a later 
observational period.
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In  conclusion,  PEMA/THFMA  is  a biocompatible material,  which enhanced  articular 
cartilage repair and  could,  therefore,  be used  for the  repair of full-thickness  articular 
cartilage  defects.  In  this  study,  the  use  of  the  biomaterial  resulted  in  marked 
improvement  of  the  repair  tissue,  both  macroscopically  and 
histologically/histochemically  throughout the  one  year  of assessment.  The  method  of 
implantation is easily reproducible  and technically simple.  Compared to  other to  date 
methods for articular cartilage repair, it requires no harvesting of osteochondral material 
and it does not involve complicated cell culture prior to implantation. In clinical practice, 
this  method could be performed arthroscopically or by an open procedure  in patients 
with localised articular cartilage defects.
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CHAPTER III.C
IMMUNOHISTOCHEMICAL ASSESSMENT 
OF THE REPAIR TISSUE 
FOLLOWING  IMPLANTATION OF PEMA/THFMA POLYMER 
IN FULL-THICKNESS ARTICULAR CARTILAGE DEFECTS
OBJECTIVE
MATERIALS
•  80 adult rabbits (specimens randomly taken from those used in Chapter III.B)
•  PEMA vs CONTROL
METHOD OF IMMUNOHISTOCHEMICAL EVALUATION
•  Silver-enhanced colloidal gold immunostaining
•  Collagen type II, keratan-sulfate, chondroitin 4-sulfate and chondroitin 6-sulfate
•  At 6 weeks, 3 months, 6 months and 1 year
RESULTS
DISCUSSION
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OBJECTIVE
The aim of the immunohistochemical study is to detect the presence of hyaline articular 
cartilage  components in the repair tissue  in the  biomaterial  group,  including  collagen 
type II, keratan-sulphate, chondroitin 4-sulphate and chondroitin 6-sulphate.
MATERIALS
The  specimens  used  for  the  immunohistochemical  study  of  the  repair  tissue  were 
selected  randomly  from  the  rabbits  used  in  the  macroscopic  and 
histological/histochemical assessment in Chapter III.B. Specimens were taken from both 
PEMA and CONTROL groups -  10 rabbits from each observational period (6 weeks, 3 
months, 6 months and 1  year). In total 80 repair tissue specimens were assessed, 40 in 
the PEMA group and 40 in the CONTROL group.
METHOD OF IMMUNOHISTOCHEMICAL EVALUATION
The silver-enhanced colloidal gold immunostaining method was adopted (Hacker et al 
1985). The  proprietary kit for the immunogold-silver  staining  was provided  byBioclin 
(Cardiff,  Wales).  Four  selected  monoclonal  antibodies  were  applied  individually:  the 
anti-type II collagen antibody (CIICI, Developmental  Studies Hybridoma Bank,  Iowa, 
USA,  dilution  1:1),  the  anti-keratan-sulphate  (5D4,  ICN  Biomedicals,  Bucks, 
UK, dilution 1:500), the anti-chondroitin  4-sulphate antibody  (2-B-6 ICN Biomedicals, 
Bucks,  UK,  dilution  1:100)  and the  anti-chondroitin 6-sulphate  antibody  (3-B-3,  ICN 
Biomedicals, Bucks, UK, dilution 1:100).
Five pm thick sections taken from the centre of the repair tissue, were dewaxed in xylene 
and  rehydrated  through  graded  series  of  ethanols  (100%,  90%,  70%,  50%).  The 
epitopes were exposed by incubating the sections with hyaluronidase (10  IU/ml,  Sigma, 
Poole,  UK) and chondroitinase ABC  (0.25  IU/ml,  Sigma, Poole,  UK)  for  2 hours  at 
37°C.  Incubation  with  the  primary  antibody was  made  overnight  at  4°C  in  a  dark, 
humidified atmosphere.
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The antibodies were diluted individually in phosphate buffered saline with 0.6% bovine 
serum  albumin  (Sigma,  Poole,  UK).  Sections  were  incubated  with  the colloidal 
gold conjugated anti-mouse Ig  secondary antibody (BioClin,  Cardiff,  Wales,  dilution 
1:50)  for 2 hours at room  temperature in a dark,  humidified atmosphere,  followed by 
fixation in  1% glutaraldehyde.  The colloidal gold was visualised by use of a physical 
silver development solution  [enhancement]  and the sections were counter-stained with 
Mayer's haematoxylin.
RESULTS
Table  II.C.l  demonstrates  analysis  of  the  immunolocalisation  of  the  cartilage 
components in the repair tissue  in both the biomaterial and the control groups.
Table III.C.1:
Immunohistochemical assessment of repair tissue 
PEMA  vs CONTROL
3  months',-
ANTIGEN
3  (30%) 3  (30%) 2  (20%) 5  (50%) 2  (20%) >50% of matrix 5  (50%)
7  (70%) 5  (50%) 3  (30%) 2  (20%) 5  (50%) 4  (40%) 2  (20%) <50% of matrix 4  (40%)
6  (60% 0  (0% 6  (60%) 5  (50% no detection 1   (10% 8  (80%
5  (50%) 2  (20%) 4  (40%) 1   (10%) 6  (60%) 1  (10%) >50% of matrix 6  (60%)
4  (40%) 4  (40%) 4  (40%) 4  (40%) 6  (60%) 7  (70%) <50% of matrix 4  (40%)
5  (50%) 4  (40% 10  (100%) 0  (0% no detection
2  (20%) 6  (60%) 2  (20%) 7  (70%) 2  (20%) 6  (60%) 6  (60%) >50% of matrix
4  (40%) 2  (20%) 2  (20%) 3  (30%) 2  (20%) 4  (40%) 6  (60%) <50% of matrix
6  (60%) I  (10%) 8  (80% 8  (80%) 0  (0%) 2  (20% no detection 1   (10%
1   (10%) 8  (80%) 2  (20%) 5  (50%) 2  (20%) 8  (80%) 7  (70%) >50% of matrix
4  (40%) 6  (60%) 3  (30%) 2  (20%) 2  (20%) 3  (30%) 4  (40%) 2  (20%) <50% of matrix
2  (20%) 6  (60%) 5  (50%) 2  (20%) no detection
Fifty per cent of the specimens in the biomaterial group showed normal distribution of 
collagen type II throughout the matrix of the repair tissue at 6 weeks and 3 months post- 
operatively.  For the  same  observational  periods  all  control  specimens  showed limited 
only distribution of collagen type II, arranged mainly around chondrocyte clusters. By 1
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year,  collagen  II  was  detected  in  80%  of  the  specimens  (30%  showing  normal 
distribution).
Glycosaminoglycans were detected in the extracellular matrix in over 80% of the 
specimens in all observational periods in the PEMA group, compared to less than 20% in 
the control group.
Statistical analysis of the results:
For the antigen detection, the data did not have paired values. All that was recorded was 
the  row and  column  sums  with the  scores  as  >50%,  <50%  and no  detection  for the 
PEMA and the CONTROL knees at 6 weeks, 3 months, 6 months and 1  year. To analyse 
such data, Fisher ’s exact test was used, which tests for independence between the row 
distribution and column distribution.
The table below shows P-values from Fisher’s exact test for PEMA vs CONTROL 
stratified by time of inspection:
Antigen 6 weeks 3 months 6 months 1 year Using combined 
time groups
Collagen type 11 .004 .002 .011 .523 3e-7
Keratan-sulphate le-5 .164 .012 .289 6e-8
Chondroitin 4-sulphate .001 .097 .021 .009 4e-8
Chondroitin 6-sulphate .001 .033 .210 .004 6e-8
The values indicate that the biomaterial enhances significantly the production of collagen 
type  II  and  glycosaminoglycans  in  the  repair  tissue  in  all  observational  periods, 
compared to the control specimens. PEMA repair is significantly superior to control up 
to  1   year post-implantation, although the enhancement effect decreases  as the time of 
observation increases.
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Fig.III.C.l
Immunohistochemical appearance of the repair tissue in  the polymer group  at 6 
weeks:
The repair tissue [rt] contains collagen type II like the normal articular cartilage [c]. The 
subchondral bone  [b]  does not contain collagen type II  and  stained negative.  The  — » 
indicates  the  transition  from  the  repair  tissue  to  the  normal  articular  cartilage, 
[p=polymer] (Silver-enhanced colloidal gold immunostaining, x 13.2)
Fig.III.C.2
Immunohistochemical appearance of the  repair tissue in  the polymer group  at 3 
months:
Large  amounts of keratan-sulfate can be detected in the deep  [d]  layers  in the repair 
tissue,  with  smaller  amounts  also  noted  in the  superficial  [s]  layer.  (Silver-enhanced 
colloidal gold immunostaining, x 66)
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Fig.III.C.3
Immunohistochemical appearance of the repair tissue in the polymer group  at 6 
months:
The repair tissue contains collagen type II evenly distributed throughout the matrix with 
larger concentration in the superficial [s] layer. (Silver-enhanced colloidal gold immuno­
staining, x 66)
Fig.III.C.4
Immunohistochemical appearance of the repair tissue in  the  polymer group  at  1 
year:
Chondroitin 4-sulphate  can be  detected  in all  layers of the  repair tissue,  with higher 
concentrations in the deep [d]  layers than in the superficial  [s]  layer.  In this particular 
specimen subchondral bone [b] has been formed that contains no chondroitin 4-sulphate 
and stained negative. (Silver-enhanced colloidal gold immunostaining, x 66)
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Fig.III.C.5
Typical immunohistochemical appearance of the repair tissue in the control group:
This specimen is of the 6-month group and shows complete absence of collagen type II 
in  the  repair  tissue  [rt].  Collagen  type  II  is  detected  in  the  articular  cartilage  [c] 
surrounding the defect, but the subchondral bone  [b]  contains no collagen type II  and 
stained negative. (Silver-enhanced colloidal gold immunostaining, x 33)
Fig.III.C.6
Immunohistochemical  appearance  of the  normal  articular  cartilage  surrounding 
the defect in the specimen shown in Fig.III.D.5:
Small concentration of collagen type II around the cells with minimal detection in the 
extracellular matrix, suggesting degeneration of the normal articular cartilage adjacent to 
the defect in the control group. (Silver-enhanced colloidal gold immunostaining, x 132)
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DISCUSSION
The  silver-enhanced  colloidal  gold  technique  used  for  the  immunohistochemical 
detection of collagen type  II  and the  glycosaminoglycans  in the  matrix  of the repair 
tissue,  is  a very sensitive method and  allows  the use of routine  histological  counter- 
staining,  such  as  Haematoxylin  and  Eosin,  which  helps  in  the  study  of  tissue 
morphology.  The  method  also  allows  use  of  low  magnification,  that  helps  in  the 
comparative analysis between groups (Hacker et al 1985). In the present study the use of 
low magnification also helped in the comparative assessment of the repair tissue with the 
adjacent normal articular cartilage.
Detection  of  collagen  type  II  and  glycosaminoglycans  was  constantly  high  in  the 
PEMA/THFMA group at all time intervals studied.  In the control group detection was 
very low at 6 weeks and 3 months and although it improved at 6 months and 1  year, it 
always  remained  significantly  lower  than  the  biomaterial  group.  Collagen  type  II  is 
found in tissues with high water and proteoglycan content, suggesting that this type of 
collagen  has  specific  properties,  to  create  and  maintain  a  highly  hydrated  matrix 
(Buckwalter  et  al  1997).  The  glycosaminoglycans,  which  are  side  chains  of  the 
proteoglycan monomer, form long strings of negative charges that repel other negatively 
charged  molecules  and  attract  cations  (Roughley  and  Lee,  1994).  The  resultant  high 
osmolarity  accounts  for the  retention  of water  in  cartilage.  Glycosaminoglycans  also 
repel each other tending to keep the molecules in distended state (Buckwalter et al 1988).
The hydrophilicity of the new polymer must be of great importance as the specific to 
hyaline  cartilage  collagen  type  II  and  glycosaminoglycans  maintain  high  water 
concentrations. Nutrition of the chondrocytes, which occurs by diffusion, may therefore 
be  facilitated  and  the  distension  of the  newly  formed  articular  cartilage  may  also  be 
advantageous by improving its bonding with the surrounding normal tissues.
In this immunohistochemical study, four principal matrix components collagen type II, 
keratan-sulphate, chondroitin 4-sulphate and chondroitin 6-sulphate, were detected in the 
repair  tissue  in  the  biomaterial  group.  Production  of  hyaline  articular  cartilage 
components in the repair tissue treated with PEMA/THFMA was significantly higher at 
the early stages post-implantation. It remained higher than the control group up to 1  year.
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CHAPTER III.D
ELECTRON MICROSCOPY 
OF THE REPAIR TISSUE 
FOLLOWING  IMPLANTATION OF PEMA/THFMA POLYMER 
IN FULL-THICKNESS ARTICULAR CARTILAGE DEFECTS
OBJECTIVE
MATERIALS
•  16 adult rabbits (specimens randomly taken from those used in Chapter III.B)
•  PEMA vs CONTROL
METHOD
•  Transmission electron microscopy
•  At 6 weeks, 3 months, 6 months and 1  year
RESULTS
DISCUSSION
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OBJECTIVE
The electron microscopy study aims to demonstrate the ultrastructural characteristics of 
the chondrocytes and the extracellular matrix in articular cartilage repair tissue treated 
with PEMA/THFMA,  in an attempt to  provide  information on the potential  mode  of 
action of the polymer in terms of chondrocyte metabolism and matrix organisation.
MATERIALS
Sixteen  specimens  [2  from  the  PEMA  and  2  from  the  control  group  at  6  weeks,  3 
months, 6 months and 1 year] were randomly taken from those used in the macroscopic 
and  histological/histochemical  assessment  in  Chapter  III.B  and  were  prepared  for 
transmission electron microscopy.
METHOD OF TRANSMISSION ELECTRON MICROSCOPY
The specimens were cut with a blade into small pieces 3x3 mm each, and were fixed in
o
2%  glutaraldehyde  in 0.1M  sodium  cacodylate  buffer at pH  7.2  for 24  hours  at  4 C 
followed by secondary fixation in an aqueous solution of 1% osmium tetroxide and 1.5% 
potassium  ferrocyanide  (de  Bruijn,  1973,  Dvorak  et  al,  1972,  Famum  and  Wilsman, 
1983)  for  one  hour.  The  samples  were  washed  in  the  same  buffer  and  dehydrated 
through a graded series of ethanols (70%, 90%,  100%). Residual polymer was carefully 
removed prior to impregnation with a 1:1 ethanol/Spurrs' resin mixture (Agar Scientific, 
Stansted, UK) for six hours including two hours vacuum impregnation at 150 mbar.  The 
1:1  mixture of ethanol/Spurrs' resin underwent four changes over twelve hours each, of 
the  Spurrs' resin alternating every six hours with vacuum infiltration.  The  specimens
o
were embedded in 8mm flat polythene capsules and cured at 70 C for 18 hours.
One pm thick sections were cut with a diamond knife for light microscopy and stained 
with  1%  Toluidine  Blue  in  1%  Borax  (Robinson  and  Gray,  1990).  The  resin  was 
removed prior to staining with Sodium Methoxide and 90 nm thick sections were cut on
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an  L.K.B.  Ultratome  III.  The  sections  were  stained  with  2%  Uranyl  Acetate  (10 
minutes) and Reynold's Lead Citrate (10 minutes) and were picked up on 3 mm diameter 
copper grids.  The electron microscope used was Phillips CM 12 fitted with ED  AX PV 
9800 X-ray Microanalysis system.
Unstained sections were used for the energy dispersive microanalysis.  They were probed 
at 80 KV with a specimen tilt of 20°, giving a final take-off angle of 40°, and counted for 
200 live seconds.
RESULTS
Figures III.D.l to III.D.6 show the ultrastructural characteristics of the repair tissue and 
the control groups.
The  PEMA/THFMA  biomaterial  used  in  this  study  appeared  to  have  enhanced 
chondrocyte migration / formation in both the superficial and the deep zones of the repair 
tissue in all observational periods.  In the superficial  layer,  chondrocytes  were  flat in 
appearance, orientated parallel to the articular surface and containing pronounced rough 
endoplasmic reticulum and mitochondria.  Electron-dense  granules  were  found  in the 
matrix of the repair tissue.  By contrast, cells in the superficial zone of the repair tissue in 
the control specimens appeared to be less productive and no granules were noted around 
these  cells  or  in  the  matrix.  The  latter  was  characteristically  depleted  of  fibres, 
particularly immediately adjacent to cells.
In the deep layers of the repair tissue in the biomaterial  group the chondrocytes were 
round and large with numerous electron-dense molecules forming a  ‘halo’  around the 
cells and into the adjacent matrix in all studied periods.  Abundant rough endoplasmic 
reticulum,  numerous  secretory  vesicles,  mitochondria  and  large  Golgi  apparatei  were 
noted in the cytoplasm of these cells. Multiple cytoplasm processes emerging from the 
cell periphery were also seen. Energy dispersive microanalysis detected Sulphur in these 
molecules up to  1   year post-implantation, suggesting the presence of proteoglycans.  In 
the control group no pericellular granules were seen at any observation period and the 
matrix showed large calibre fibrils consistent with collagen type I.
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Another  ultrastructural  characteristic  observed  in  both  groups,  more  common  in  the 
polymer group, was the formation of chondrocyte clusters.  They were found mainly in 
the deep layers of the repair tissue enclosed in thin pericellular layer of small calibre 
fibres.  Many  short processes  were  seen  emerging  from  the  cells  within the  clusters. 
These were significantly more numerous in the surfaces of the chondrocytes looking at 
the centre of the cluster rather than those looking at its periphery.
The  matrix  of the  neocartilage  in  the  biomaterial  group  appeared  to  have  a  well- 
organised arrangement of predominantly small calibre collagen fibrils,  consistent with 
collagen  type  II.  This  collagen  mesh  appeared  to  be  more  pronounced  around  the 
chondrocytes  in  the  1  year  specimens.  However,  compared  with  normal  articular 
cartilage, the matrix in the repair tissue appeared to be significanlty depleted of fibres, 
although it outnumbered hyaline articular cartilage in cells. In the control specimens the 
newly  formed  tissue  revealed  a  disorganised  arrangement  of  multidirectional  large 
calibre collagen fibrils and few only cells with chondrocyte phenotype that appeared to 
be flattened in all layers. Chondrocyte degeneration with ghost cells, empty lacunae and 
excessive  intracellular  deposition  of  lipids  were  frequently  noted  in  the  control 
specimens at all observational periods. Mild chondrocyte degeneration was also noted at 
1  year in the repair tissue in the PEMA/THFMA group.
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Fig.III.D.1
Ultrastructural characteristics of the repair tissue in the polymer group at 6 weeks:
Large, highly productive, round chondrocytes  [c]  with multiple cytoplasmic processes. 
Electron dense granules are noted at the periphery of the cells and in the extracellular 
matrix [m], (Uranyl acetate and Reynold’ s lead citrate staining, x 17000, the bar equals 
lfim)
Fig.III.D.2
Energy  dispersive  micro-analysis  of the  repair  tissue  in  the  polymer  group  at  6 
weeks:
The electron-dense granules seen in Fig.III.D.1  were probed in unstained, 90 nm thick 
sections.  Molecular  sulphur  [SKa   peak]  was  detected  suggesting  the  presence  of 
proteoglycans  in  these  granules.  The  osmium  [OsZ,a  peak]  is  due  to  fixation  of the 
specimen with osmium, while the copper [Cu£a peak] molecule derives from the copper 
grid used for the mounting of the specimen.
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Fig.III.D.3
Ultrastructural characteristics of the repair tissue in the polymer group at 1 year:
Highly  productive  chondrocytes  with  multiple  cytoplasm  processes  and  numerous 
electron-dense  granules  at the  periphery  of the  cells  and  in the  adjacent extracellular 
matrix. The collagen fibres in the matrix [mj are forming characteristic ‘lacunae’ around 
each chondrocyte.  (Uranyl acetate and Reynold’ s lead citrate staining,  x 5100,  the bar 
equals Sum)
Fig.III.D.4
Energy  dispersive  micro-analysis  of the  repair tissue  in  the  polymer  group  at  1 
year:
The electron-dense granules seen in Fig.III.D.3  were probed in unstained, 90 nm thick 
sections.  Molecular  sulphur  [SA Ta  peak]  was  detected  suggesting  the  presence  of 
proteoglycans in these granules at 1  year. The osmium [OsZ,a peak] is due to fixation of 
the  specimen with osmium,  while the  copper  [CuKa peak]  molecule  derives  from the 
copper grid used for the mounting of the specimen.
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Fig.III.D.5
Ultrastructural characteristics of the repair tissue in the control group at 6 weeks: 
The  chondrocytes  are  surrounded  by  loose  extracellular  matrix  [mj  without  the 
characteristic electron-dense granules seen in the polymer group.  (Uranyl acetate  and 
Reynold’ s lead citrate staining, x 5100, the bar equals 3pm)
Fig.III.D.6
Ultrastructural characteristics of the repair tissue in the control group at 1 year:
The extracellular matrix  [m]  is dense with large-calibre collagen fibrils arranged in a 
multidirectional,  disorganised  pattern  around  the  scattered  chondrocytes  [c].  (Uranyl 
acetate and Reynold’s lead citrate staining, x 5100, the bar equals 3pm)
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DISCUSSION
The ultrastructure of the repair tissue in the biomaterial group showed large number of 
highly productive chondrocytes with multiple electron-dense granules around the cells 
and  in  the  extracellular  matrix.  These  granules  contain  molecular  Sulphur  and  we 
speculate that they represent proteoglycan molecules secreted by the cells.
It is  well known  that  the  proteoglycan content of cartilage  matrix is  correlated  with 
compressive  strength  (Buckwalter,  1983,  Carlson  et  al  1986)  and  that  loss of  this 
component  leads  to  increased  mechanical  stress and  subsequent  dysfunction  of 
chondrocytes (Reimann et al 1982). Moreover, the capability of the articular cartilage to 
repair is related to the stress placed upon it (Carlsson et al 1986) and excessive loading 
can be harmful.  If therefore PEMA/THFMA enhances proteoglycan production by the 
chondrocytes,  it  can  provide  a  strong  mechanical  shelter,  which  prevents  cell 
dysfunction and  death,  thus  improving the  formation  as  well  as  the  longevity  of the 
repair  tissue.  It  can  also  be  hypothesised  that  the  grossly  disorganised  multiple 
orientation of the collagen fibrils that has been recorded in the control specimens,  is the 
result of excessive abnormal mechanical loading applied during joint movement on the 
repair tissue.
It has been postulated that insulin-like growth factors can be crucial for the homeostasis 
of the extracellular  matrix of articular  cartilage  in  vivo  (McQuillan  et  al  1986)  and 
therefore  it is possible  that  the hydrophilic  PEMA/THFMA  attracts/adsorbs growth 
factors, which effectively enhance the overall repair process.
The chondron concept was introduced by Benninghoff in 1925 to describe the functional 
and metabolic unit of the chondrocyte and its pericellular micro-environment in hyaline 
cartilage (Poole  et al  1990).  Ultrastructural  studies  have  shown that the  chondron in 
adult  articular cartilage consists of a chondrocyte and its  pericellular matrix,  both 
enclosed within an impacted fibrillar capsule (Poole et al 1987), similar to that observed 
in the  1   year specimens in the biomaterial group in this study.  Chondrons exist in the 
middle and deep  layers of normal adult articular cartilage and their pericellular matrix 
is rich in proteoglycans (Bayliss et al 1983) bound with strong cross-links to the collagen 
fibril  meshwork  (Poole  et  al  1990).  The  latter  consists, among  other  collagens, of
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collagen  types  II,  VI  and  IX (Poole  et  al  1988)  of  which  type  VI  collagen 
provides an adhesive  mechanism  for  substratum  attachment (Linsenmayer et al 1986). 
It is also believed that collagen type VI is exclusive to the capsule of the chondron and 
does  not form  a  general  component of the  territorial and  inter-territorial 
matrices. As far as the function role of the chondron is concerned,  Poole also postulates 
that it acts hydrodynamically  to protect the chondrocyte during compressive loading. In 
this study formation of chondrons was observed predominantly in the biomaterial group.
Transmission electron microscopy showed that PEMA/THFMA enhanced chondrocyte 
formation  and  matrix  collagen  organisation  in  the  repair  tissue.  Energy  dispersive 
microanalysis  helped  in  the  characterisation  and  chemical  analysis  of  the  multiple 
electron dense granules seen exclusively in the biomaterial specimens at all observational 
periods  up  to  1   year  post-implantation.  We  postulate  that  the  mode  of  action  of 
PEMA/THFMA  is  by  formation  of chondrons,  distributed  through  the  whole  of the 
repair  tissue,  which  produce  large  amounts  of proteoglycans.  The  integrity  of these 
chondrons  provides  further  mechanical  protection  to  the  chondrocytes 
against excessive/abnormal  loading and  therefore,  particularly in  the  proteoglycan- 
depleted matrix, they improve the tissue characteristics of the repair tissue.
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CHAPTER IILE
IMAGE ANALYSIS OF THE REPAIR TISSUE 
FOLLOWING  IMPLANTATION OF PEMA/THFMA POLYMER 
IN FULL-THICKNESS ARTICULAR CARTILAGE DEFECTS
OBJECTIVE
MATERIALS
•  40 adult rabbits (specimens randomly taken from those used in Chapter III.B)
•  PEMA vs CONTROL
METHOD
•  Cell count using Image Analysis from periphery and centre of repair and from 
adjacent normal articular cartilage
•  At 6 weeks, 3 months, 6 months and 1  year
RESULTS
DISCUSSION
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OBJECTIVE
This study aims to assess quantitatively histological characteristics [number of cells] of 
the repair tissue in the PEMA/THFMA group, compared to the control group and to 
normal articular cartilage, using a computerised technique.
MATERIALS AND METHOD
The  image  analysis  system used  in this  study comprised of an Olympus  microscope, 
connected  to  a  SONY  video  camera  and  connected  to  an  Apple  Macintosh  Quadra 
computer  with  a  Neotec  image  grabber  programme  and  an  Optilab  (Groftec,  Paris, 
France) image analysis programme.
Five specimens in each observational period [6 weeks, 3 months, 6 months and  1   year] 
from both the biomaterial and the control group were randomly taken from those used in 
the  macroscopic  and  histological/histochemical  assessment  in  Chapter  III.B.  In  all 
specimens the number of cells in the repair tissue was calculated in the centre of the 
defect  and  also  at  the  periphery.  Evaluation  of the  normal  articular  cartilage  was 
performed at the closest to the defect normal articular cartilage that was fully supported 
by subchondral bone.
Sections  5  pm  thick  stained  with  Safranin-0  were  used  and  selected  areas  were 
calibrated. For each section a number of images were taken from the edge and from the 
centre of the repair tissue and also from the adjacent normal articular cartilage. Twenty- 
four bit colour images were obtained at 44 [2.2 x 20] magnification. Images were then 
thresholded to select a biniary image of only the chondrocyte lacunae. The images were 
then further processed using filters, which enhanced the lacunae. The number of lacunae 
was then determined within the image.
The  Image  Analysis  system  an  example  of the  computerised  images  are  shown  in 
Fig.III.E.l and III.E.2.
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Fig.III.E.l:
The Image Analysis system:
The microscope is connected to a video camera and to a computer with an image grabber 
and an image analysis programme
Fig.III.E.2:
Image  analysis  picture  following  the  filter  process  that  selected  only  the 
chondrocyte lacunae:
Centre / repair tissue
Intermediate Particles Detection Report
•  L o w er G ra y : 1
•  U p p er G ra y : 1
•  M in im u m  d etectab le: 8 .5 4 3 7 2 e-0 6
•  M ax im u m  d etectab le: 2 .7 9 9 6  le+ 0 0
•  D etected  p articles: 7 4
•  T o u ch in g  b o rd er: 2
•  M in im u m  a re a : 9 .3 9 8 1 0 e -0 6
•  M ax im u m  a re a : 3 .3 3 6 3 2 e-0 4
•  M ean  a re a : 8 .7 3 7 6 9 e-0 5
•  S tan d ard  d ev iatio n : 7 .1 8 3 8 0 e-0 5
•  S u m  a re a : 6 .4 6 5 8 9 e-0 3
•  T o tal a re a : 1 .3 1 2 3 2 e-0 1
•  P ercen tag e: 4 .9 2 7 0 8 e+ 0 0
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RESULTS
The number of cells was calculated in the periphery and the centre of the repair tissue as 
well as in the adjacent normal articular cartilage, and the mean values and the standard 
deviations are presented in Table III.E.l.
Table III.E.l:
N um ber of cells in  the periphery and the centre of the repair tissue 
and the adjacent to the defect norm al articular cartilage 
Im age A nalysis at 6 w eeks, 3  m onths, 6  m onths and 1  year 
PEMA v s C O N T R O L
(>   week* 3  months 6  months .............7 year
I’l  M  \ C O M  KOI PEMA C O M  ROI. PEMA C O M  ROE PEMA CONTROL
PERIPHERY 108 86 79 T. 106 '  '48  ' ' O X  ' 74 “
92 47 91 78 94 72 76 79
99 38 71 99 111 43 84 52
106 62 60 108 87 67 72 54
119 68 62 79 92 61 91 71
MEAN 104.8 60.2 72.6 91.4 98.0 58.2 78.2 66.0
Sl> 10.1 18.7 I2.S 12.9 10.1 12.4 9.3 12.2
;; Iltlllf msmmmM
CENTRE .....114..... 68 os 69 108 73 98 45
132 79 121 78 124 79 76 68
118 101 131 64 101 54 105 71
109 86 100 81 98 63 68 51
116 71 109 82 108 47 87 62
MEAN 117.8 81.0 111.8 74.8 107.8 63.2 86.8 59.4
SI) _ 8.6___ 13.2 14.1 "9 10.1 13.2 15.2 11.1
Al'mCLM 78 35 "  M
—
93 “ 31 S2  ' 48
93 48 93 86 78 38 89 27
104 56 74 52 104 46 64 43
101 51 96 58 85 34 78 61
98 41 108 64 74 51 93 51
MEAN 94.8 46.2 87.0 67.6 86.8 40.0 81.2 46.0
SD 10.2 8 3 17.7 14.1 12.0 8.3 11.3 12.5
Table III.E.l  shows that PEMA/THFMA increased the cellularity of the repair tissue in 
all observational periods by an average of 43.3 cells, compared to the control group. The 
repair tissue contained more cells in the centre than in the periphery in both groups. The 
number  of  cells,  however,  in  the  centre  of  the  defect  in  the  polymer  group  was 
significantly higher than that in the control group. The cellularity in the normal articular 
cartilage adjacent to the defect was significantly lower in the control group. This hypo- 
cellularity in the adjacent to the defect normal articular cartilage was more apparent in 
the 6 month and  1   year specimens.  Graphic presentation and statistical  analysis of the 
results follows.
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G raphic presentation of num ber of cells 
in the periphery and the centre of the repair tissue and the adjacent norm al 
articular cartilage at 6  w eeks, 3  m onths, 6  m onths and 1  year
Image analysis - Periphery
■   P E M A / T H F M A
■ c o n t r o l
6 weeks  3 months  6 months 
Time
Im age analysis  - Centre
■PEMA/THFMA ■PEMA/THFMA
■ c o n t r o l
I l k
3 months  6 months 6 weeks
Image  analysis  - Adjacent
150.0
J   100.0  -
50.0
■PEMA/THFMA
■ co n tro l
o.o -t-
weeks  3 months  6 months  1  year
Tim e
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Statistical analysis o f the results:
As a precursor to any detailed analysis, it is useful to examine the data visually. This is 
done in this study by producing error bars for the means of each of the cells, in separate 
plots for each of the tissue regions.
Error bars for peripheral tissue
3
U
fa
CN1
C 3  
60
- - Control
0 weeks 3 months 0 months 1  year
Time
Error bars for centred tissue
—  Pema
— Control
0 weeks 1   year
Error birrs for adjacent tissue
•1
U
*a
fa
—  Pema
- - Control
0 weeks 3 months 0 months 1  year
These  plots  give  the  means  and  95%  confidence  intervals  for  each  set  of  five 
measurements. They suggest that:
•  PEMA/THFMA produces higher cell counts than control.
•  The cell counts decrease over time.
•  An increasing order of cell count by tissue type is: adjacent, peripheral, centre.
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The most serious threat to these assertions is the measurements made at 3 months at the 
peripheral  tissue.  One  option  is  to  simply  ignore  these  particular  measurements  and 
assume  they  are  simply  due  to  randomness.  With  this  assumption,  the  trends  are 
quantified using a 3-way ANOVA. The stepwise selection procedure settled on a model, 
which  included the  principal  effects  and  one  interaction term  between  treatment  and 
time.
Df SumSq Mean Sq F value p-value
treatment 1 34995 34995 224.7419 <2.2e-16
time 3 4474 1491 9.5773 1.286e-05
tissue 2 7370 3685 23.6648 3.850e-09
treatment - time 3 2072 691 4.4348 0.005712
Residuals 1 0 0 15571 156
The p-value column tells us that treatment, time and tissue all have a significant effect on 
the cell count. The significance of the treatment-time interaction suggests that treatment 
and time effect is not simply additive.
To estimate the size of the effects we need to decide on a reference level for each of the 
factors. This reference level is an arbitrary benchmark which is used to see how much 
the other levels deviate from. The reference levels are shown below:
Factor Reference level
Treatment Pema
Time 6 weeks
Tissue Peripheral
Comparisons:
Estimate Std. Error p-value
Intercept 106.900 3.720 <2e-16
treatment = control -43.333 4.556 l.lle-15
time = 3 months -5.850 5.178 0.261319
time = 6 months -8.267 4.556 0.072636
time = lyear -23.733 4.556 1.02e-06
tissue = middle 7.912 3.120 0.012748
tissue = adjacent -11.213 3.120 0.000507
control. 3 months 15.133 7.204 0.038195
control. 6 months -0.400 6.444 0.950627
control. 1 year 18.400 6.444 0.005227
The intercept tells us the model’s predicted value for the reference level. This is  106.9 
cells with a standard error of 3.720 cells. The other rows make comparisons with this. 
The ‘treatment = control’ row says that the average control group is 43.3 cells less than 
the PEMA group.
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DISCUSSION
Histological analysis of articular cartilage and of the repair tissue has been traditionally 
performed qualitatively.  While new techniques and grading systems have attempted to 
improve the quantitative nature of histological assessment, the advent of computer-based 
analysis  systems  has  enabled  development  of  more  quantitative  methodologies  for 
cartilage  repair  (Hacker  et  al  1997).  In  this  study,  in  an  attempt  to  quantify  certain 
characteristics of the repair tissue in articular cartilage defects, the image analysis system 
has  been  employed.  It  is  a  versatile  technique  that  has  found  applications  in  many 
scientific disciplines. Advantages include the high reproducibility of the system as well 
as the high accuracy (Hunt et al 1993).
This study focuses on the quantitative analysis of the number of cells in the repair tissue 
and  in  the  surrounding  the  defect  normal  articular  cartilage  in  defects  treated  with 
PEMA/THFMA,  compared  to  control  specimens  where  no  biomaterial  has  been 
implanted.  In previous studies it has been shown that there was a five-fold difference 
between  manual  and  automatic  counts  (Hunt  et  al  1993).  It  was  found  that,  when 
manually assessed, the cell count in tissues was up to 87% higher due to the fact that cell 
debris and non-cellular material were included in the count. The advantage of the image 
analysis system is that these objects can be safely deleted because the system recognises 
only stained cells in a particular frame.
Many parameters were initially analysed in this study including number of cells, size of 
cells and total area covered by cells, the final comparison between the normal and the 
repaired articular cartilage is based on the number of cells alone. This is because the size 
of cells was found to vary enormously in the same section, thus presenting difficulty in 
the statistical analysis of the values. The number of cells in the repair tissue, however, 
was more constant and easily comparable with the number of cells in the adjacent to the 
defect normal articular cartilage. Finally, the total area of the repair tissue occupied by 
cells  was  also  difficult  to  be  statistically  correlated  since  it  depends  on  the  highly 
variable size of cells.
The centre of the repair tissue was found to have more cells per measured area than the 
periphery.  Both values  were  higher  compared to  the  number  of cells  in the  adjacent
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normal articular cartilage. It appears that the number of cells in the centre of the repair 
tissue  is  higher  at  6  weeks  and  3  months  as  compared  to  the  6  month  and  1  year 
specimens.  This  probably  illustrates  the  attraction  of  mesenchymal  cells  by  the 
biomaterial in the first weeks of implantation that results in the differentiation of more 
cells to chondrocytes.  Similarly, in the centre of the repair tissue there are more cells 
compared to the periphery and this most probably reflects the higher concentration or 
rather the more accumulative action of the biomaterial in the centre of the defect.
The number of cells in the repair tissue remains higher than the adjacent normal articular 
cartilage  by  1  year  in  the  biomaterial  group,  with  no  apparent  degeneration  in  the 
adjacent articular cartilage. This continuing hypercellularity of the repair tissue suggests 
that PEMA/THFMA may initially attract the undifferentiated mesenchymal cells while 
later on it creates the necessary micro-environment / extracellular matrix for the support / 
function of the formed chondrocytes.
It is  concluded that the  image analysis  system used  in this  study for the  quantitative 
evaluation of the number of cells in the repair tissue was found easy to use, although the 
existing great variations in other tissue characteristics among different areas/sections of 
the repair tissue present a difficulty in their statistical correlation.
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CHAPTER IV
BIOCHEMICAL ANALYSIS OF THE REPAIR TISSUE 
FOLLOWING  IMPLANTATION OF PEMA/THFMA POLYMER 
IN FULL-THICKNESS ARTICULAR CARTILAGE DEFECTS
OBJECTIVE
MATERIALS
•  15 adult rabbits
•  PEMA vs CONTROL, PEMA vs SHAM (no defect), CONTROL vs SHAM 
METHOD
•  Quantitative assessment of water, DNA, glycosaminoglycans and hydroxyproline
•  At 6 weeks
RESULTS
DISCUSSION
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OBJECTIVE
The aim of this study is to quantitatively assess the composition of the repair tissue in the 
biomaterial group, compared to the control group and also to normal articular cartilage.
MATERIALS AND METHODS
Fifteen female adult Sandy-Lop rabbits were used in this study. Both knees were operated on 
in all rabbits,  10 knees receiving the new biomaterial PEMA/THFMA [PEMA group], ten 
knees receiving no  biomaterial and allowing natural  repair  [CONTROL  group],  and ten 
knees receiving ‘sham’  operations with no cartilage defect [SHAM group]. The pattern of 
the knee operations [right knee/left knee] in all 15 rabbits had as follows:
Rabbit 1:  PEMA/CONTROL 
Rabbit 2;  SHAM/CONTROL 
Rabbit3:  SHAM/PEMA 
Rabbit 4:  PEMA/CONTROL 
RabbitS:  SHAM/CONTROL
Rabbit 6:  SHAM/PEMA 
Rabbit 7:  PEMA/CONTROL 
Rabbit 8:  SHAM / CONTROL 
Rabbit 9:  SHAM /PEMA 
Rabbit 10: PEMA / CONTROL
Rabbit 11: SHAM / CONTROL 
Rabbit 12: SHAM / PEMA 
Rabbit 13: PEMA / CONTROL 
Rabbit 14: SHAM / CONTROL 
Rabbit 15: SHAM 1 PEMA
The knees in the PEMA and the control groups were operated using the same approach and 
method of implantation as described in Chapter III.B. In the ten knees that received ‘sham’ 
operations, an arthrotomy was performed but no defect was created in the articular cartilage, 
the joint was washed with normal saline and the wound was closed using absorbable sutures. 
No immobilisation was applied to any of the operated knees in all groups and the rabbits 
were group-housed in floor-pens.
All  rabbits  were  sacrificed  at  6  weeks  after  the  operation  by  intravenous  injection  of 
Pentobarbitone  sodium  (Euthatal  600mg).  Full-thickness  cartilage  slices  from  the  repair 
tissue in the knees of the PEMA and control groups, and from anatomically similar sites of 
the  normal  articular  cartilage  in  the  femoral  trochlea  in the  knees  who  received  ‘sham’ 
operations, were taken with a 4.5 mm biopsy punch. The cartilage plugs were trimmed of 
underlying  bone  and  they  were  weighed  and  dried  at  60°C  until  a  constant  weight  was 
obtained  in  three  consecutive  measurements.  One  ml  papain  digest  buffer  (cysteine 
hydrochloride  lOmM, EDTA  lOmM in phosphate buffered saline, buffered to pH 6.0 with
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NaOH)  containing  5pil  of papain (Sigma P3125)  was  added to  the  dried cartilage  slices, 
activated at 60°C and allowed to digest overnight.
Quantitative  biochemical  analysis  included  water  content,  DNA,  glycosaminoglycan  and 
hydroxyproline contents. All samples were assayed blindly.
Water content:
The percentage water was calculated from the formula:
vvet weight - dry weight xm 
wet weight
DNA content:
The DNA content of the papain digest samples was measured using the fluorimetric assay of 
Kapuscinski  and  Skoszylas  (1977).  Duplicate  samples  (200pl)  of papain  digest  of DNA 
solutions, containing 0-15.0 pg /ml in 0.01M NaCl, were diluted with 300pl 0.01M NaCl 
and 400pl 0.01M Tris-HCl buffer, pH 7.0. One hundred pi of a solution containing lpg/ml 
fluorimetric dye 4',6-diamidino-2-phenylindole-2HCl (DAPI) was then added to each sample 
and mixed. Fluorescence was measured at 460nm on a Perkin-Elmer Fluorimeter.
Glycosaminoglycan content:
The  glycosaminoglycan  (GAG)  concentration  was  measured  in  papain  digests  of  the 
cartilage by a modification of the  1,9-dimethylmethylene blue  (DMB)  dye  binding assay 
described by Famdale et al (1982). Forty pi of the digest was added in duplicate to a 96 well 
plate.  Two  hundred  and fifty  pi  of the DMB  dye  reagent (containing  16mg  DMB,  0.5% 
ethanol, 0.2% sodium formate and 0.2% formic acid in a litre, stored in a dark bottle at room 
temperature)  were  added.  Standards  containing  5-50pg/ml  shark  chondroitin-4-S04  were 
treated in the same way. The metachromatic shift in absorption at 600-535 nm, when the dye 
is complexed with sulphated GAG, was measured on a Bio-Rad Plate reader and the results 
were calculated using Microplate Manager© on an Apple Mac computer.
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Hydroxyproline:
Hydroxyproline was measured in acid hydrolysed papain digests by a modification of the 
method of Bergman and Loxley (1970). After overnight hydrolysis in 0.5 ml concentrated 
HC1  at  100°C,  1.0  ml  of an oxidant solution (containing  sodium acetate trihydrate  57  g, 
trisodium citrate 37.5 g, citric acid 5.5  g and 385 ml propan-2-ol made up to  1  litre with 
distilled water) was added. The pH was adjusted to 5-6 with saturated lithium hydroxide and 
the volume of each sample was made up to 5.0 ml with distilled water and stored at 4°C until 
assay.  One  hundred  pi  of  test  sample  of  standard  solution  containing  0-20.0  pg/ml 
hydroxyproline in propan-2-ol were added in duplicate to a 96 well plate. An equal volume 
of propan-2-ol was added to each well followed by 10 ml of freshly prepared chloramine T 
(7 g per 100 ml distilled water), the plate was sealed and mixed for 5 min on a plate mixer. 
One  hundred  pi  of  freshly  prepared  Ehrlich’s  [DMAB]  reagent,  (containing  p- 
dimethylamino-benzaldehyde (17.6 g) and 44.3 ml of perchloric acid (SG 1.54) made up to 
100 ml with propan-2-ol immediately before use), was added to  each well, the plate was 
sealed, mixed for 5 minutes at room temperature and heated to 60°C for 30 minutes in an 
oven. After cooling, the absorbance was read at 540 nm on a Bio-Rad Plate reader and the 
results were calculated using Microplate Manager© on an Apple Mac computer.
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RESULTS
In  one  of the  PEMA  group  knees  [left knee,  rabbit no  6],  dislocated patella and  severe 
inflammation/adhesions in the joint were noted at termination. This knee was excluded from 
the study. The overall results of the biochemical analysis are presented in Table IV. 1.
Table IV.l;
B iochem ical analysis of the repair tissue in the PEMA/THFMA group com pared to control 
specim ens and to norm al articular cartilage at 6  weeks
group wet weight dry weight % water DNA mg/g GAG mg/g oh-pro mg/g
R2:  SHAM 0.0131 0.0071 45.80 18.85 0.64 35.41
R3:  SHAM 0.0152 0.0084 44.74 35.69 0.96 45.72
RS:  SHAM 0.0181 0.0084 53.59 8.90 0.80 30.67
R6:  SHAM 0.0174 0.0087 50.00 25.21 0.60 32.56
R8:  SHAM 0.0053 0.0024 54.72 31.51 1.18 49.46
R9:  SHAM 0.0141 0.0068 51.77 9.61 0.78 37.49
R ll: SHAM 0.0098 0.0038 61.22 8.24 1.06 88.50
R12: SHAM 0.0188 0.0098 47.87 22.71 0.60 31.97
RI4: SHAM 0.0133 0.006 54.89 13.84 0.71 45.59
R15: SHAM 0.0128 0.0061 52.34 34.47 0.90 43.82
516.94 209.03 8.23 441.19
SHAM mean 51.694 20.903 0.823 44.119
SHAM SI) 4.884 10.662 0.199 16.947
RJ:  PEMA 0.0625 0.0341 45.44 37.73 1.20 43.90
R3:  PEMA 0.046 0.0216 53.04 40.59 1.58 64.80
R4:  PEMA 0.0652 0.0348 46.63 36.33 1.13 40.12
R7:  PEMA 0.0299 0.0141 52.84 43.02 1.89 69.16
R9:  PEMA 0.0132 0.0048 63.64 50.27 1.34 54.51
RIO: PEMA 0.0341 0.0187 45.16 37.26 1.40 38.33
R12: PEMA 0.0617 0.0348 43.60 36.97 1.09 41.24
R13: PEMA 0.0247 0.011 55.47 45.60 2.05 54.07
R1S: PEMA 0.0028 0.002 28.57 39.56 1.80 65.99
434.39 367.33 13.48 472.12
PEMA mean 48.266 40.814 1.498 52.458
PEMA SI) 9.76 4.688 0.350 12.104
Rl:  CONTROL 0.0396 0.0168 57.58 7.62 0.24 11.56
R2:  CONTROL 0.0464 0.0261 43.75 3.51 0.18 10.65
R4:  CONTROL 0.0374 0.0204 45.45 2.64 0.16 6.73
RS:  CONTROL 0.038 0.0212 44.21 2.21 0.17 9.40
R7:  CONTROL 0.038 0.021 44.74 3.07 0.15 7.00
R8:  CONTROL 0.042 0.0257 38:81 5.74 0.17 9.51
RIO: CONTROL 0.0403 0.0287 28.78 3.81 0.17 8.11
R ll: CONTROL 0.0426 0.0318 25.35 1.43 0.14 4.48
R13: CONTROL 0.0407 0.0205 49.63 3.10 0.18 8.68
R14: CONTROL 0.0417 0.0248 40.53 3.27 0.16 7.75
418.83 36.4 1.72 83.87
COM ROE mean 41.883 3.64 0.172 8.387
COM ROE SI) 9.384 1.794 0.027 12.692
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Statistical analysis o f the results:
The biochemical analyses were all calculated using the dry weight of tissue and statistical 
comparison was made using the un-paired student ”t" test
Water      GAG____________
SHAM PEMA
SHAM - -
PEMA non-sign. -
CONTROL p<.005 non-sign
SHAM PEMA
SHAM - -
PEMA p<.0005 -
CONTROL p<.0005 p<.0005
DNA
SHAM PEMA
SHAM - -
PEMA P<0005 -
CONTROL p<.0005 p< 0005
Hydroxyproline
SHAM PEMA
SHAM - -
PEMA non-sign -
CONTROL p<.005 p<.005
Water Content
There  was  no  significant difference  between the  percentage  of water  in  normal  articular 
cartilage [sham] and the repair tissue in the PEMA group. However, there was a significant 
lowering (approximately 20%) in the water content of the repair tissue in the control group.
DNA
The DNA content of the repair tissue in the PEMA group was significantly higher than the 
DNA content in normal articular cartilage. There was a high degree of consistency within the 
group demonstrated by the small (<9.0%) standard deviation. The increase in cellularity was 
not due to the effect of operation itself, as in the control group it was significantly reduced.
GAG
There was a statistically significant increase in the GAG concentration in the repair tissue in 
the  PEMA  group  and  decrease  in the  control  group  when  compared  to  normal  articular 
cartilage.
Hydroxyprol  ine
There is no significant difference in the small elevation in the hydroxyproline content of the 
PEMA  group  compared  to  normal  articular  cartilage,  although  the  reduction  of 
hydroxyproline  in  the  control  group  was  significant  when  compared  to  normal  articular 
cartilage.
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DISCUSSION
Biochemical assessment is essential in the evaluation of the repair tissue in articular cartilage 
defects. Biochemical analysis has also been used extensively for the assessment of articular 
cartilage  following  cryopreservation  of  osteoarticular  allografts  (Schachar  et  al  1992), 
following joint disuse and joint instability (Muller et al 1994), and for the changes affecting 
the  opposing  to  the  defect articular  surface  (Richardson  and  Clark,  1990).  Non-invasive 
techniques such as magnetic resonance imaging of the articular cartilage appear to correlate 
with the collagen content of the articular cartilage (Fragonas et al 1998) and it is a possibility 
that other techniques will be developed in the future to enable the non-invasive analysis of 
the articular cartilage composition.
In this study, the repair tissue in the PEMA group showed high concentration of water and 
hydroxyproline, similar to that in the normal articular cartilage in the ‘sham’ group. The high 
water  concentration  is  characteristic  and  determines  the  properties  of hyaline  articular 
cartilage  (Maroudas  and  Schneiderman,  1987).  Water  interacts  with the matrix  structural 
macromolecules maintaining hydration of the cartilage tissue and allowing exchange with 
fluids outside the tissue.  Water also contributes to joint lubrication and to nutrition of the 
chondrocytes through diffusion (Newman,  1998). Hydroxyproline is a characteristic amino 
acid of the polypeptide chain of collagen, rarely found in other tissues (Grant and Prockop, 
1972,  Eyre,  1980).  The  total  collagen  content  of  articular  cartilage  specimens  can  be 
determined on the basis of the hydroxyproline content (Vachon et al 1990).
This  study  showed  that  the  DNA  content  of the  repair  tissue  in  the  PEMA  group  was 
significantly  higher  than  that  in  the  normal  articular  cartilage.  The  DNA  concentration 
reflects the cellularity of the tissue (Kim et al 1988), thus confirming that the repair tissue in 
the  PEMA  group  is  significantly  more  cellular  than  the  normal  articular  cartilage.  This 
increased cellularity of the repair tissue in the biomaterial group has already been reported in 
the  histological/histochemical  assessment  [Chapter  III.B]  and  in  the  image  analysis 
assessment [Chapter III.E] of the repair tissue in all observational periods up to 1   year post­
implantation.
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Glycosaminoglycans  form part  of the  proteoglycan molecule  (Roughley  and  Lee,  1994). 
Their  concentrations  vary  with  injury  and  disease  of cartilage  (Hardingham  et  al  1992, 
Rosenberg, 1992). The significant increase in the amount of glycosaminoglycans detected in 
the  repair  tissue  in  the  biomaterial  group  reflects  either  the  increased  amount  of 
proteoglycans  synthesized  by  each  chondrocyte  or  it  results  from  the  larger  number  of 
chondrocytes  in  the  repair  tissue,  although  each  cell  produces  normal  amounts  of 
proteoglycans. The overall increased amounts of proteoglycans make the repair tissue able to 
sustain higher compression loading without tissue degeneration and failure.
In the control group, by contrast, all studied components of the repair tissue were found to be 
significantly  reduced  confirming  the  presence  of a  less  cellular type  of repair with  less 
proteoglycans in the extracellular matrix, changes similar to those in osteoarthritis. Guilak et 
al  (1994)  reported  37%  decrease  in  the  proteoglycan  content  and  36%  decrease  in  the 
collagen content in canine osteoarthritic articular cartilage.
It is concluded that the repair tissue in full-thickness articular cartilage defects treated with 
PEMA/THFMA  is  biochemically  similar  to  hyaline  articular  cartilage,  although  it 
demonstrates  hypercellularity  and  overproduction  of proteoglycans  at  6  weeks.  Control 
specimens present biochemical composition similar to that noted in degenerative arthritis.
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CHAPTER V
COMPARATIVE STUDY OF ARTICULAR CARTILAGE REPAIR 
USING PEMA/THFMA POLYMER 
IN THREE AGE GROUPS
OBJECTIVE
MATERIALS
•  30 adult rabbits (from the study in Chapter III.B) compared with 10 young and 10 old 
rabbits
•  PEMA vs CONTROL
•  YOUNG vs ADULT vs OLD
METHOD
•  Macroscopic, Histological/Histochemical and Immunohistochemical assessment
•  At 6 weeks
RESULTS
DISCUSSION
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OBJECTIVE
The aim of this study  is  to  compare the effect of the  PEMA/THFMA  polymer  in  the 
repair of articular cartilage defects  in rabbits of three different age  groups,  i.e. young, 
adult and old.  The  clinical  applications  of the  method in articular cartilage  pathology 
would increase dramatically should the biomaterial appear effective in all ages.
MATERIALS  AND  METHODS
For the microscopic and histological/histochemical assessment, we compared the results 
of the 30 adult rabbits assessed in the study in Chapter III.B at 6 weeks  [ADULT AGE 
GROUP, rabbits 1-30] with 10 young rabbits  3-5  months old weighing  3.1 (2.9-3.3) kg 
[YOUNG AGE GROUP, rabbits  121-130], and with  10 old rabbits 32-36  months old 
and  weighing 4.9 (4.7-5.7) kg [OLD AGE GROUP, rabbits  131-140].  Female Sandy- 
Lop rabbits, group-housed in floor-pens were used in all groups.
For the immunohistochemical correlation involved the 10 specimens of the adult rabbits 
assessed at 6 weeks in the study in Chapter III.C, the 10 specimens in the young group 
and the 10 specimens in the old age group.
The young and the old animals underwent the same operation as the adult ones, with 
implantation of PEMA/THFMA in one knee and the other knee receiving no biomaterial 
and used as control. Animals were  sacrificed at 6 weeks post-operatively by intravenous 
injection of pentobarbitone sodium (Euthatal, 600 mg). The specimens were assessed by 
Macroscopic  and  Histological/Histochemical  Evaluation  using  the  Articular  Cartilage 
Repair  Scoring  System  (described  in  Chapter  III.A),  and  Immunohistochemical 
Evaluation using the silver-enhanced colloidal gold staining (described in Chapter III.C).
RESULTS
Mild inflammatory reaction was noted in 21.6% of the control knees and in 9.1% of the 
knees  in  the  biomaterial  group  among  the  adult  rabbits  [Chapter  III.B].  Mild
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inflammatory response was also noted in the synovium in 6 (30%) knees in the young 
and old rabbits in the control group (1  in the young and 5  in the old group) and in 4 
(20%)  knees  in the  biomaterial  group  (1  in  the  young  and  3  in  the  old  group).  No 
infection or foreign body reaction was noted in any of the specimens.  One knee in  the 
biomaterial  group [OLD AGE GROUP] and 5 knees in the control group [1 in YOUNG 
AGE  GROUP  and  4  in  OLD  AGE  GROUP]  developed joint  effusion/heamarthrosis 
immediately post-operatively;  at termination no haemarthrosis was noted and synovial 
fluid was cultured and showed no bacterial growth.
Osteoarthritic changes were noted in 6 (30%)  of the knees in the old group  (4 in the 
biomaterial and 2 in the control group). These changes consisted of severe destruction of 
the articular cartilage in the femoral condyles and the tibial plateaux with ebumated bone 
and peripheral osteophyte formation. Degenerative changes were not noted in the young 
rabbits in this study.
The macroscopic and histological/histochemical results are presented in Tables V.l, V.2 
and V.3 accompanied by graphic presentations of PEMA vs Control in each age group 
and of the PEMA effect compared in all age groups. Table V.4 analyses the results per 
criterion of assessment. Results are followed by their statistical analysis.
145Table V.l:
M acroscopic and H istological/H istochem ical assessm ent per criterion 
S coring at 6  w eek s. R abbits 121-130 
PEMA v s CONTROL. Y oung ag e group
PEMA 121 122 123 124 125 126 127  128 129 130
Area 2 0 2 0 2 0 2 0 2 0 10 2 0 2 0 2 0 2 0
Level 10 10 10 10 5 10 10 5 10 10
Surface 10 10 10 5 10 10 10 10 5 5
Cells 2 0 2 0 10 2 0 2 0 2 0 2 0 2 0 2 0 10
PGs 10 5 5 10 10 10 10 5 10 10
Structure 5 10 5 10 10 5 5 10 10 5
Bonding 2 0 10 10 2 0 2 0 2 0 2 0 2 0 10 2 0
TOTAL 95 85 70 95 95 85 95 90 85 80
SCORE
CONTROL 121 122 123 124 125 126 127 128 129 130
Area 10 10 20 2 0 10 0 0 0 10 0
Level 0 5 5 10 5 5 5 10 5 5
Surface 10 10 10 5 5 5 5 5 10 5
Cells 10 2 0 10 10 10 10 2 0 2 0 10 10
PGs 10 10 10 5 5 10 10 5 5 5
Structure 10 5 5 5 0 5 0 5 5 5
Bonding 2 0 10 10 10 0 0 0 10 10 2 0
TOTAL 70 70 70 65 35 35 40 55 55 50
SCORE
PEMA MEANS CONTROL MEANS PEMA SD CONTROL SD
Area 19.00 8.00 3.16 7.89
Level 9.00 5.50 2.11 2.84
Surface 8.50 7.00 2.42 2.58
Cells 18.00 13.00 4.22 4.83
PGs 8.50 7.50 2.42 2.64
Structure 7.50 4.50 2.64 2.84
Bonding 17.00 9.00 4.83 7.38
TOTAL 87.50 54.50 8.25 14.23
SCORE
Age study  - young
100  x
Criteria
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Table V.2:
M acroscopic and H istological/H istochem ical assessm ent per criterion 
S coring at 6  w eek s. R abbits 1-30 
PEMA vs CONTROL. A dult age group
PEMA 1 2 3 4 J 6 7 8 9 10  11  12  13 14 IS  16  17  18  19  20  21 22 23  24  25  26  27  28  29  30
Area 20 20 10 20 20 10 0 20 10 20 20 20 20 20 10 20 0 0 20 20 10 20 10 20 10 20 0 20 20 20
Level 10 5 10 10 10 0 0 10 10 10 10 5 10 10 10 10 0 5 10 10 10 10 10 10 10 5 0 10 10 10
Surface 10 5 10 10 10 10 5 10 10 10 10 10 10 10 10 10 0 5 10 10 10 10 10 10 10 10 5 10 10 10
Cells 20 20 20 20 20 20 10 20 20 20 20 20 20 20 20 20 10 10 10 20 20 20 20 20 20 20 0 20 20 20
PGs 10 10 10 10 10 10 5 10 10 10 10 10 10 10 10 10 5 10 10 10 10 10 10 10 10 10 5 10 10 10
Structure 10 5 5 5 10 5 0 5 5 5 5 10 5 10 10 10 0 0 5 5 10 10 5 5 5 0 0 0 10 5
Bonding 20 20  20 20 10 20 10 20 20 20 20 10 10 20 20 10 0 10 20 20 10 20 20 20 10 20 0 20 20 20
TOTAL 1 0 0 85 85 95  90 75  30 95 85 95 95 85 85 1 0 0 90 90 15 40 85 95 80 1 0 0 85 95 75 85 10 90 10 95
SCORE
CONTROL 1 2 3 4 5 6 7 8 9 10  11  12  13 14 IS  16  17  18  19  20  21 22 2324252627282930
Area 10 0 10 10 10 20 10 10 20 0 0 0 10 20 10 10 10 10 10 20 20 10 0 10 0 0 0 10 20 0
Level 5 0 5 5 5 10 5 10 10 0 5 0 10 5 5 5 5 10 10 10 5 0 0 0 10 10 0 5 5 0
Surface 0 5 5 5 10 10 10 5 0 0 5 0 10 5 5 5 5 5 5 10 5 0 5 5 10 10 5 5 5 0
Cells 10 10 10 10 10 20 10 10 20 10 0 0 10 10 10 10 0 10 10 20 10 0 10 10 0 0 10 20 10 10
PGs 5 0 5 10 5 10 10 5 0 5 0 0 10 10 5 5 0 10 5 5 10 0 10 5 0 5 10 10 0 5
Structure 0 0 0 0 0 5 0 0 0 5 0 0 0 0 5 5 5 0 0 0 0 0 0 5 0 0 0 5 5 5
Bonding 10 10 0 0 10 10 0 10 10 10 0 0 10 10 20 10 10 0 0 20 20 10 0 10 0 0 0 *P 10 10
TOTAL
SCORE
40 25 35 40 50  85 45 50 60 30 1 0 0 60 60 60 50 35 45 40 85 70 2 0 25 45 2 0 25 25 65 55 30
PEMA MEANS CONTROL MEANS PEMA SD CONTROL SD
Area 15.00 9.00 7.31 7.12
Level 8.00 5.17 3.62 3.82
Surface 9.00 5.17 2.42 3.34
Cells 18.00 9.33 4.84 5.83
PGs 9.50 5.33 1.53 3.92
Structure 5.33 1.50 3.46 2.33
Bonding 16.00 7.33 6.21 6.40
TOTAL 80.83 42.83 24.21 20.33
SCORE
100 T
90
80  -
70  -
£  60 
o
Age study - adult
I P E M A  
I Control
S  50 
5
40
30
L
✓   c f  / '
Criteria
147f
Chapter V
Table V.3:
M acroscopic and H istological/H istochem ical assessm ent per criterion 
S coring at 6  w eek s. R abbits 131-140 
PEMA vs CONTROL. O ld ag e group
PEMA 131 132 133 134 135 136  137 138 139  140
Area 2 0 10 20 10 2 0 0 2 0 10 0 10
Level 10 5 5 5 10 5 10 5 0 5
Surface 5 5 5 10 10 5 10 5 0 5
Cells 2 0 10 10 2 0 10 2 0 2 0 2 0 10 2 0
PGs 10 10 5 5 5 0 5 10 0 10
Structure 10 10 5 5 5 10 5 10 5 5
Bonding 2 0 10 10 10 10 10 2 0 10 10 10
TOTAL
SCORE
95 60 60 65 70 50 90 70 25 65
CONTROL 131 132 133 134 135 136 137  138 139  140
Area 10 0 10 0 0 10 0 0 0 0
Level 10 5 0 5 0 5 0 5 10 5
Surface 5 0 0 0 5 10 5 0 0 0
CeUs 10 0 10 10 0 0 10 10 10 0
PGs 10 5 5 0 0 5 10 10 5 0
Structure 5 5 5 0 0 5 0 0 5 0
Bonding 2 0 10 10 2 0 10 10 0 0 0 10
TOTAL
SCORE
70 25 40 35 15 45 25 25 30 15
PEMA MEANS CONTROL MEANS PEMA SD CONTROL SD
Area 1 2 .0 0 3.00 7.89 4.83
Level 6 .0 0 4.50 3.16 3.69
Surface 6 .0 0 2.50 3.16 3.54
Cells 16.00 6 .0 0 5.16 5.16
PGs 6 .0 0 5.00 3.94 4.08
Structure 7.00 2.50 2.58 2.64
Bonding 1 2 .0 0 9.00 4.22 7.38
TOTAL 65.00 32.50 19.58 16.37
SCORE
100 
90 
80 4 
70
g  60
o 0
*  50 
c  1 0
1  40  4
30
20
10
0
T
□  PEMA 
E  Control
s f
Age study - old
L
O *
Criteria
4-
& <4  4 “
A
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Macroscopic and histological/histochemical assessment of the repair tissue
at 6 weeks
Graphic presentation of the effect of PEMA/THFMA in three age groups
Age comparison - PEM A
100 T
90 -
□ YOUNG 
■ ADULT 
BOLD
Criteria
In all age groups PEMA scored higher than the control. The difference between the three 
age groups is minimal particularly when considering the standard deviations.
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Table V.4:
M acroscopic and H istological/H istochem ical assessm ent of repair tissue by criterion and
the overall repair at 6  w eeks 
PEMA vs CONTROL. T hree age groups
C R IT E R IO N
YOUNG  GROUP AIH-LT GROUP  |  OLD GROUP
PEMA CONTROL PEMA CONTROL!  PEMA CONTROL
n”10 n=l 0 ii=30 n-30  j   n-=I0 n=l()
ARK V
100% resurfacing
>50% resurfacing
9  (90%)
1  (10%) 4  (40%)
19  (63.3%)  6  (20.0%)
(23.3%)  15  (50.0%)
(-1 0 % )
4  (40%)
<50% resurfacing
~  LEVEL  ..........
N o r m a l   c a r t i l a g e   level
0  (0%) 4  (40%)  4  (13.3%) 9  (30.0%)
2  ( 2 U % ) 22  (73.3%) 9  pu.u% )
2_(20%)_ 
T T 'i 0%)"
7  (70%)
2  (20%)
2  (20%)  7  (70%) 4  (13.3%)  13  (43.3%) 5  (50%)
( in>-o  depre.viimi
“ si"RKArK ‘
■ 1(11 i > ;,) i  x  (20 o% ) |  1   (10% ) 3  (30".,)
Smooth, glistering 7  (70%) 4  (40%) 25  (83.3%) 7  (23.3%) 1   (10%)
Irregular, opaque 3  (30%) 6   ( 6 0 % ) 4  (13.3%) 17  (56.6%) 3  (30%)
Disrupted by fissurcs 0  (0%) 0  (0%)
CELLS
1   (3 3%) 6  (20.0%) 1   ( 10%)
Chondrocytes 8  (80%) 3  (30%) 23  (83 3%) 4   ( 1 3   3 % ) 6  (60%) 0  (0%)
4  (13.3%) 20  (66.6%) 4  (40%) 6  (60%)
1   (33.3%) .........
7  (70%) 5  (50%) 27  (90.0%) 10  (33.3%) 4  (40%) (30%)
3  (30%) 5  (50%) 3  (9.9%) 12  (40.0%) 4  (40%)
Low H i J M 0  (0 0%) 8  (26.6%) 2  (20%) (30%)
H>aline-like tissue 5  (50%) 1  (10% ) 8   ( 2 6 . 6 % ) 0  (0.0%) 4  (40%) 0  (0%)
Moderately disorganised
5_ (?']%)
3  (9.9%) 2  (20%) 2  (20%) 7  (70%)
5  (50%) 8  (26.6%) 16  (53.3%)
0  (0%) 11  (36.6%) 0  (0%)
ARTICULAR
CARTILAGE
REPAIR
young  g roup 
I’EMA  " j CONTROL
1 1 -10  II--1 0
ADI  L I  CROC I’ _
i’KMA  TcON j K()j.
n-30  j   11-30
o ld   g r o u p   ;  
1 ‘LM A   “fc ONntcif;  
11= 10  !   n =io  i
GOOD 2  (20%) 7  (70%) 4  (13.3%) 10  (33.3%) 7  (70%) 1  (10%)
POOR 0  (0%) 3  (30%) 4  (13.3%) 18  (60.0%) 1   (10%) 9  (90%)
In all age groups PEMA was superior to control. Excellent overall repair was noted in 
80% of the PEMA young group, in 73.3% of the PEMA adult group and in 20% of the 
PEMA old group specimens. In the control group 2 (6.6%) knees from the adult rabbits 
had  excellent  result.  No  excellent  results  were  noted  in  the  control  young  or  in  the 
control old groups. There were no poor results in the PEMA young group, compared to 
30% in the controls.  In the old age group  10% of the PEMA specimens  showed poor 
repair compared to 90% in the controls.
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Statistical analysis o f macroscopic and histological/histochemical results:
The macroscopic and histological/histochemical results were assessed with McNemar’s 
test. The Wilcoxon test evaluated the total scores. However, the number of rabbits used 
for the young and old groups was 10, rather than 30, so the statistical power is decreased. 
This should be bom in mind when interpreting the p-values, as an insignificant p-value 
can be interpreted as either there is no effect or that the test has insufficient power to 
detect an effect; there is no way to distinguish between these two interpretations.
Score Young Adult Old
Area .046 0.019 .122
Level .206 0.031 .721
Surface .371 6.4e-4 .149
Cells .074 l.le-4 1
PGs .683 0.002 .801
Structure .284 0.002 .564
Bonding .172 6.7e-4 .262
Total Score .008 1.5e-5 .009
The adult column is a replicate of the 6 week column in the main trial [Chapter III.B]. It 
can be concluded from these tests that PEMA/THFMA has an effect also on young and 
on old animals.  To determine if there is a trend in age, logistic regression is used again 
in a similar vein to its usage in the study in Chapter III.B, except ‘time of measurement’ 
is replaced here with ‘age group’. The reference event is excellent repair with 
PEMA/THFMA treatment in the young age group.
Pr( score = i | treatment, age group )=  0,,  i = poor, good, excellent
log ( 6j)  C C j + Ptreatment,  i  Page,  i
Analysis o f deviance:
V ariab le d .f. D ev ian ce resid u al d .f. resid u al d ev ian ce p -v alu e
T re a tm e n t 2 5 2 .5 4 3 8 2 5 .0 7 4 .0 1 1
A g e 4 1 7 .2 6 1 4 7 .8 1 3 .2 3 1
The  above  indicates that the  effect of age  is  non-significant.  The  presentation of the 
coefficients is unnecessary if it is decided that age does not have an effect, because the 
only remaining covariate is treatment, whose effect size is estimated more accurately in 
the study in Chapter III.B.
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Table V.5 demonstrates analysis of the immunolocalisation of the cartilage components 
in the repair tissue in both the biomaterial and the control groups in all three age groups.
Table V.5:
Immunohistochemical assessment of repair tissue at 6 weeks. 
PEMA  vs CONTROL. Three age groups
ANTIGEN
YOUNG  GROUP ADULT  GROUP OLD  GROUP
PEMA
n=10
CONTROL
n=10
PEMA
n=10
CONTROL
n=10
PEMA
n=10
CONTROL
n=!0
Collagen type II ‘
>50% of matrix 7  (70%) 1  (10%) 5  (50%) 0  (0%) 5  (50%) 0  (0%)
<50% of matrix 3  (30%) 4  (40%) 4  (40%) 2  (20%) 3  (30%) 0  (0%)
no detection 0  (0%) 5  (50%) 1  (10%) 8  (80%) 2  (20%) 10  (100%)
Kcratan-Sulphate .... ' '  ......... ^  * \
>50% of matrix 8  (80%) 2  (20%) 6  (60%) 0  (0%) 7  (70%) 0  (0%)
<50% of matrix 2  (20%) 6  (60%) 4  (40%) 0  (0%) 3  (30%) 4  (40%)
no detection 0  (0%) 2  (20%) 0  (0%) 10  (100%) 0  (0%) 6  (60%)
Chondroitin 4-Sulphate :  ;  :   :  ■
>50% of matrix 8  (80%) 1  (10%) 6  (60%) 0  (0%) 6  (60%) 1  (10%)
<50% of matrix 2  (20%) 5  (50%) 3  (30%) 2  (20%) 3  (30%) 2  (20%)
no detection 0  (0%) 4  (40%) 1  (10%) 8  (80%) 1  (10%) 7  (70%)
Chondroitin 6-Sulphate *
>50% of matrix 9  (90%) 2  (20%) 7  (70%) 0  (0%) 5  (50%) 2  (20%)
<50% of matrix 1  (10%) 8  (80%) 3  (30%) 4  (40%) 5  (50%) 2  (20%)
no detection 0  (0%) 0  (0%) 0  (0%) 6  (60%) 0  (0%) 6  (60%)
Collagen type II is seen evenly distributed in the extracellular matrix of the repair tissue 
in 70% of the PEMA repairs in the young group and 50% of the PEMA repairs in the 
adult and the old groups. In the control group only one repair contained collagen type II 
distributed in over half of the matrix. This repair occurred in a young rabbit while no 
repair tissue from the other age groups contained significant amounts of collagen type II.
In the control group in general, collagen type II was detected in the deepest layers in the 
repair tissue, while the superficial layers contained minimal or no collagen type II. This 
explains the early degeneration of the superficial layer in the repair tissue in the control 
group observed as early as 6 weeks.
With regard to detection of glycosaminoglycans in the matrix of the repair tissue, over 
60% of all specimens  in the PEMA group were found to contain glycosaminoglycans 
distributed throughout the whole of the matrix. This trend continued in all age groups.
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Statistical analysis o f immunohistochemical results:
The  immunohistochemical  results  were  assessed  with Fisher’s  exact  test  and  the  p- 
values are presented below:
Antigen Young Adult Old
Collagen type II .007 .004 7e-4
Keratin-Sulphate .033 le-5 .001
Chondroitin 4-sulphate .005 .001 .018
Chondroitin 6-sulphate .005 .001 .016
This  analysis  indicates  that  PEMA  produces  repair  tissue  that  contains  significantly 
larger amounts of hyaline cartilage components, compared to the control group.
PEMA/THFMA appears to be equally effective in all ages and the effect of age on the 
quality of the repair tissue is not statistically significant.
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Fig.V.l
Histological appearance of the repair tissue in the polymer group in a young rabbit:
The repair tissue [rt] comprises of numerous cells with chondrocytic phenotype, evenly 
distributed  within  the  extracellular  matrix.  The  arrow  indicates  the  smooth  transition 
from the normal articular cartilage to the repair tissue. [p=polymer, b=subchondral bone, 
c= normal articular cartilage] (1/un thick section, Toluidine blue staining, x 13.2)
Fig.V.2
Histological appearance of the repair tissue in the polymer group in a young rabbit:
Higher magnification of the specimen shown in Fig.V.l  focusing on the transitional area 
[— >]  between  the  repair  tissue  [rt]  and  the  surrounding  the  defect  normal  articular 
cartilage [c]. (1/un thick section, Toluidine blue staining, x 33)
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Fig.V.3
Histological appearance of the repair tissue in the polymer group in a young rabbit:
The  repair tissue  comprises  of numerous  cells  with  chondrocytic phenotype;  multiple 
mitoses of the cells are noted in this age group. (Haematoxylin/Eosin staining, x 132)
Fig.V.4
Histological appearance of the repair tissue in the polymer group in a young rabbit:
Complete integration of the repair tissue [rt] with normal articular cartilage [c]. The cells 
in  the  edge  of the  repair  tissue  outnumber  those  in  the  edge  of the  normal  articular 
cartilage. (ly.m thick section, Toluidine blue staining, x 132)
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Fig. V.5
Histochemical  appearance  of the  repair  tissue  in  the  polymer  group  in  a  young 
rabbit:
The extracellular matrix of the repair tissue shows zonal differentiation between the deep 
[d] layers containing higher concentration of proteoglycans and the superficial [s] layer 
showing  lower  concentration  of proteoglycans  and  smaller  cells  lying  parallel  to  the 
articular surface. (Sajranin-0 staining, x 66)
Fig.V.6
Immunohistochemical  appearance  of the  repair tissue  in  the polymer group  in  a 
young rabbit:
The repair tissue contains collagen type II evenly distributed throughout the matrix, with 
higher concentration in the superficial [s] layer and lower concentration in the deep  [d] 
layers. (Silver-enhanced colloidal gold immuno-staining, x 66)
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Fig.V.7
Histological  appearance  of  the  repair  tissue  in  the  polymer  group  in  an  adult 
rabbit:
The  repair  tissue  [rt]  contains  numerous  cells  with  chondrocytic  phenotype  evenly 
distributed throughout the matrix with large numbers of cells in the middle layers. The 
— ►   indicates the transition from the repair tissue to the normal articular cartilage [c]. [b= 
subchondral bone, p= polymer] (Haematoxylin/Eosin staining, x 13.2)
Fig.V.8
Histochemical  appearance  of the  repair tissue  in  the  polymer  group  in  an  adult 
rabbit:
The  repair  tissue  [rt]  contains  high  concentration  of  proteoglycans,  similar  to  the 
concentration  in  the  normal  articular  cartilage  [c].  The  subchondral  bone  has  no 
proteoglycans and stained negative. [p=polymer] (Safranin-0 staining,  x 13.2)
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Fig.V.9
Macroscopic appearance of the repair tissue in the polymer group in an old rabbit:
Complete resurfacing of the defect in the femoral trochlea [ft). The repair tissue is fully 
integrated  with  the  surrounding  the  defect  normal  articular  cartilage  [►]  and  the 
transitional area is smooth, except for a small region which is irregular [— ► ].
Fig. V. 10
Macroscopic  appearance  of the  posterior  aspect  of  the  femoral  condyle  in  the 
specimen shown in Fig V.9:
Severe osteoarthritic changes with complete destruction of the articular cartilage [c] and 
exposure of the subchondral bone [b]. The ► indicate the remaining parts of the articular 
cartilage that show signs of advanced degeneration.
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Fig.V.ll
Histological appearance of the repair tissue in the polymer group in an old rabbit:
The repair tissue [rt] is fully integrated with the surrounding the defect normal articular 
cartilage  [c].  The  ►   indicates  the  transition  from  the  repair  tissue  to  the  adjacent 
articular  cartilage.  [b=subchondral  bone,  p=polymer]  (Haematoxylin/Eosin staining,  x 
13.2)
Fig. V. 12
Histochemical  appearance  of  the  repair  tissue  in  the  polymer  group  in  an  old 
rabbit:
The repair tissue [rt] contains high concentration of proteoglycans, similar to that of the 
normal  articular  cartilage  [c].  The  subchondral  bone  contains  no  proteoglycans  and 
stained negative. [p=polymer] (Safranin-O staining, x 13.2)
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Fig. V. 13
Histological appearance of the repair tissue in the polymer group in an old rabbit:
Complete bonding of the repair tissue [rt] to the surrounding the defect normal articular 
cartilage  [c].  The  cells  in  the  repair  tissue  outnumber  those  in  the  normal  articular 
cartilage, a finding similar to that in the young and adult age groups. (1 pim thick section, 
Toluidine blue staining, x 132)
Fig.V.14
Immunohistochemical appearance of the repair tissue in the polymer group in an 
old rabbit:
The repair tissue [rt] contains collage type II like the normal articular cartilage [c]. The 
subchondral  bone  [b]  contains  no  collagen  type  II  and  is  stained  negative.  (Silver- 
enhanced colloidal gold immuno-staining, x 33)
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Fig.V.15
Histological appearance of the repair tissue in the control group in a young rabbit:
The repair tissue  [rt]  is fibrocartilaginous and contains pieces of subchondral bone  [*]. 
The adjacent to the defect normal articular cartilage [c] shows signs of degeneration with 
fibrillation and empty cell lacunae. The ►   indicate the incomplete bonding of the repair 
tissue, [b=subchondral bone] (Haematoxylin/Eosin staining, x 33)
Fig.V.16
Histological appearance of the repair tissue in the control group in an old rabbit:
The repair tissue [rt]  is fibroblastic and there is significant degeneration and fibrillation 
[►]  in the superficial layer of the normal articular cartilage  [c]  adjacent to the defect. 
[b=subchondral bone] (Haematoxylin/Eosin staining, x 33)
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DISCUSSION
The structure, composition and metabolism of the articular cartilage are known to change 
with age (Buckwalter et  al  1985, Webber  et al 1987, Stanescu et al 1-988, Flannery et al 
1990,  Amer, 1994).  There  are  many  macroscopic  changes  as  well  as  microscopic 
alterations in the cartilage cellularity and extracellular matrix structure, which are age- 
related.  The present study used the new PEMA/THFMA polymer system for articular 
cartilage repair in three different age groups of rabbits and showed enhancement of the 
biological repair in all ages.
Vignon  et  al  (1976)  studied  the  femoral  head  in  humans  and  found  an  age-related 
decrease in cell numbers that was more pronounced in the superficial as compared to the 
deeper zones of cartilage. It was also apparent that there is a close correlation between 
reduced cellularity and increased frequency of fibrillation in the superficial zone of the 
articular cartilage. Chondrocyte growth factor responsiveness shows qualitative changes 
during development and, after skeletal maturity, there is a profound decline in the levels 
of DNA  synthesis  and  cell  replication in response to  the  known chondrocyte  growth 
factors (Gueme et al  1995).  Our results showed predominance of chondrocytes in the 
repair tissue in the PEMA group at 6 weeks in all ages without a statistically significant 
change with age.
Hollander et al (1995)  examined articular cartilage explants  from human knees using 
immunohistochemistry.  They  specifically  studied denaturation  [loss  of triple helix]  of 
collagen type II and found that in ageing the first damage to collagen type II occurs in 
the superficial and upper middle zones extending to the lower middle and deep zones 
with increasing degeneration.  They also  noted that the  initial  damage  of the  collagen 
fibrils always occurs around chondorcytes, thus implicating them in the denaturation of 
collagen  type  II.  In  our  study  in  the  control  group,  immunohistochemistry  detected 
collagen type II in the deeper layers of the repair tissue only, correlating with the early 
degeneration of the superficial layer of the repair tissue observed in this group from as 
early as 6 weeks. Only one repair tissue specimen (10%) in the young age control group 
contained collagen type II in more than half of the matrix. On the contrary, in the PEMA 
group, 70% of the young specimens, 50% of the adult specimens and 50% of the old age 
specimens  contained  abundant  collagen  type  II  evenly  distributed  throughout  the
162Chapter V
extracellular matrix of the repair tissue. Collagen type II provides mechanical protection 
of the repair tissue against tensile stresses and shear forces and thus it can be speculated 
that the early degenerative changes seen in the repair tissue in the control group in all 
ages could reflect the mechanical disadvantage of the depleted of collagen type II repair 
tissue in this group.
Bank et al (1998) showed that the age-related accumulation of non-enzymatic glycation 
affects biomechanical properties of human articular cartilage. They indicated extensive 
tissue remodelling at young age, with slow turnover of collagen after maturity. They also 
showed that maturation starts in the second decade of life in the upper half of the tissue, 
and  occurs  last  in  the  tissue  close  to  bone.  Madsen  et  al  (1983)  studied  articular 
chondrocytes  in  rabbits  of different  age  groups  and  found  that  ageing  chondrocytes 
produce qualitatively and quantitatively different matrix components. Levels of elastin, 
collagen  and  proteoglycan  decreased  to  50%  or  even  lower  levels  in  60-month-old 
rabbits as compared to  1-week-old animals. The decreased ability of mature cartilage to 
replace  lost  proteoglycans  rapidly  (Amer,  1994)  would increase  the  susceptibility of 
cartilage to  degeneration.  These findings  would  also  suggest a delay  in the repair of 
articular cartilage defects in old age, and thus we can speculate that the repair tissue in 
the PEMA group in the old rabbits will continue improving after the 6-week observation 
period in our study. Some degree of improvement is also anticipated in the control knees 
in the old rabbits, although, taken into account the results in the young and adult rabbits, 
this improvement is expected to be minimal.
The articular cartilage of older individuals has xanthous appearance as opposed to the 
white  colour  of  young  cartilage  (Sokoloff,  1983).  This  may  be  due  to  increased 
intracellular lipofuscin and to non-enzymatic advanced glycosylation of the extracellular 
matrix constituents (Kirstein et al 1990). The expression of extracellular matrices seems 
to be closely related to  aging and degenerative changes  (Ishibashi et al  1996).  In our 
study, no significant colour changes were noted in the normal articular cartilage and the 
repair tissue in the three age groups.
Proteoglycans in ageing cartilage are smaller in size (Hardingham and Bayliss,  1990), 
while  the  total  glycosaminoglycan  content  in  human  articular  cartilage  may  not 
significantly change with ageing, although there is a decrease in the relative amount in
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chondroitin-sulphate and an increase in keratan-sulphate content (Roughley and White, 
1980).  The  changes  in chondroitin-sulphate  are  thought to  account  for the  decreased 
water content in aged cartilage. Ageing chondrocytes appear to assemble link protein- 
stabilized  aggregates  more  slowly  (Plaas  et  al  1988).  Chondrocytes  also  synthesize 
qualitatively  different proteoglycans  with  age.  Proteoglycans  produced  by  cells  from 
older animals showed decreased size and aggregation and an increase in the amount of 
chondroitin 6-sulphate (Madsen et al 1983). This change does not appear to occur in the 
repair  tissue  itself.  In  our  studies  using  the  silver-enhanced  colloidal  gold 
immunostaining, it was shown that the repair tissue in the old age rabbits, at least for the 
first 6 weeks, contains smaller amounts of chondroitin 6-sulphate in both the PEMA and 
the control groups.
The  cartilage  reduces  its  thickness  in  weight-bearing  and  also  in non-weight-bearing 
joints  with  age  (Meachim,  1971)  and  it  shows  fibrillations  and  softening  of  the 
superficial layers as a result of loss of proteoglycans and discontinuity in the collagen 
network (Meachim, 1972). Wachtel et al (1995) using x-ray scattering techniques found 
a  statistically  significant  tendency  towards  less  dense  collagen  packing  in  human 
articular cartilage as a result of ageing.
The  mechanical  properties  of  cartilage, including  tensile  fracture  stress  and tensile 
stiffness also change adversely with increasing age (Kempson,  1981, Kempson,  1991), 
rendering the  cartilage  susceptible to mechanical  failure.  Luder  in  1998,  following  a 
microscopic study on human mandibular condyles from adolescence to old age, believes 
that both maturational and later age changes seem to depend markedly on articular load 
bearing. The rabbits in our study were fully weight bearing immediately post-operatively 
and  they  were  group-housed  in  floor  pens  that  allowed  more  significantly  more 
physiological mobility and weight bearing of the operated knees.
Osteoarthritic changes were noted in 4 (20%) of the knees treated with PEMA/THFMA 
in the old group of rabbits. The changes were severe, showing complete destruction of 
the  articular  cartilage  in the  posterior  aspect  of the  femoral  condyles  with  ebumated 
subchondral bone and osteophyte formation. In all these 4 knees, the articular cartilage 
defects in the femoral trochlea were fully resurfaced by 6 weeks  [3  good,  1   excellent 
repair].  It  is  therefore  possible  to  assume  that  PEMA/THFMA  enhances  articular
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cartilage regeneration and repair, even in the presence of osteoarthritic changes in the 
treated joint.
In  Chapter  III.B  it  was  shown  that  the  repair  tissue  following  implantation  of 
PEMA/THFMA  in  articular  cartilage  defects  in  adult  rabbits  maintains  satisfactory 
structure and composition up to 1  year post-operatively. It is not yet determined how the 
newly formed repair tissue will behave in the long term in the young and old age groups. 
However, it appears from this study that the biomaterial is equally effective in all three 
age  groups.  Thus,  the  use  of  PEMA/THFMA  polymer  in  clinical  practice  could 
potentially challenge the traditional methods of treatment of articular cartilage defects in 
patients of all ages.
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CHAPTER VI
COMPARATIVE STUDY OF ARTICULAR CARTILAGE REPAIR 
USING PEMA/THFMA POLYMER 
AND POLY METHYL METHACRYLATE POLYMER fPMMA/MMAI
OBJECTIVE
MATERIALS
•  10 adult rabbits
•  PEMA vs PMMA
METHOD
•  Macroscopic, Histological/Histochemical and Immunohistochemical assessment
•  At 6 weeks
RESULTS
DISCUSSION
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OBJECTIVE
Full-thickness articular cartilage defects were treated either with PEMA/THFMA or with 
the conventional bone cement PMMA/MMA. Both polymers were implanted using the 
same technique. The aim of this study is to clarify, among others, whether the method of 
implantation matters mostly, or whether the chemistry of the polymer is critical.
MATERIALS AND METHODS
This study used 10 female adult Sandy-Lop  rabbits.  Both knees were operated on in 
each  rabbit,  one  knee  received  PEMA/THFMA  [PEMA]  and  the  other  knee 
PMMA/MMA  [PMMA].  The  method  of  implantation  and  preparation  of  the 
PEMA/THFMA polymer was the same as described in Chapter III.B. For the preparation 
of the PMMA/MMA system,  1   gr PMMA powder (containing  10% Barium  Sulphate) 
was mixed with 0.5 ml MMA liquid (containing 2.5% V/V N,N-dimethyl-p-toluidine).
Animals  were sacrificed at 6  weeks after operation  with  intravenous  injection  of 
Pentobarbitone  Sodium  (Euthatal  600  mg).  Specimens  were  evaluated  using  the 
Macroscopic  and  Histological/Histochemical  Assessment  of  the  Articular  Cartilage 
Repair Scoring System [Chapter III.A], and also using Immunohistochemistry involving 
the  10  control  specimens  of the  adult  rabbits  assessed  at  6  weeks  with  the  silver- 
enhanced colloidal gold immunostaining [Chapter III.C]. Furthermore, the results in the 
PMMA group were also compared with the results in the control group at 6 weeks from 
the study in Chapter III.B, in order to assess whether or not implantation of conventional 
bone cement in articular cartilage defects is preferable to ‘natural’ healing of the defect.
RESULTS
No infection was recorded in neither group. There was mild inflammatory reaction of the 
synovium in 2 (20%) knees in the PEMA group and 5 (50%) knees in the PMMA group 
of which three knees also showed significant foreign body reaction of the synovium to 
particles  of bone  cement.  The  macroscopic  and  histological/histochemical  results  are 
presented in Tables VI. 1, VI.2 and VI.3 followed by statistical analysis.
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Table VI.l:
M acroscopic and H istological/H istochem ical assessm ent per criterion 
S coring at 6  w eek s. R abbits 141-150 
PEMA vs PMMA
PEMA
Area
Level
Surface
CeUs
PGs
Structure
Bonding
TOTAL
SCORE
R141  R142  R143  R144  R14S  R146  R147  R148  R149  R1S0
20
10
10
20
10
10
20
20
10
10
10
10
10
10
1 0 0  80
10
10
10
20
10
5
20
85
20
5
10
20
10
5
20
90
20
10
10
20
5
5
20
90
20
10
10
10
10
5
20
85
10
5
10
20
10
10
10
75
20
5
5
10
5
5
20
70
10
10
10
20
5
0
10
65
20
10
10
20
10
5
20
95
PMMA R141 R142 R143 R144 R145 R146 R147 R148 R149 R1S0
Area 10 10 0 10 10 2 0 10 0 0 0
Level 5 0 0 5 0 5 0 10 0 5
Surface 10 5 0 5 5 5 0 5 10 10
Cells 10 2 0 10 10 0 2 0 0 10 0 10
PGs 10 5 5 5 0 5 5 5 0 10
Structure 10 10 5 5 0 0 5 0 5 10
Bonding 10 2 0 10 10 0 10 2 0 10 0 10
TOTAL 65 70 30 50 15 65 40 40 15 55
SCORE
PEMA MEANS PMMA MEANS PEMA SD PMMA SD
Area 17.00 7.00 4.83 6.75
Level 8.50 3.00 2.42 3.50
Surface 9.50 5.50 1.58 3.69
Cells 17.00 9.00 4.83 7.38
PGs 8.50 5.00 2.42 3.33
Structure 6.00 5.00 3.16 4.08
Bonding 17.00 10.00 4.83 6.67
TOTAL
SCORE
83.50 44.50 11.07 20.06
100 
90 
80 
70 
60 
50 
40 
30  -  
20 
1  0 
0
&
PEMA  vs  PMMA
PEMA
PMMA
it ii, li.ii ii.ii.ifaj
& j f
< b °
&
C rite ria A
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Table VI.2:
M acroscopic and H istological/H istochem ical assessm ent per criterion 
S coring at 6  w eek s. R abbits 141-150 and 1-30 
PMMA vs CONTROL
PMMA R141 R142 R143 R144 R145 R146 R147 R148 R149 R150
Area 10 10 0 10 10 2 0 10 0 0 0
Level 5 0 0 5 0 5 0 10 0 5
Surface 10 5 0 5 5 5 0 5 10 10
Cells 10 2 0 10 10 0 2 0 0 10 0 10
PGs 10 5 5 5 0 5 5 5 0 10
Structure 10 1 0 5 5 0 0 5 0 5 10
Bonding 10 2 0 10 10 0 10 2 0 10 0 10
TOTAL 65 70 30 50 15 65 40 40 15 55
SCORE
CONTROL 1 2 I 4 5 6 7 8 9 10 11 12  13 14 15  16  17 18  19  20  21 22 23  24  25  26  27  28  29  30
Area 10 0 10 10 10 2 0 10 10  2 0 0 0 0 1 0 2 0 10 10 10 10 10 2 0  2 0 10 0 1 0 0 0 0 10 2 0 0
Level 5 0 5 5 5 10 5 10 10 0 5 0 1 0 5 5 5 5 10 10 10  5 0 0 0 1 0 1 0 0 ,5 5 0
Surface 0 5 5 5 10 10 10 5 0 0 5 0 10 5 5 5 5 5 5 10  5 0 5 5 10 1 0 5 5 5 0
Cells 10 10 10 10 10 2 0 1 0 10 2 0 10 0 0 1 0 10 10 10 0 10 10 2 0  1 0 '  0 1 0 1 0 0 0 10 2 0 1 0 10
PGs 5 0 5 10 5 10 10 5 0 5 0 0 1 0 10 5 5 0 10 5 5  10 0 1 0 5 0 5 10 10 0 5
Structure 0 0 0 0 0 5 0 0 0 5 0 0 0 0 5 5 5 0 0 0  0 0 0 5 0 0 0 5 5 5
Bonding 10 10 0 0 10 10 0 10 10 10 0 0 10 1 0 2 0 10 10 0 0 2 0  2 0 10 0 1 0 0 0 0 10 1 0 10
TOTAL
SCORE
40 25 35  40 50  85 45 50  60 30 1 0 0 60 60 60 50 35  45  40 85  70 2 0 25  45  20  25 25 65 55  30
PMMA MEANS CONTROL MEANS PMMA SD CONTROL SD
Area 7.00 9.00 6.75 7.12
Level 3.00 5.17 3.50 3.82
Surface 5.50 5.17 3.69 3.34
Cells 9.00 9.33 7.38 5.83
PGs 5.00 5.33 3.33 3.92
Structure 5.00 1.50 4.08 2.33
Bonding 1 0 .0 0 7.33 6.67 6.40
TOTAL 44.50 42.83 20.06 20.33
SCORE
100  -
90  -
80  -
70  -
2 J   60  - o o
w  50  c
(9
£   40  4-
30
20  --
10  --
PMMA vs CONTROL
I   PMMA 
I  Control
Ibxliiii-L
Criteria
.cT
&
< < y
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Table VL3:
M acroscopic and H istological/H istochem ical assessment of repair tissue by criterion and
the overall repair at 6  w eeks 
PEMA vs PMMA vs CONTROL
6  weeks  ~j
AREA
PEMA
n=I0
PMMA  ;   CONTROL  !  
n-10  n=30
100% resurfacing 7  (70%) 1  (10%) 6  (20.0%)
>50% resurfacing 3  (30%) 5  (50%) 15  (50.0%)
<50% resurfacing 0  (0%) 4  (40%) 9  (30.0%)
LEVEL
Normal cartilage level 7  (70%) 1  (10%) 9  (30.0%)
Minimal depression 3  (30%) 4  (40%) 13  (43.3%)
Gross depression 0  (0%) 5  (50%) 8  (26.6%)
SURFACE
Smooth, glistering 9  (90%) 3  (30%) 7  (23.3%)
Irregular, opaque 1   (10%) 5  (50%) 17  (56.6%)
Disrupted by fissures 0  (0%) 2  (20%) 6  (20.0%)
CELLS
Chondrocytes 7  (70%) 2  (20%) 4  (13.3%)
Fibroblasts 3  (30%) 5  (50%) 20  (66.6%)
Other 0  (0%) 3  (30%) 6  (20.0%)
PGs
Normal 7  (70%) 2  (20%) 10  (33.3%)
Moderate 3  (30%) 6  (60%) 12  (40.0%)
Low 0  (0%) 2  (20%) 8  (26.6%)
STRUCTURE
Hyaline-like tissue 3  (30%) 3  (30%) 0  (0.0%)
Moderately disorganised 6  (60%) 4  (40%) 9  (30.0%)
Grossly disorganised 1   (10%) 3  (30%) 21  (70.0%)
BONDING
Complete 7  (70%) 2  (20%) 3  (9.9%)
Incomplete 3  (30%) 6  (60%) 16  (53.3%)
Minimal 0  (0%) 2  (20%) 11  (36.6%)
ARTICULAR 
CARTILAGE REPAIR
PEMA
n=10
PMMA
n=10
COM KOI.
n=30
EXCELLENT 6  (60%) 0  (0%) 2  (6.6%)
GOOD 4  (40%) 5  (50%) 10  (33,3%)
POOR 0  (0%) 5  (50%)  [   18  (60.0%)
Seven (70%) of the defects implanted with PEMA/THFMA were fully resurfaced by 6 
weeks  with  hyaline-like  articular  cartilage,  fully  integrated  with  the  surrounding  the 
defect  normal  articular  cartilage.  The  reparative  tissue  contained  numerous  cells 
expressing chondrocyte phenotype. These cells were distributed throughout the whole of 
the extracellular matrix with the cells in the deep layers being larger than those in the
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superficial layer. All specimens that were stained with safranin-O showed normal or near 
to normal concentration of proteoglycans in the repair tissue compared to the adjacent 
normal articular cartilage. Moreover, a ‘zonal’ differentiation with lighter staining of the 
superficial layer compared to the deep layers, characterisitc of mature articular cartilage, 
was noted in all specimens in the PEMA group.
Of the defects implanted with PMMA/MMA, all were repaired with fibrocartilaginous 
type of tissue, incompletely bonded to the surrounding normal articular cartilage. In all 
but 2 specimens, the tissue of the periphery of the repair presented with a characteristic 
acellular edge and degenerative changes, worse in the superficial layer.  Histochemistry 
showed  proteoglycans  in  the  deep  layer  of  the  repair  tissue  only  and  no  ‘zonal’ 
differentiation.
Statistical analysis of macroscopic and histological/histochemical results:
PEMA vs PMMA
The scores of the seven criteria were tested using the Me Nemar's test and the total score 
was assessed using the  Wilcoxon test.  However, the number of animals used for each 
group was 10, rather than 30, so the statistical power is decreased. This should be bom in 
mind when interpreting the p-values,  as an insignificant p-value can be interpreted as 
either there is no effect or that the test has insufficient power to detect an effect; there is 
no way to distinguish between these two interpretations.
Score P-value
Area .046
Level .112
Surface .046
Cells .300
PGs .072
Structure .801
Bonding .262
Total Score .006
The analysis indicates that PEMA is significantly superior to PMMA, with the area and 
surface appearance being mostly influenced.
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PMMA vs Control
In this analysis the control group is taken from the main trial and the PMMA group from 
the PEMA vs  PMMA experiment,  hence no pairing exists.  Therefore Fisher's test is 
used and the p-values are shown below:
Score p-value
Area .890
Level .296
Surface .889
Cells .659
PGs .644
Structure .007
Bonding .596
Total score .730
The only significant difference is in the structure score, where the PMMA group scores 
higher than the control group. Notably, the total score is non-significant, confirming that 
the PMMA bone cement when implanted in articular cartilage defects is not superior to 
the ‘natural’ healing of the control knees.
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Table VI.4 demonstrates analysis of the immunolocalisation of the cartilage components 
in the repair tissue in the PEMA, the PMMA as well as the control groups at 6 weeks.
Table VI.4;
Immunohistochemical assessment of repair tissue at 6 weeks
PEMA  vs PMMA vs CONTROL
6  weeks
Collagen PUMA PMMA CONTROL
type II n-10 n=IO n-10
>50% of matrix 0  (f.f.%) 0  (0%) 0  (0%)
<50% of matrix 3  (30%) 0  (0%) 2  (20%)
no ddedion 1   (10%) 10  (100%) 8  (80%)
■
Keratan-Sulphate
>50% of matrix 7  (70%) 1  (10%) 0  (0%)
<50% of matrix 3  (60%) 2  (20%) 0  (0%)
no detection 0  (0%) 7  (70%) 
■ ■ ■ ■ ■
10  (100%)
Chondroitin 4-Sulphate
>50% of matrix 7  (70%) 2  (20%) 0  (0%)
<50% of matrix 2  (20%) 3  (30%) 2  (20%)
no detection i  (i <m 5  f^n%)
i i i i l B j i P i
8  (80%)
Chondroitin 6-Sulphate
>50% of matrix 8  (80%) 0  (0%) 0  (0%)
<50% of matrix 2  (20%) 3  (30%) 4  (40%)
no detection 0  (0%) 7  (70%) 6  (60%)
In the  PEMA  group,  immunohistochemistry  detected  cartilage  components,  including 
collagen type II, keratan sulphate, and chondroitin 4- and 6-sulphate, evenly distributed 
throughout the matrix of the reparative tissue in over 60% of the defects. In the PMMA 
group no  collagen type  II  was  detected in  any of the  specimens.  In over  50%  of the 
specimens in the same group, the repair tissue contained no glycosaminoglycans. When 
glycosaminoglycan  aggregations  were  present,  they  were  localised  exclusively 
pericellularly and predominantly in the deep layers of the repair tissue.
Statistical analysis of immunohistochemical results:
The  Fisher’s  exact  test  was  used  for  the  statistical  correlation  and  the  p-values  are 
presented below:
Antigen p-value
Collagen type II le-4
Keratin- sulphate .002
Chondroitin 4-sulphate .068
Chondroitin 6-sulphate le-4
This analysis indicates that PMMA is significantly inferior to PEMA, but it is 
indistinguishable from the control.
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Fig.  VI. 1
Histochemical  appearance  of  the  repair  tissue  in  the  poly-methyl-methacrylate 
group:
The  repair  tissue  [rt]  is  fibroblastic  containing  low  concentration  of proteoglycans, 
compared to the concentration of proteoglycans in the normal articular cartilage [c]. The 
subchondral bone [b] contains no proteoglycans and stained negative. The [*] indicates 
the poly-methyl-methacrylate plug. (Safranin-0 staining, x 13.2)
Fig.VI.2
Histological appearance of the repair tissue in the poly-methyl-methacrylate group:
The  repair  tissue  [rt]  comprises  predominantly  of cells  with  fibroblastic  phenotype. 
[*=poly-methyl-methacrylate plug] (Haematoxylin/Eosin staining, x 33)
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Fig.VI.3
Histochemical appearance of the repair tissue in the polymer group:
The repair tissue [rt] contains high concentration of proteoglycans, similar to that noted 
in the normal articular cartilage [c]. The subchondral bone [b] contains no proteoglycans 
and stained negative. The — >  indicates the transition from the repair tissue to the normal 
articular cartilage [p=polymer] (SaJranin-0 staining, x 33)
Fig.VI.4
Immunohistochemical appearance of the repair tissue in the polymer group:
The repair tissue contains keratan-sulphate distributed around the chondrocytes as well 
as in the extracellular matrix. (Silver-enhanced colloidal gold immuno-staining, x 132)
175Chapter VI
Fig.VI.3
Fig.VI.4Chapter VI
DISCUSSION
The  poly-methyl-methacrylate  [PMMA]  bone  cement  has  been  widely  used  in 
orthopaedic surgery mainly to fix prosthetic implants to bone. PMMA has also been used 
as a drug carrier system, delivering a variety of agents including antibiotics (Marks et al 
1976, Elson et al 1977, Downes and Maughan, 1989) and growth hormone (Downes et al 
1990). The incorporation, however, of peptide hormones in PMMA should be viewed 
with caution, because the heat, produced in the exothermic polymerisation reaction, may 
lead to the denaturation of proteins (Downes,  1991). Recently (Corry and Moran, 1998) 
the  PMMA acrylic  bone  cement  has  also  been  assessed  as  a possible  local  delivery 
vehicle for the application of non-steroidal  anti-inflammatory drugs.  PMMA provides 
good bonding with the bone and therefore it could be successfully used to restore the 
continuity of the subchondral bone in articular cartilage defects by providing a stable 
foundation for the growth of the articular cartilage on its top. Poly-methyl-methacrylate 
has been well tolerated in a vast number of patients treated worldwide.
In this study, PMMA did not improve the quality of the repair tissue in full-thickness 
articular  cartilage  defects  at  6  weeks,  compared  to  the  ‘natural’  healing  of defects 
without implantation of a biomaterial.  It is possible that the high exothermic reaction 
released during polymerisation of the bone cement, damages the mesenchymal cells that 
potentially would migrate to the defect area and differentiate to chondrocytes. It has been 
shown  (Patel  and  Braden,  1991)  that heterocyclic  methacrylates,  like  the  poly-ethyl- 
methacrylate  [PEMA], gave lower exothermic reactions than the conventional methyl- 
methacrylate-based systems and this can probably provide an explanation as to the better 
results obtained by the PEMA/THFMA system in articular cartilage repair.
Contrary  to  the  shrinkage  of the  PMMA/MMA  system,  the  PEMA/THFMA  system 
exhibits high water uptake in vitro (Patel and Braden,  1991).  If the material maintains 
high  water  uptake  in  vivo,  it  may  absorb  tissue  fluids  and  the  dissolved  proteins, 
including growth factors from the synovial fluid, the bone matrix (Syftestad and Caplan, 
1986)  and  the  bone  marrow,  thus  creating  an  environment  which  could  encourage 
cartilage overgrowth.
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Vale et al (1997) assessed the interaction of PMMA on cultured human fibroblasts and 
found that it induced significant reduction in cell viability by liberating  free radicals. 
Also Zambonin et al (1998) studied PMMA on human osteoblast populations and found 
that  it  inhibited  cell  proliferation  and  collagen  synthesis,  whereas  it  stimulated 
osteocalcin and IL-6 production, thus encouraging osteolysis. In our study there was no 
evidence  of  osteolysis  in  the  bone  adjacent  to  PMMA,  probably  because  the 
observational period  of 6  weeks  was  too  short  for the  development of the  osteolytic 
effect.
It appears from this study that the conventional bone cement PMMA/MMA does not 
enhance articular cartilage regeneration and repair, compared to ‘natural’ healing of the 
defects  without  biomaterial.  Thus,  it  can  be  safely  concluded  that  the  significant 
enhancement  of the  repair  tissue  following  implantation  of PEMA/THFMA  in  full­
thickness articular cartilage defects is related to the properties of this biomaterial.
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CHAPTER VII
COMPARATIVE STUDY OF ARTICULAR CARTILAGE REPAIR 
USING PEMA/THFMA POLYMER 
AND PEMA/THFMA LOADED WITH GROWTH HORMONE
OBJECTIVE
MATERIALS
•  10 adult rabbits
•  PEMA vs PEMA + GROWTH HORMONE 
METHOD
•  Macroscopic, Histological/Histochemical and Immunohistochemical assessment
•  At 6 weeks
RESULTS
DISCUSSION
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OBJECTIVE
The  purpose  of this  study  is  to  investigate  the  PEMA/THFMA  polymer  as  a  drug 
delivery  system  for  articular  cartilage  repair.  Growth  hormone  has  been  selected, 
although growth factors, antibiotics, etc could also be incorporated in the biomaterial.
MATERIALS AND METHODS
Ten adult female Sandy-Lop rabbits were used.  Both knees were operated on in each 
rabbit,  the  one  knee  received  PEMA/THFMA  [PEMA  group]  and  the  other  knee 
received  PEMA/THFMA  with  Growth  Hormone  [PEMA+GH  group].  For  the 
preparation of the  GH-loaded polymer,  12IU  of lyophilized  Growth  Hormone  (Novo 
Nordisk  A/S)  was  added  to  the  PEMA  powder  and  thoroughly  mixed  prior  to  the 
addition of the monomer liquid. Further preparation of the polymer and implantation in 
the articular cartilage defects were performed as described in Chapter III.B.
The  animals  were  sacrificed  at  6  weeks  by  intravenous  injection  of Pentobarbitone 
Sodium  (Euthatal  600  mg)  and  the  specimens  underwent  Macroscopic  and 
Histological/Histochemical  Assessment  [Chapter  III.B]  using  the  Articular  Cartilage 
Repair  Scoring  System  [Chapter  III.A],  as  well  as  Immunohistochemical  Evaluation 
using the silver-enhanced colloidal gold immunostaining [Chapter III.C].
RESULTS
One  knee  (10%)  in the  polymer  group  and two  knees  (20%)  in the  growth hormone 
group showed mild inflammatory reaction of the synovium.
Neither  infection nor  foreign body reaction  was  recorded  in the  operated  knees.  The 
macroscopic  and  histological/histochemical  results  are  presented  in  Tables  VII. 1   and 
VII.2 followed by statistical analysis.
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Table VII.1:
M acroscopic and H istological/H istochem ical assessm ent per criterion 
Scoring at 6 w eeks. R abbits 151-160 
PEMA vs PEMA+GH
PEMA
Area
Level
Surface
Cells
PGs
Structure
Bonding
TOTAL
SCORE
R151  R1S2  R153  R154  R1SS  R156  R157  R158  R159  R160
20  20
10
10
20
10
10
20
100
10
10
20
10
5
10  20  20  10
10
10
20
10
5
5
10
20
10
5
10
10
10
10
10
20  10  20  20
5
5
20
5
10
20
20
10
10
20
5
10
10
95  75  90  90  75  85
20  20
10
10
20
10
10
10
10
10
5
5
10  20
90  80
10
10
5
20
10
0
0
55
PEMA+GH R151 R152 R153 R154 R155 R156 R157 R158 R159 R160
Area 20 20 20 20 20 10 20 20 10 20
Level 10 10 10 10 10 10 10 10 10 5
Surface 10 10 10 10 10 10 10 10 10 5
Cells 20 20 20 20 10 20 20 10 20 10
PGs 10 10 10 10 10 10 10 10 10 5
Structure 10 10 10 10 10 10 10 5 10 5
Bonding 20 20 20 20 20 20 10 20 10 20
TOTAL
SCORE
100 100 100 100 90 90 90 85 80 70
PEMA MEANS PEMA+GH MEANS PEMA SD PEMA+GH SD
Area 17.00 18.00 4.83 4.22
Level 9.00 9.50 2.11 1.58
Surface 9.00 9.50 2.11 1.58
Cells 18.00 17.00 4.22 4.83
PGs 8.50 9.50 2.42 1.58
Structure 7.00 9.00 3.50 2.11
Bonding 15.00 18.00 7.07 4.22
TOTAL 83.50 90.50 12.92 10.12
SCORE
100  y
90  -  
80 
70  - 
60
50  -  
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Table VII.2:
M acroscopic and H istological/H istochem ical assessm ent of repair tissue per criterion and
the overall repair at 6 w eeks
PEMA vs PEMA+GH
6  weeks
AREA
PEMA
n=10
PEMA+GH
n=10
100% resurfacing 7  (70%) 8  (80%)
>50% resurfacing 3  (30%) 2 (20%)
<50% resurfacing 0  (0%) 0  (0%)
LEVEL
Normal cartilage level 8  (80%) 9  (90%)
Minimal depression 2  (20%) 1  (10%)
C  iross depression 
SURFACE
_  __0_£)'"d_____ />  (0%)
Smooth, glistering 8  (80%) 9  (90%)
Irregular, opaque 2  (20%) 1  (10%)
Disrupted by fissures 0  (0%) 0  (0%)------
____
CELLS
Chondrocytes 8  (80%) 7  (70%)
Fibroblasts 2  (20%) 3  (30%)
Other 0  (0%) 0  (0%)
PGs
Normal 7  (70%) 9  (90%)
Moderate 3  (30%) 1   (10%)
Low 0  (0%) 0  (0%)
STRUCTURE
Hyaline-like tissue 5  (50%) 8  (80%)
Moderately disorganised 4  (40%) 2  (20%)
Grossly disorganised 1  (10%) 0  (0%)
BONDING
Complete 6  (60%) 8  (80%)
Incomplete 3  (30%) 2  (20%)
Minimal 1  (10%) 0  (0%)
ARTICULAR
CARTILAGE
REPAIR
PEMA
n=10
PEMA+GH
n=10
EXCELLENT 6  (60%) 8  (80%)
GOOD 4  (40%) 2  (20%)
POOR 0  (0%) 0  (0%)
Growth  hormone  made  the  repair  tissue  more  proliferative,  with  numerous  large 
chondrocytes  evenly distributed  throughout the  matrix  and  showing  multiple  mitoses, 
similar to those observed in young rabbits in Chapter V.Chapter VII
The arrangement of the collagen fibrils in the matrix also improved and consequently the 
structure of the repair tissue scored higher (80% hyaline-like structure) compared to 50% 
in the  unloaded PEMA group.  With regard to  the  other criteria,  however,  significant 
tissue improvement was not apparent in the growth hormone group.
Statistical analysis of macroscopic and histological/histochemical results:
All scores for the macroscopic and histological/histochemical evaluation of the PEMA vs 
PEMA+GH  repair  were  tested  using  the  Me  Nemary s  test  and  the  total  score  was 
assessed using the  Wilcoxon test. However, the number of rabbits used was  10, rather 
than  30,  so  the  statistical  power  is  decreased.  This  should  be  bom  in  mind  when 
interpreting the p-values, as an insignificant p-value can be interpreted as either there is 
no effect or that the test has insufficient power to detect an effect; there is no way to 
distinguish between these two interpretations.
S core P-value
A rea .5 6 4
L evel .5 6 4
S u rface .3 1 7
C ells .5 6 4
P G s .3 1 7
S tructure .1 8 0
B onding .5 6 4
T otal S co re .0 2 1
The overall score gives some weight to the possibility that growth hormone improves the 
characteristics of the repair tissue, although this is not significant.
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Table VII.3 demonstrates analysis of the immunolocalisation of the cartilage components 
in the repair tissue in the PEMA and the PEMA + GH groups at 6 weeks.
Table VII.3:
Immunohistochemical assessment of repair tissue at 6 weeks 
PEMA vs PEMA+GH
6  weeks
Collagen 
type II
PEMA
n=10
PEMA+GH
n=10
>50% of matrix 5  (50%) 8  (80%)
<50% of matrix 3  (30%) 2  (20%)
no detection 2  (20%) 0  (0%)
Keratan-Sulphate
>50% of matrix 7  (70%) 8  (80%)
<50% of matrix 3  (30%) 2  (20%)
no detection 0  (0%) 0  (0%)
Chondroitin 4-Sulphate
>50% of matrix 7  (70%) 6  (60%)
<50% of matrix 1   (10%) 4  (40%)
no detection 2  (20%) 0  (0%)
Chondroitin 6-Sulphate
>50% of matrix 7  (70%) 7  (70%)
<50% of matrix 2  (20%) 3  (30%)
no detection 1  (10%) 0  (0%)
Immunohistochemistry showed the presence of collagen type II in all specimens in the 
PEMA loaded with growth hormone group. In 80% of these specimens the collagen type 
II was found to be evenly distributed throughout the whole of the matrix of the repair 
tissue (compared to  50% in the unloaded PEMA group). Formation and distribution of 
glycosaminoglycans  in  the  repair  tissue,  however,  did  not  improve  further  by 
incorporating growth hormone in the polymer.
Statistical analysis of the immunohistochemical results:
The immunohistochemical results were assessed with Fisher’s exact test.
Antigen P-value
Collagen type II .628
Keratin- sulphate 1
Chondroitin 4-sulphate .164
Chondroitin 6-sulphate 1
This analysis confirms that the addition of growth hormone to PEMA/THFMA results in 
statistically not significant increase or decrease in the production of antigens in the repair 
tissue.
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Fig.VELl
Histological appearance of the repair tissue in the growth hormone group:
The  repair  tissue  [rt]  contains  numerous  cells  with  chondrocytic  phenotype,  evenly 
distributed throughout the matrix and is fully integrated with the surrounding the defect 
normal articular cartilage [c]. The — ►  indicates the transition from the repair tissue to the 
normal  articular  cartilage.  [b=subchondral  bone,  p=polymer]  (Haematoxylin/Eosin 
staining, x 13.2)
Fig.VTI.2
Histochemical appearance of the repair tissue in the growth hormone group:
The repair tissue [rt] contains high concentration of proteoglycans, similar to that in the 
normal articular cartilage [c]. The subchondral bone [b] does not contain proteoglycans 
and stained negative. The ►   indicates the transition from the repair tissue to the normal 
articular cartilage, [p=polymer] (Safranin-0 staining, x 13.2)
184Chapter VII
:? v
Fig.  VII. 1
Fig.VTI.2Chapter VII
Fig.  VII.3
Histological appearance of the repair tissue in the growth hormone group:
The  repair  tissue  contains  numerous  chondrocytes  showing  mitoses,  similar  to  those 
observed in young rabbits in the experiment in Chapter V. (Haematoxylin/Eosin staining, 
x 132)
Fig.VII.4
Immunohistochemical  appearance  of  the  repair  tissue  in  the  growth  hormone 
group:
The repair tissue contains collagen type II in large amounts in both the superficial [s] and 
the deeper layers. [m=middle layers] (Silver-enhanced colloidal gold immuno-staining, x 
66)
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Fig.VII.5
Histological appearance of the repair tissue in the polymer group:
The repair tissue [rt] is fully integrated with the surrounding the defect normal articular 
cartilage [c]. The repair tissue in the polymer group appears to be less ‘mature’ than that 
observed  in  the  growth  hormone  group.  [p=polymer,  b=subchondral  bone] 
(Haematoxylin/Eosin staining, x IS.2)
Fig.VII.6
Immunohistochemical appearance of the repair tissue in the polymer group:
The  repair tissue  contains  chondroitin  6-sulphate  throughout the  matrix,  with  higher 
concentration in the deep  [d]  layers than in the superficial  [s]  layer.  (Silver-enhanced 
colloidal gold immuno-staining, x 66)
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DISCUSSION
The PEMA/THFMA polymer system polymerises at room temperature, which makes it 
suitable for the release of water-soluble drugs / growth factors. In this study the polymer 
has been exploited as a drug delivery system for the recombinant growth hormone, to 
achieve high local  concentrations  of the hormone  at the  site  of the  articular cartilage 
defect. The human growth hormone was preferred to be used as it has been found to be 
more stable than the growth hormone of other species (Purcell et al  1989, Brems et al 
1990, Pikal and Dellerman, 1991, Pikal et al 1992).
It has been shown (Di Silvio et al  1994) that PEMA/THFMA releases growth hormone 
in  vitro.  The  release  is  rapid  during  the  first  24  hours,  followed  by  a  slower  but 
continuous  release  up  to  nine  days.  The  release  appears  to  be  dose-dependent  and 
different methods of mixing have a significant effect on the amount of growth hormone 
released; fast mixing increases the porosity of the polymer with subsequent increase in 
growth hormone release. The exact mechanism of drug release from polymers remains 
unclear;  diffusion of drugs  from the polymer matrix  appears to play a part (Graham, 
1978, Heller et al  1978, Cardinal et al  1981, Langer et al  1981) and also release of the 
drug  via pores  or  channels  (Gale  et  al  1980,  Brook  and  van Noort,  1985)  has  been 
suggested. A possible explanation of the mode of drug release from the PEMA/THFMA 
polymer (Di Silvio et al 1994) appears to be that the drug becomes ‘encapsulated’ by the 
polymer particles,  and  the  hydrophilic  nature  of this  polymer  enables  water  to  enter 
within the particles and form ‘water clusters’. This in turn results in an increase in the 
drug released out of the polymer.
Growth  hormone  acts  primarily  by  increasing  serum  IGF-1  (Sledge,  1973)  by  direct 
stimulation of the liver production (Salmon,  1957, Schimpff et al 1977, Wu et al 1974). 
Moreover, growth hormone may also exert effect on cartilage matrix (Meier and Solursh, 
1972i, Meier and Solursh, 1972ii, Meier and Solursh, 1973) and cartilage growth (Regal, 
1964, Silberberg et al 1964). It has also been suggested that high local concentrations of 
growth hormone may increase IGF-1 receptors or IGF-1 release (Nilsson et al 1986, Han 
et al 1987).
Stimulation of glycosaminoglycan production by growth hormone was a finding in this 
study,  although results did not reach statistical  significance compared to the unloaded
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PEMA group. These findings correlate also with findings by Lane Smith et al (1989). 
With regard to the keratan-sulphate in particular, the fact that the levels increase with age 
(Simunek and Muir, 1972, Bayliss and Ali, 1978, Inerot et al 1978, Roughley and White, 
1980,  Zim  et  al  1984)  and  also  with  chondrocyte  specialisation (Zanetti  et  al  1985) 
suggests that growth hormone may contribute to early maturation of chondrocytes in the 
repair tissue,  although it is  no mitogenic to  rabbit articular chondrocytes  (Jones  et al 
1986).  The  precise  mechanism  by  which  growth  hormone  initiates  IGF-1  action  is 
unclear, but it has been hypothesized that it can lead to increased local production of 
IGF-1  (Watanabe et al 1985). It can therefore be speculated that, if the PEMA/THFMA 
polymer system releases growth hormone  in vivo, the high local  concentration of the 
hormone  contributes  to  proliferation  and  maturation  of the  chondrocytes  and  further 
improvement of the structure of the repair tissue. Both these characteristics were indeed 
noted in the reparative tissue in the growth hormone group in this study.
Growth Hormone and Insulin-like Growth Factor-I [IGF-I] have been implicated in the 
modulation of osteoblast and chondrocyte function (Ernst and Froesch,  1988, Nilsson et 
al  1990ii).  IGF-I  produced  in  response  to  growth  hormone  stimulates  long  bone 
elongation by its effect on epiphyseal cartilage, and it is synthesized by a variety of cells, 
including bone and cartilage, so it may act as a local regulator of cell proliferation (Hock 
et  al  1988,  Linkhart and Keffer,  1991).  It has  also been shown that growth hormone 
enhances chondrogenesis and osteogenesis in cells in culture, with some of the effects 
being mediated by IGF-I (Scheven et al  1991) and also  in vivo when incorporated in 
implanted  biomaterials  (Downes  et  al  1991).  This  study  also  showed  significant 
proliferation  of  the  chondrocytes  in  the  growth  hormone  group  with  cell  division 
resmbling that seen in the growing immature articular cartilage.
The PEMA/THFMA polymer system exhibits high water absorption that continues for 
long time  and this property of the material  appears to be promising  in the  long term 
release of the growth hormone in vivo. Patel and Braden (1991) showed that the water 
uptake  amounted  to  34%  in  two  years  without  the  system  equilibrating.  They  also 
showed evidence of water ‘clustering’  within the polymer that can further increase the 
amount of the drug released from the polymer system. It can thus be speculated that the 
repair  tissue  in  the  growth  hormone  group,  although  it  showed  non-significant 
improvement at 6 weeks in this study, it will further improve in long term trials.
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Adult articular cartilage possesses neither blood supply nor lymphatic drainage 
and  neural  elements.  Thus,  the  tissue  remains  isolated  and,  after  they  are 
surrounded  by  their  extra-cellular  matrix,  the  articular  chondrocytes  are 
sheltered even from immunological recognition. As a result, articular cartilage 
is ineffective in responding to injury, unless the underlined subchondral bone 
is penetrated and cells  recruited  from the marrow elements  initiate  a repair 
response.  The  extent  to  which  the  newly  formed  repair  tissue  resembles 
articular cartilage depends on the age, the species of the host and the size and 
location of the defect. However, complete restoration of the hyaline articular 
cartilage and the subchondral bone to a normal status is rarely seen and, to 
date,  no  treatment  has  been  shown  to  guarantee  such  a  repair  in  articular 
cartilage defects.
Synthetic  polymer  systems  are  easy  to  hanlde,  cheap  to  produce  and, 
particularly the conventional  poly-methyl-  methacrylate  has been in clinical 
use  for many years.  The newly  developed polymer system,  based on poly- 
ethyl-methacrylate polymer  and  tetra-hydro-furfuryl  methacrylate  monomer, 
has been exploited in this study for the repair of large, full-thickness articular 
cartilage defects created in a weight-bearing surface of the knee joint in the 
rabbit  model.  The  polymer  enhanced  articular  cartilage  repair  significantly 
with 73.3% of the repairs being excellent by 6 weeks, compared to 6.6% in the 
control group where no biomaterial was used. These results are similar or even 
superior  to  those  achieved  by  other  methods  of articular  cartilage  repair 
[O’Driscoll  and  Salter,  1986,  Gorandson  et  al,  1995,  Brittberg  et  al,  1996, 
Hunziker et al,  1996,  Chew et al,  1997 and Peter et al,  1998]. Moreover, it 
appears that using the PEMA/THFMA biomaterial, there is a consistency in 
the bonding of the repair tissue to the surrounding normal articular cartilage, 
that is complete in 66.6% at 6 weeks and remains so in 46.6% at 1  year.
189The effect of age appears to be significant in this study, although PEMA was 
superior to control  groups at all ages.  Excellent overall repair was noted in 
80% of the PEMA young group, in 73.3% of PEMA adult group and in 20% of 
the PEMA old group specimens. A large number of specimens in the old group 
showed osteoarthritic  changes present in the treated joints,  which created a 
challenge in using PEMA polymer for the repair of articular cartilage defects 
in early  osteoarthritis.  This  study has  not  included  defects  created  in areas 
affected by osteoarthritis and thus we cannot extrapolate any conclusions on 
the success of the method in treating osteoarthritic defects.
The  PEMA  polymer  appears  to  be  significantly  more  effective  than  the 
conventional bone cement [poly-methyl-methacrylate polymer system] in the 
repair of articular cartilage defects in the rabbit model. The high exothermic 
reaction produced during polymerisation of the conventional bone cement and 
its  limited  ability  to  attract  water  may  have  an  adverse  effect  on  articular 
cartilage repair. Furthermore, incorporation of growth hormone in the PEMA 
polymer system showed no significant improvement in the quality of the repair 
tissue at 6 weeks. The result can be associated with inadequate quantity of the 
growth hormone, loaded in the polymer system, or instead, can be due to the 
limited period of observation.  Long-term studies of articular cartilage repair 
with PEMA loaded with variable doses of growth hormone will clarify whether 
the repair tissue is dose- or indeed time-dependent.
In-vitro analysis of the behavior of PEMA polymer system has been limited in 
this study simply due to a concurrent in vitro evaluation of the polymer from 
other co-workers  in our Institute.  Sawtell  et al  [1995], performed  extensive 
studies confirming that the PEMA system can support chondrocytes in vitro 
allowing  cells  to  remain  rounded,  which  is  important  in  order  to  maintain 
chondrocyte phenotype [Watt and Dudhia, 1988].
190It is  advisable that further studies are performed in the future to clarify the 
origin of the cells when the PEMA polymer is used for the repair of articular 
cartilage defects. Although it is possible that the origin of the cells is the same 
as in the control  group, most probably originating from the undifferentiated 
cells [Shapiro et al, 1993], it appears that the PEMA polymer provides a micro­
environment suitable for the differentiation of those cells to chondrocytes at 
the early stages of repair. Moreover, there are good reasons for studying joint 
development in relation to  degenerative  diseases  and repair of the  articular 
cartilage,  since  a  feature  of these  diseases  and  the  repair  response  can  be 
manifested in renewed cell division and upregulated matrix synthesis, which 
resemble aspects of development [Archer et al, 1994]. The PEMA system can 
be  used  loaded  with  bone-morphogenetic  proteins  and  growth  and 
differentiation factors that have been found to play a fundamental role during 
skeletogenesis and repair [Francis et al, 1999].
It  appears  that  the  centuries-old  supposition  that  the  articular  cartilage  is 
incapable of healing has been reconsidered and over the last ten to fifteen years 
many  methods  have  shown  satisfactory  results  in  repairing  full-thickness 
defects in weight-bearing surfaces. Better understanding of morphogenesis will 
enable the future generation of researchers to reproduce fetal developmental 
signals for the prevention of genetic disorders affecting the articular cartilage, 
while local gene supplementation and transfer will improve the management of 
injuries, particularly when used as vehicles in the targeted delivery of growth 
factors.
191GENERAL COMMENTS
CONCLUSIONS
•  PEMA/THFMA  is  a  biocompatible  material  that  does  not  induce  foreign  body 
reaction when used intra-articularly.
•  PEMA/THFMA can enhance repair in large, full-thickness articular cartilage defects 
in  a  weight-bearing  area  in  the  knee  joint  of  the  rabbit.  Up  to  1   year  post­
implantation the quality of the repair tissue is superior to that of the control defects 
that healed ‘naturally’ without treatment.
•  PEMA/THFMA can be effective in young, adult and old rabbits. Up to 6 weeks post­
implantation the quality of the repair tissue in articular cartilage defects is superior in 
the polymer group compared to the control group in all age groups.
•  PEMA/THFMA can enhance articular cartilage repair in the presence of advanced 
osteoarthritic changes in the same joint.
•  PEMA/THFMA  can  be  used  as  a  drug  delivery  system  in  vivo.  The  use  of 
recombinant growth hormone incorporated in the polymer, however, did not improve 
significantly the quality of the repair tissue in articular cartilage defects, compared to 
the unloaded PEMA/THFMA up to 6 weeks post-implantation.
192•  The properties of the PEMA/THFMA system are of paramount importance, although 
the implantation technique, where the polymer is recessed into the subchondral bone, 
may also play an important role in the repair of articular cartilage defects.
•  The method of implantation of PEMA/THFMA in articular cartilage defects that was 
applied in our studies is simple and easily reproducible. It does not require in vitro 
culture of cells and in clinical practice it can be performed in one stage by open or 
arthroscopic procedure.
•  The  Articular  Cartilage  Repair  Scoring  System  that  was  developed  for  the 
macroscopic and histological/histochemical assessment of the repair tissue, helps in 
the  comparative  analysis  between  different  treatments  and  in  the  evaluation  and 
monitoring of the repair tissue in experimental studies and in clinical applications.
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